(23486, 'HP:0002916', 'Abnormality of chromosome segregation', 'XPO:0127631', 'abnormally localised centriole', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(23487, 'HP:0002916', 'Abnormality of chromosome segregation', 'XPO:0135131', 'increased cell population proliferation in hindlimb region', 0.40540540540540543, 5.835653092541957, 1.5381174557839463, 'HP:0011017', 'Abnormal cellular physiology'),
(23488, 'HP:0002916', 'Abnormality of chromosome segregation', 'XPO:0127428', 'abnormally localised endoplasmic reticulum', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(23489, 'HP:0002916', 'Abnormality of chromosome segregation', 'XPO:0135735', 'increased cell population proliferation in process', 0.4166666666666667, 5.835653092541957, 1.5593338712067029, 'HP:0011017', 'Abnormal cellular physiology'),
(23490, 'HP:0002916', 'Abnormality of chromosome segregation', 'XPO:0100231', 'abnormal compound organ', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(23491, 'HP:0002916', 'Abnormality of chromosome segregation', 'XPO:0130989', 'abnormally increased number of ciliated cell', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(23492, 'HP:0002916', 'Abnormality of chromosome segregation', 'XPO:0101136', 'abnormal ooplasm', 0.5416666666666666, 3.6715585125471644, 1.4102343283876786, 'UPHENO:0086172', 'abnormal cell'),
(23493, 'HP:0002916', 'Abnormality of chromosome segregation', 'XPO:0101264', 'abnormal mitotic spindle', 0.5909090909090909, 3.6715585125471644, 1.4729417174039097, 'UPHENO:0086172', 'abnormal cell'),
(23494, 'HP:0002916', 'Abnormality of chromosome segregation', 'XPO:0131297', 'abnormally decreased number of melanoblast', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(23495, 'HP:0002916', 'Abnormality of chromosome segregation', 'XPO:0126548', 'abnormally localised centrosome', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(23496, 'HP:0002916', 'Abnormality of chromosome segregation', 'XPO:0131328', 'abnormally decreased number of paracrine cell', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(23497, 'HP:0002916', 'Abnormality of chromosome segregation', 'XPO:0102024', 'abnormal cilium morphology', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(23498, 'HP:0002916', 'Abnormality of chromosome segregation', 'XPO:0125053', 'absent zygote', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(23499, 'HP:0002916', 'Abnormality of chromosome segregation', 'XPO:0127819', 'abnormally localised ciliary axoneme', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(23500, 'HP:0002916', 'Abnormality of chromosome segregation', 'XPO:0107273', 'abnormal basal region', 0.42857142857142855, 1.706362323152461, 0.8551597151958877, 'UPHENO:0002536', 'abnormal anatomical entity'),
(23501, 'HP:0002916', 'Abnormality of chromosome segregation', 'XPO:0100265', 'abnormal sensory epithelial cell', 0.52, 3.6715585125471644, 1.3817418089225373, 'UPHENO:0086172', 'abnormal cell'),
(23502, 'HP:0002916', 'Abnormality of chromosome segregation', 'XPO:0100070', 'abnormal anatomical system', 0.42857142857142855, 1.706362323152461, 0.8551597151958877, 'UPHENO:0002536', 'abnormal anatomical entity'),
(23503, 'HP:0002916', 'Abnormality of chromosome segregation', 'XPO:0131551', 'abnormally localised actin cytoskeleton', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(23504, 'HP:0002916', 'Abnormality of chromosome segregation', 'XPO:0101498', 'abnormal stage II oocyte', 0.5652173913043478, 3.6715585125471644, 1.440565418328227, 'UPHENO:0086172', 'abnormal cell'),
(23505, 'HP:0002916', 'Abnormality of chromosome segregation', 'XPO:0107259', 'abnormal animal-vegetal axis', 0.45, 1.706362323152461, 0.8762779498644294, 'UPHENO:0002536', 'abnormal anatomical entity'),
(23506, 'HP:0002916', 'Abnormality of chromosome segregation', 'XPO:0125160', 'absent exocrine cell', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(23507, 'HP:0002916', 'Abnormality of chromosome segregation', 'XPO:0100317', 'abnormal respiratory system', 0.4583333333333333, 1.8210412618256888, 0.9135884804823818, 'HP:0000118', 'Phenotypic abnormality'),
(23508, 'HP:0002916', 'Abnormality of chromosome segregation', 'XPO:0100503', 'abnormal blastomere D2', 0.5416666666666666, 3.6715585125471644, 1.4102343283876786, 'UPHENO:0086172', 'abnormal cell'),
(23509, 'HP:0002916', 'Abnormality of chromosome segregation', 'XPO:0101283', 'abnormal left-ventral blastomere', 0.5416666666666666, 3.6715585125471644, 1.4102343283876786, 'UPHENO:0086172', 'abnormal cell'),
(23510, 'HP:0002916', 'Abnormality of chromosome segregation', 'XPO:0126671', 'abnormally localised zygote', 0.4482758620689655, 3.6715585125471644, 1.2829150624062098, 'UPHENO:0086172', 'abnormal cell'),
(23511, 'HP:0002916', 'Abnormality of chromosome segregation', 'XPO:0131032', 'abnormally increased number of acid secreting cell', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(23512, 'HP:0002916', 'Abnormality of chromosome segregation', 'XPO:0100675', 'abnormal dorsal vegetal hemisphere blastomere', 0.4642857142857143, 3.6715585125471644, 1.305623286610558, 'UPHENO:0086172', 'abnormal cell'),
(23513, 'HP:0002916', 'Abnormality of chromosome segregation', 'XPO:0102704', 'abnormal mitochondrial cloud morphology', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(23514, 'HP:0002916', 'Abnormality of chromosome segregation', 'XPO:0100363', 'abnormal cardiovascular system', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(23515, 'HP:0002916', 'Abnormality of chromosome segregation', 'XPO:0100546', 'abnormal whole organism', 0.47368421052631576, 1.706362323152461, 0.8990422069704646, 'UPHENO:0002536', 'abnormal anatomical entity'),
(23516, 'HP:0002916', 'Abnormality of chromosome segregation', 'XPO:0101570', 'abnormal forelimb region', 0.42857142857142855, 1.706362323152461, 0.8551597151958877, 'UPHENO:0002536', 'abnormal anatomical entity'),
(23517, 'HP:0002916', 'Abnormality of chromosome segregation', 'XPO:0141715', 'abnormal septum', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(23518, 'HP:0002916', 'Abnormality of chromosome segregation', 'XPO:0101278', 'abnormal pigment cell', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(23519, 'HP:0002916', 'Abnormality of chromosome segregation', 'XPO:0138578', 'decreased cell population proliferation in anatomical system', 0.40540540540540543, 5.835653092541957, 1.5381174557839463, 'HP:0011017', 'Abnormal cellular physiology'),
(23520, 'HP:0002916', 'Abnormality of chromosome segregation', 'XPO:0100702', 'abnormal glial cell', 0.5, 3.6715585125471644, 1.3549093166236559, 'UPHENO:0086172', 'abnormal cell'),
(23521, 'HP:0002916', 'Abnormality of chromosome segregation', 'XPO:0135322', 'increased cell population proliferation in marginal zone (sensu neural)', 0.40540540540540543, 5.835653092541957, 1.5381174557839463, 'HP:0011017', 'Abnormal cellular physiology'),
(23522, 'HP:0002916', 'Abnormality of chromosome segregation', 'XPO:0125833', 'absent kinetochore', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(23523, 'HP:0002916', 'Abnormality of chromosome segregation', 'XPO:0131066', 'abnormally increased number of myoblast', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(23524, 'HP:0002916', 'Abnormality of chromosome segregation', 'XPO:0102703', 'abnormal endoplasmic reticulum morphology', 0.4482758620689655, 3.6715585125471644, 1.2829150624062098, 'UPHENO:0086172', 'abnormal cell'),
(23525, 'HP:0002916', 'Abnormality of chromosome segregation', 'XPO:0100786', 'abnormal presumptive axial mesoderm', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(23526, 'HP:0002916', 'Abnormality of chromosome segregation', 'XPO:0100335', 'abnormal commissural interneuron', 0.4482758620689655, 3.6715585125471644, 1.2829150624062098, 'UPHENO:0086172', 'abnormal cell'),
(23527, 'HP:0002916', 'Abnormality of chromosome segregation', 'XPO:0107270', 'abnormal proximal-distal axis', 0.45, 1.706362323152461, 0.8762779498644294, 'UPHENO:0002536', 'abnormal anatomical entity'),
(23528, 'HP:0002916', 'Abnormality of chromosome segregation', 'XPO:0131195', 'abnormally decreased number of Merkel cell', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(23529, 'HP:0002916', 'Abnormality of chromosome segregation', 'XPO:0131351', 'abnormally decreased number of apoptotic cell', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(23530, 'HP:0002916', 'Abnormality of chromosome segregation', 'XPO:0103642', 'increased cell population proliferation', 0.5172413793103449, 5.835653092541957, 1.7373661832679608, 'HP:0011017', 'Abnormal cellular physiology'),
(23531, 'HP:0002916', 'Abnormality of chromosome segregation', 'XPO:0100531', 'abnormal proliferative region', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(23532, 'HP:0002916', 'Abnormality of chromosome segregation', 'XPO:0142030', 'abnormally localised desmosome', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(23533, 'HP:0002916', 'Abnormality of chromosome segregation', 'XPO:0126697', 'abnormally localised proepicardium', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(23534, 'HP:0002916', 'Abnormality of chromosome segregation', 'XPO:0136515', 'increased cell population proliferation in apical region', 0.40540540540540543, 5.835653092541957, 1.5381174557839463, 'HP:0011017', 'Abnormal cellular physiology'),
(23535, 'HP:0002916', 'Abnormality of chromosome segregation', 'XPO:0101327', 'abnormal blastomere V1.2.1', 0.4482758620689655, 3.6715585125471644, 1.2829150624062098, 'UPHENO:0086172', 'abnormal cell'),
(23536, 'HP:0002916', 'Abnormality of chromosome segregation', 'XPO:0139617', 'decreased cell population proliferation in apical region', 0.40540540540540543, 5.835653092541957, 1.5381174557839463, 'HP:0011017', 'Abnormal cellular physiology'),
(23537, 'HP:0002916', 'Abnormality of chromosome segregation', 'XPO:0102109', 'abnormal pericyte morphology', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(23538, 'HP:0002916', 'Abnormality of chromosome segregation', 'XPO:0100724', 'abnormal kinetochore', 0.5909090909090909, 3.6715585125471644, 1.4729417174039097, 'UPHENO:0086172', 'abnormal cell'),
(23539, 'HP:0002916', 'Abnormality of chromosome segregation', 'XPO:0100570', 'abnormal axon', 0.4482758620689655, 3.6715585125471644, 1.2829150624062098, 'UPHENO:0086172', 'abnormal cell'),
(23540, 'HP:0002916', 'Abnormality of chromosome segregation', 'XPO:0131131', 'abnormally increased number of absorptive cell', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(23541, 'HP:0002916', 'Abnormality of chromosome segregation', 'XPO:0126318', 'abnormally localised cell', 0.48148148148148145, 3.6715585125471644, 1.3295816755533123, 'UPHENO:0086172', 'abnormal cell'),
(23542, 'HP:0002916', 'Abnormality of chromosome segregation', 'XPO:0141314', 'abnormal Roux spot morphology', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(23543, 'HP:0002916', 'Abnormality of chromosome segregation', 'XPO:0100676', 'abnormal blastomere D2.2', 0.4482758620689655, 3.6715585125471644, 1.2829150624062098, 'UPHENO:0086172', 'abnormal cell'),
(23544, 'HP:0002916', 'Abnormality of chromosome segregation', 'XPO:0100649', 'abnormal growth cone', 0.4482758620689655, 3.6715585125471644, 1.2829150624062098, 'UPHENO:0086172', 'abnormal cell'),
(23545, 'HP:0002916', 'Abnormality of chromosome segregation', 'XPO:0141271', 'increased surface breathing', 0.42105263157894735, 1.4755025719078136, 0.7882031722869998, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(23546, 'HP:0002916', 'Abnormality of chromosome segregation', 'XPO:0130986', 'abnormally increased number of germ cell', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(23547, 'HP:0002916', 'Abnormality of chromosome segregation', 'XPO:0101494', 'abnormal blastomere D1.2.1', 0.4482758620689655, 3.6715585125471644, 1.2829150624062098, 'UPHENO:0086172', 'abnormal cell'),
(23548, 'HP:0002916', 'Abnormality of chromosome segregation', 'XPO:0102336', 'abnormal Merkel cell morphology', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(23549, 'HP:0002916', 'Abnormality of chromosome segregation', 'XPO:0100002', 'abnormal head', 0.4074074074074074, 1.8210412618256888, 0.861339479684008, 'HP:0000118', 'Phenotypic abnormality'),
(23550, 'HP:0002916', 'Abnormality of chromosome segregation', 'XPO:0138837', 'decreased cell population proliferation in process', 0.4166666666666667, 5.835653092541957, 1.5593338712067029, 'HP:0011017', 'Abnormal cellular physiology'),
(23551, 'HP:0002916', 'Abnormality of chromosome segregation', 'XPO:0101221', 'abnormal larval immune system', 0.44, 1.8210412618256888, 0.8951302448265857, 'HP:0000118', 'Phenotypic abnormality'),
(23552, 'HP:0002916', 'Abnormality of chromosome segregation', 'XPO:0141786', 'abnormal pigment metabolic process', 0.4782608695652174, 4.758907843651163, 1.508641575552437, 'HP:0001939', 'Abnormality of metabolism/homeostasis'),
(23553, 'HP:0002916', 'Abnormality of chromosome segregation', 'XPO:0101481', 'abnormal skeletal muscle satellite cell', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(23554, 'HP:0002916', 'Abnormality of chromosome segregation', 'XPO:0131061', 'abnormally increased number of keratin accumulating cell', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(23555, 'HP:0002916', 'Abnormality of chromosome segregation', 'XPO:0101113', 'abnormal stage IV oocyte', 0.5652173913043478, 3.6715585125471644, 1.440565418328227, 'UPHENO:0086172', 'abnormal cell'),
(23556, 'HP:0002916', 'Abnormality of chromosome segregation', 'XPO:0100417', 'abnormal dense regular connective tissue', 0.4230769230769231, 1.8210412618256888, 0.8777474203034321, 'HP:0000118', 'Phenotypic abnormality'),
(23557, 'HP:0002916', 'Abnormality of chromosome segregation', 'XPO:0139618', 'decreased cell population proliferation in axial region', 0.40540540540540543, 5.835653092541957, 1.5381174557839463, 'HP:0011017', 'Abnormal cellular physiology'),
(23558, 'HP:0002916', 'Abnormality of chromosome segregation', 'XPO:0125454', 'absent myoblast', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(23559, 'HP:0002916', 'Abnormality of chromosome segregation', 'XPO:0100653', 'abnormal myoblast', 0.6190476190476191, 3.6715585125471644, 1.5076039119696991, 'UPHENO:0086172', 'abnormal cell'),
(23560, 'HP:0002916', 'Abnormality of chromosome segregation', 'XPO:0127513', 'abnormally localised nucleate erythrocyte', 0.4482758620689655, 3.6715585125471644, 1.2829150624062098, 'UPHENO:0086172', 'abnormal cell'),
(23561, 'HP:0002916', 'Abnormality of chromosome segregation', 'XPO:0101074', 'abnormal germinal vesicle', 0.52, 3.6715585125471644, 1.3817418089225373, 'UPHENO:0086172', 'abnormal cell'),
(23562, 'HP:0002916', 'Abnormality of chromosome segregation', 'XPO:0101409', 'abnormal perivitelline space', 0.5652173913043478, 3.6715585125471644, 1.440565418328227, 'UPHENO:0086172', 'abnormal cell'),
(23563, 'HP:0002916', 'Abnormality of chromosome segregation', 'XPO:0126133', 'absent mitotic cell', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(23564, 'HP:0002916', 'Abnormality of chromosome segregation', 'XPO:0127339', 'abnormally localised migrating myoblast', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(23565, 'HP:0002916', 'Abnormality of chromosome segregation', 'XPO:0141299', 'abnormal actin filament morphology', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(23566, 'HP:0002916', 'Abnormality of chromosome segregation', 'XPO:0101448', 'abnormal myelin accumulating cell', 0.6190476190476191, 3.6715585125471644, 1.5076039119696991, 'UPHENO:0086172', 'abnormal cell'),
(23567, 'HP:0002916', 'Abnormality of chromosome segregation', 'XPO:0101497', 'abnormal ciliary axoneme', 0.5416666666666666, 3.6715585125471644, 1.4102343283876786, 'UPHENO:0086172', 'abnormal cell'),
(23568, 'HP:0002916', 'Abnormality of chromosome segregation', 'XPO:0125824', 'absent nucleus', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(23569, 'HP:0002916', 'Abnormality of chromosome segregation', 'XPO:0107284', 'abnormal migrating myoblast', 0.5909090909090909, 3.6715585125471644, 1.4729417174039097, 'UPHENO:0086172', 'abnormal cell'),
(23570, 'HP:0002916', 'Abnormality of chromosome segregation', 'XPO:0100081', 'abnormal anatomical entity in vitro', 0.5, 1.706362323152461, 0.9236780616514774, 'UPHENO:0002536', 'abnormal anatomical entity'),
(23571, 'HP:0002916', 'Abnormality of chromosome segregation', 'XPO:0100120', 'abnormal genital system', 0.4074074074074074, 1.8210412618256888, 0.861339479684008, 'HP:0000118', 'Phenotypic abnormality'),
(23572, 'HP:0002916', 'Abnormality of chromosome segregation', 'XPO:0141738', 'abnormal carbon dioxide homeostasis', 0.4444444444444444, 1.4755025719078136, 0.8098017787384251, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(23573, 'HP:0002916', 'Abnormality of chromosome segregation', 'XPO:0130973', 'abnormally increased number of stem cell', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(23574, 'HP:0002916', 'Abnormality of chromosome segregation', 'XPO:0100151', 'abnormal primordium', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(23575, 'HP:0002916', 'Abnormality of chromosome segregation', 'XPO:0100976', 'abnormal multiciliated cell', 0.5909090909090909, 3.6715585125471644, 1.4729417174039097, 'UPHENO:0086172', 'abnormal cell'),
(23576, 'HP:0002916', 'Abnormality of chromosome segregation', 'XPO:0133441', 'abnormally increased number of cilium in the ciliated cell', 0.4482758620689655, 3.6715585125471644, 1.2829150624062098, 'UPHENO:0086172', 'abnormal cell'),
(23577, 'HP:0002916', 'Abnormality of chromosome segregation', 'XPO:0100004', 'abnormal cell', 0.65, 3.6715585125471644, 1.5448343060521594, 'UPHENO:0086172', 'abnormal cell'),
(23578, 'HP:0002916', 'Abnormality of chromosome segregation', 'XPO:0102258', 'abnormal primordial germ cell morphology', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(23579, 'HP:0002916', 'Abnormality of chromosome segregation', 'XPO:0131308', 'abnormally decreased number of oxygen accumulating cell', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(23580, 'HP:0002916', 'Abnormality of chromosome segregation', 'XPO:0101461', 'abnormal sperm entry point', 0.5652173913043478, 3.6715585125471644, 1.440565418328227, 'UPHENO:0086172', 'abnormal cell'),
(23581, 'HP:0002916', 'Abnormality of chromosome segregation', 'XPO:0141775', 'abnormal nitrogen compound metabolic process', 0.4782608695652174, 4.758907843651163, 1.508641575552437, 'HP:0001939', 'Abnormality of metabolism/homeostasis'),
(23582, 'HP:0002916', 'Abnormality of chromosome segregation', 'XPO:0100277', 'abnormal blastocoel', 0.42857142857142855, 1.706362323152461, 0.8551597151958877, 'UPHENO:0002536', 'abnormal anatomical entity'),
(23583, 'HP:0002916', 'Abnormality of chromosome segregation', 'XPO:0100638', 'abnormal polar body', 0.6190476190476191, 3.6715585125471644, 1.5076039119696991, 'UPHENO:0086172', 'abnormal cell'),
(23584, 'HP:0002916', 'Abnormality of chromosome segregation', 'XPO:0100135', 'abnormal surface structure', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(23585, 'HP:0002916', 'Abnormality of chromosome segregation', 'XPO:0100989', 'abnormal right blastomere', 0.5416666666666666, 3.6715585125471644, 1.4102343283876786, 'UPHENO:0086172', 'abnormal cell'),
(23586, 'HP:0002916', 'Abnormality of chromosome segregation', 'XPO:0101513', 'abnormal basal body', 0.5909090909090909, 3.6715585125471644, 1.4729417174039097, 'UPHENO:0086172', 'abnormal cell'),
(23587, 'HP:0002916', 'Abnormality of chromosome segregation', 'XPO:0102520', 'abnormal microtubule morphology', 0.4482758620689655, 3.6715585125471644, 1.2829150624062098, 'UPHENO:0086172', 'abnormal cell'),
(23588, 'HP:0002916', 'Abnormality of chromosome segregation', 'XPO:0131725', 'abnormal phosphorylation of RNA polymerase II C-terminal domain', 0.4444444444444444, 1.4755025719078136, 0.8098017787384251, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(23589, 'HP:0002916', 'Abnormality of chromosome segregation', 'XPO:0100386', 'abnormal limb', 0.44, 1.8210412618256888, 0.8951302448265857, 'HP:0000118', 'Phenotypic abnormality'),
(23590, 'HP:0002916', 'Abnormality of chromosome segregation', 'XPO:0141778', 'abnormal biosynthetic process', 0.4782608695652174, 4.758907843651163, 1.508641575552437, 'HP:0001939', 'Abnormality of metabolism/homeostasis'),
(23591, 'HP:0002916', 'Abnormality of chromosome segregation', 'XPO:0100999', 'abnormal serous membrane', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(23592, 'HP:0002916', 'Abnormality of chromosome segregation', 'XPO:0107288', 'abnormal larval alimentary system', 0.4074074074074074, 1.8210412618256888, 0.861339479684008, 'HP:0000118', 'Phenotypic abnormality'),
(23593, 'HP:0002916', 'Abnormality of chromosome segregation', 'XPO:0131666', 'abnormal adherens junction', 0.5909090909090909, 3.6715585125471644, 1.4729417174039097, 'UPHENO:0086172', 'abnormal cell'),
(23594, 'HP:0002916', 'Abnormality of chromosome segregation', 'XPO:0102934', 'abnormal subcortical cytoplasm morphology', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(23595, 'HP:0002916', 'Abnormality of chromosome segregation', 'XPO:0101016', 'abnormal egg', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(23596, 'HP:0002916', 'Abnormality of chromosome segregation', 'XPO:0142067', 'abnormally necrotic desmosome', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(23597, 'HP:0002916', 'Abnormality of chromosome segregation', 'XPO:0125115', 'absent paracrine cell', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(23598, 'HP:0002916', 'Abnormality of chromosome segregation', 'XPO:0131720', 'abnormal mitotic spindle assembly', 0.5, 10.281312506061912, 2.2673015355331447, 'HP:0002916', 'Abnormality of chromosome segregation'),
(23599, 'HP:0002916', 'Abnormality of chromosome segregation', 'XPO:0126472', 'abnormally localised secondary spermatogonium', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(23600, 'HP:0002916', 'Abnormality of chromosome segregation', 'XPO:0125976', 'absent centriole', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(23601, 'HP:0002916', 'Abnormality of chromosome segregation', 'XPO:0130988', 'abnormally increased number of pericyte', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(23602, 'HP:0002916', 'Abnormality of chromosome segregation', 'XPO:0131559', 'abnormally localised spindle microtubule', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(23603, 'HP:0002916', 'Abnormality of chromosome segregation', 'XPO:0101405', 'abnormal ring structure', 0.5416666666666666, 3.6715585125471644, 1.4102343283876786, 'UPHENO:0086172', 'abnormal cell'),
(23604, 'HP:0002916', 'Abnormality of chromosome segregation', 'XPO:0141907', 'abnormal putrescine metabolic process', 0.44, 4.758907843651163, 1.447038165082909, 'HP:0001939', 'Abnormality of metabolism/homeostasis'),
(23605, 'HP:0002916', 'Abnormality of chromosome segregation', 'XPO:0127815', 'abnormally localised ciliated non-epidermal cell', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(23606, 'HP:0002916', 'Abnormality of chromosome segregation', 'XPO:0101141', 'abnormal Keller explant', 0.47368421052631576, 1.706362323152461, 0.8990422069704646, 'UPHENO:0002536', 'abnormal anatomical entity'),
(23607, 'HP:0002916', 'Abnormality of chromosome segregation', 'XPO:0141783', 'abnormal collagen metabolic process', 0.4782608695652174, 4.758907843651163, 1.508641575552437, 'HP:0001939', 'Abnormality of metabolism/homeostasis'),
(23608, 'HP:0002916', 'Abnormality of chromosome segregation', 'XPO:0136025', 'increased cell population proliferation in joint region', 0.40540540540540543, 5.835653092541957, 1.5381174557839463, 'HP:0011017', 'Abnormal cellular physiology'),
(23609, 'HP:0002916', 'Abnormality of chromosome segregation', 'XPO:0126159', 'absent apoptotic cell', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(23610, 'HP:0002916', 'Abnormality of chromosome segregation', 'XPO:0100907', 'abnormal cytoplasm', 0.5909090909090909, 3.6715585125471644, 1.4729417174039097, 'UPHENO:0086172', 'abnormal cell'),
(23611, 'HP:0002916', 'Abnormality of chromosome segregation', 'XPO:0115615', 'abnormally posteriorly mislocalised primordial germ cell', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(23612, 'HP:0002916', 'Abnormality of chromosome segregation', 'XPO:0141892', 'abnormal inositol metabolic process', 0.44, 4.758907843651163, 1.447038165082909, 'HP:0001939', 'Abnormality of metabolism/homeostasis'),
(23613, 'HP:0002916', 'Abnormality of chromosome segregation', 'XPO:0135477', 'increased cell population proliferation in whole organism', 0.42857142857142855, 5.835653092541957, 1.5814531869511603, 'HP:0011017', 'Abnormal cellular physiology'),
(23614, 'HP:0002916', 'Abnormality of chromosome segregation', 'XPO:0101575', 'abnormal vitelline membrane', 0.5416666666666666, 3.6715585125471644, 1.4102343283876786, 'UPHENO:0086172', 'abnormal cell'),
(23615, 'HP:0002916', 'Abnormality of chromosome segregation', 'XPO:0126983', 'abnormally localised primordial germ cell', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(23616, 'HP:0002916', 'Abnormality of chromosome segregation', 'XPO:0100784', 'abnormal left blastomere', 0.5416666666666666, 3.6715585125471644, 1.4102343283876786, 'UPHENO:0086172', 'abnormal cell'),
(23617, 'HP:0002916', 'Abnormality of chromosome segregation', 'XPO:0101466', 'abnormal secondary myofiber', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(23618, 'HP:0002916', 'Abnormality of chromosome segregation', 'XPO:0100762', 'abnormal intersomitic region', 0.42857142857142855, 1.706362323152461, 0.8551597151958877, 'UPHENO:0002536', 'abnormal anatomical entity'),
(23619, 'HP:0002916', 'Abnormality of chromosome segregation', 'XPO:0101241', 'abnormal nucleate erythrocyte', 0.6190476190476191, 3.6715585125471644, 1.5076039119696991, 'UPHENO:0086172', 'abnormal cell'),
(23620, 'HP:0002916', 'Abnormality of chromosome segregation', 'XPO:0101133', 'abnormal motor neuron', 0.48148148148148145, 3.6715585125471644, 1.3295816755533123, 'UPHENO:0086172', 'abnormal cell'),
(23621, 'HP:0002916', 'Abnormality of chromosome segregation', 'XPO:0100665', 'abnormal egg jelly', 0.42857142857142855, 1.706362323152461, 0.8551597151958877, 'UPHENO:0002536', 'abnormal anatomical entity'),
(23622, 'HP:0002916', 'Abnormality of chromosome segregation', 'XPO:0131110', 'abnormally increased number of paracrine cell', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(23623, 'HP:0002916', 'Abnormality of chromosome segregation', 'XPO:0141772', 'abnormal water homeostasis', 0.4444444444444444, 1.4755025719078136, 0.8098017787384251, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(23624, 'HP:0002916', 'Abnormality of chromosome segregation', 'XPO:0100640', 'abnormal notochordal sheath', 0.4074074074074074, 1.8210412618256888, 0.861339479684008, 'HP:0000118', 'Phenotypic abnormality'),
(23625, 'HP:0002916', 'Abnormality of chromosome segregation', 'XPO:0131136', 'abnormally increased number of multiciliated cell precursor', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(23626, 'HP:0002916', 'Abnormality of chromosome segregation', 'XPO:0126388', 'abnormally localised oocyte', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(23627, 'HP:0002916', 'Abnormality of chromosome segregation', 'XPO:0100458', 'abnormal autopod', 0.4074074074074074, 1.8210412618256888, 0.861339479684008, 'HP:0000118', 'Phenotypic abnormality'),
(23628, 'HP:0002916', 'Abnormality of chromosome segregation', 'XPO:0102764', 'abnormal apoptotic cell morphology', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(23629, 'HP:0002916', 'Abnormality of chromosome segregation', 'XPO:0100006', 'abnormal anatomical structure', 0.5, 1.706362323152461, 0.9236780616514774, 'UPHENO:0002536', 'abnormal anatomical entity'),
(23630, 'HP:0002916', 'Abnormality of chromosome segregation', 'XPO:0127343', 'abnormally localised filopodium', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(23631, 'HP:0002916', 'Abnormality of chromosome segregation', 'XPO:0100573', 'abnormal extraembryonic structure', 0.45, 1.706362323152461, 0.8762779498644294, 'UPHENO:0002536', 'abnormal anatomical entity'),
(23632, 'HP:0002916', 'Abnormality of chromosome segregation', 'XPO:0100192', 'abnormal epithelium', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(23633, 'HP:0002916', 'Abnormality of chromosome segregation', 'XPO:0141745', 'abnormal creatinine homeostasis', 0.4444444444444444, 1.4755025719078136, 0.8098017787384251, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(23634, 'HP:0002916', 'Abnormality of chromosome segregation', 'XPO:0141770', 'abnormal urate homeostasis', 0.4444444444444444, 1.4755025719078136, 0.8098017787384251, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(23635, 'HP:0002916', 'Abnormality of chromosome segregation', 'XPO:0100268', 'abnormal circulatory system', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(23636, 'HP:0002916', 'Abnormality of chromosome segregation', 'XPO:0102165', 'abnormal melanoblast morphology', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(23637, 'HP:0002916', 'Abnormality of chromosome segregation', 'XPO:0131512', 'absent adherens junction', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(23638, 'HP:0002916', 'Abnormality of chromosome segregation', 'XPO:0101940', 'abnormal early embryonic cell morphology', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(23639, 'HP:0002916', 'Abnormality of chromosome segregation', 'XPO:0101406', 'abnormal cleavage furrow', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(23640, 'HP:0002916', 'Abnormality of chromosome segregation', 'XPO:0131531', 'absent cortical actin cytoskeleton', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(23641, 'HP:0002916', 'Abnormality of chromosome segregation', 'XPO:0139620', 'decreased cell population proliferation in anterior region', 0.40540540540540543, 5.835653092541957, 1.5381174557839463, 'HP:0011017', 'Abnormal cellular physiology'),
(23642, 'HP:0002916', 'Abnormality of chromosome segregation', 'XPO:0101174', 'abnormal articular system', 0.4074074074074074, 1.8210412618256888, 0.861339479684008, 'HP:0000118', 'Phenotypic abnormality'),
(23643, 'HP:0002916', 'Abnormality of chromosome segregation', 'XPO:0101472', 'abnormal zygote cortex', 0.5652173913043478, 3.6715585125471644, 1.440565418328227, 'UPHENO:0086172', 'abnormal cell'),
(23644, 'HP:0002916', 'Abnormality of chromosome segregation', 'XPO:0126473', 'abnormally localised germ cell', 0.4482758620689655, 3.6715585125471644, 1.2829150624062098, 'UPHENO:0086172', 'abnormal cell'),
(23645, 'HP:0002916', 'Abnormality of chromosome segregation', 'XPO:0100289', 'abnormal chondroblast', 0.6190476190476191, 3.6715585125471644, 1.5076039119696991, 'UPHENO:0086172', 'abnormal cell'),
(23646, 'HP:0002916', 'Abnormality of chromosome segregation', 'XPO:0125724', 'absent polar body', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(23647, 'HP:0002916', 'Abnormality of chromosome segregation', 'XPO:0139670', 'decreased cell population proliferation in dorso-lateral region', 0.40540540540540543, 5.835653092541957, 1.5381174557839463, 'HP:0011017', 'Abnormal cellular physiology'),
(23648, 'HP:0002916', 'Abnormality of chromosome segregation', 'XPO:0101157', 'abnormal female organism', 0.45, 1.706362323152461, 0.8762779498644294, 'UPHENO:0002536', 'abnormal anatomical entity'),
(23649, 'HP:0002916', 'Abnormality of chromosome segregation', 'XPO:0100856', 'abnormal simple organ', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(23650, 'HP:0002916', 'Abnormality of chromosome segregation', 'XPO:0107272', 'abnormal axial region', 0.42857142857142855, 1.706362323152461, 0.8551597151958877, 'UPHENO:0002536', 'abnormal anatomical entity'),
(23651, 'HP:0002916', 'Abnormality of chromosome segregation', 'XPO:0138580', 'decreased cell population proliferation in female organism', 0.4166666666666667, 5.835653092541957, 1.5593338712067029, 'HP:0011017', 'Abnormal cellular physiology'),
(23652, 'HP:0002916', 'Abnormality of chromosome segregation', 'XPO:0100060', 'abnormal regenerating tissue', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(23653, 'HP:0002916', 'Abnormality of chromosome segregation', 'XPO:0127740', 'abnormally localised yolk platelet', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(23654, 'HP:0002916', 'Abnormality of chromosome segregation', 'XPO:0100993', 'abnormal ligament cell', 0.4482758620689655, 3.6715585125471644, 1.2829150624062098, 'UPHENO:0086172', 'abnormal cell'),
(23655, 'HP:0002916', 'Abnormality of chromosome segregation', 'XPO:0101109', 'abnormal egg cell-free extract', 0.45, 1.706362323152461, 0.8762779498644294, 'UPHENO:0002536', 'abnormal anatomical entity'),
(23656, 'HP:0002916', 'Abnormality of chromosome segregation', 'XPO:0139626', 'decreased cell population proliferation in antero-ventral region', 0.40540540540540543, 5.835653092541957, 1.5381174557839463, 'HP:0011017', 'Abnormal cellular physiology'),
(23657, 'HP:0002916', 'Abnormality of chromosome segregation', 'XPO:0101636', 'abnormal cell morphology', 0.4642857142857143, 3.6715585125471644, 1.305623286610558, 'UPHENO:0086172', 'abnormal cell'),
(23658, 'HP:0002916', 'Abnormality of chromosome segregation', 'XPO:0136321', 'increased cell population proliferation in multicellular anatomical structure', 0.4166666666666667, 5.835653092541957, 1.5593338712067029, 'HP:0011017', 'Abnormal cellular physiology'),
(23659, 'HP:0002916', 'Abnormality of chromosome segregation', 'XPO:0126082', 'absent perivitelline space', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(23660, 'HP:0002916', 'Abnormality of chromosome segregation', 'XPO:0136521', 'increased cell population proliferation in ventral region', 0.40540540540540543, 5.835653092541957, 1.5381174557839463, 'HP:0011017', 'Abnormal cellular physiology'),
(23661, 'HP:0002916', 'Abnormality of chromosome segregation', 'XPO:0127821', 'abnormally localised apoptotic cell', 0.4482758620689655, 3.6715585125471644, 1.2829150624062098, 'UPHENO:0086172', 'abnormal cell'),
(23662, 'HP:0002916', 'Abnormality of chromosome segregation', 'XPO:0100901', 'abnormal blastomere D1.2.2', 0.4482758620689655, 3.6715585125471644, 1.2829150624062098, 'UPHENO:0086172', 'abnormal cell'),
(23663, 'HP:0002916', 'Abnormality of chromosome segregation', 'XPO:0126600', 'abnormally localised progenitor cell', 0.4482758620689655, 3.6715585125471644, 1.2829150624062098, 'UPHENO:0086172', 'abnormal cell'),
(23664, 'HP:0002916', 'Abnormality of chromosome segregation', 'XPO:0102147', 'abnormal somatic stem cell morphology', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(23665, 'HP:0002916', 'Abnormality of chromosome segregation', 'XPO:0141841', 'abnormality of whole organism mass', 0.4074074074074074, 1.8210412618256888, 0.861339479684008, 'HP:0000118', 'Phenotypic abnormality'),
(23666, 'HP:0002916', 'Abnormality of chromosome segregation', 'XPO:0100084', 'abnormal anatomical group', 0.45, 1.706362323152461, 0.8762779498644294, 'UPHENO:0002536', 'abnormal anatomical entity'),
(23667, 'HP:0002916', 'Abnormality of chromosome segregation', 'XPO:0101198', 'abnormal digestive enzyme secreting cell', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(23668, 'HP:0002916', 'Abnormality of chromosome segregation', 'XPO:0100232', 'abnormal lymphatic system', 0.4583333333333333, 1.8210412618256888, 0.9135884804823818, 'HP:0000118', 'Phenotypic abnormality'),
(23669, 'HP:0002916', 'Abnormality of chromosome segregation', 'XPO:0100189', 'abnormal enteroendocrine cell', 0.48148148148148145, 3.6715585125471644, 1.3295816755533123, 'UPHENO:0086172', 'abnormal cell'),
(23670, 'HP:0002916', 'Abnormality of chromosome segregation', 'XPO:0100336', 'abnormal interneuron', 0.4642857142857143, 3.6715585125471644, 1.305623286610558, 'UPHENO:0086172', 'abnormal cell'),
(23671, 'HP:0002916', 'Abnormality of chromosome segregation', 'XPO:0125523', 'absent acid secreting cell', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(23672, 'HP:0002916', 'Abnormality of chromosome segregation', 'XPO:0124716', 'absent cell', 0.4482758620689655, 3.6715585125471644, 1.2829150624062098, 'UPHENO:0086172', 'abnormal cell'),
(23673, 'HP:0002916', 'Abnormality of chromosome segregation', 'XPO:0107278', 'abnormal medial region', 0.42857142857142855, 1.706362323152461, 0.8551597151958877, 'UPHENO:0002536', 'abnormal anatomical entity'),
(23674, 'HP:0002916', 'Abnormality of chromosome segregation', 'XPO:0107286', 'abnormal efferent neuron', 0.4642857142857143, 3.6715585125471644, 1.305623286610558, 'UPHENO:0086172', 'abnormal cell'),
(23675, 'HP:0002916', 'Abnormality of chromosome segregation', 'XPO:0101040', 'abnormal axial mesoderm', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(23676, 'HP:0002916', 'Abnormality of chromosome segregation', 'XPO:0136520', 'increased cell population proliferation in dorsal region', 0.40540540540540543, 5.835653092541957, 1.5381174557839463, 'HP:0011017', 'Abnormal cellular physiology'),
(23677, 'HP:0002916', 'Abnormality of chromosome segregation', 'XPO:0101500', 'abnormal endodermal cell', 0.48148148148148145, 3.6715585125471644, 1.3295816755533123, 'UPHENO:0086172', 'abnormal cell'),
(23678, 'HP:0002916', 'Abnormality of chromosome segregation', 'XPO:0115505', 'dead whole organism', 0.45, 1.706362323152461, 0.8762779498644294, 'UPHENO:0002536', 'abnormal anatomical entity'),
(23679, 'HP:0002916', 'Abnormality of chromosome segregation', 'XPO:0101297', 'abnormal barrier cell', 0.6190476190476191, 3.6715585125471644, 1.5076039119696991, 'UPHENO:0086172', 'abnormal cell'),
(23680, 'HP:0002916', 'Abnormality of chromosome segregation', 'XPO:0100216', 'abnormal hepato-pancreatic progenitor cell', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(23681, 'HP:0002916', 'Abnormality of chromosome segregation', 'XPO:0130964', 'abnormally increased number of cell', 0.4482758620689655, 3.6715585125471644, 1.2829150624062098, 'UPHENO:0086172', 'abnormal cell'),
(23682, 'HP:0002916', 'Abnormality of chromosome segregation', 'XPO:0100308', 'abnormal early embryonic cell', 0.5909090909090909, 3.6715585125471644, 1.4729417174039097, 'UPHENO:0086172', 'abnormal cell'),
(23683, 'HP:0002916', 'Abnormality of chromosome segregation', 'XPO:0139580', 'decreased cell population proliferation in thoracic region', 0.40540540540540543, 5.835653092541957, 1.5381174557839463, 'HP:0011017', 'Abnormal cellular physiology'),
(23684, 'HP:0002916', 'Abnormality of chromosome segregation', 'XPO:0107285', 'abnormal flexural organ', 0.4074074074074074, 1.8210412618256888, 0.861339479684008, 'HP:0000118', 'Phenotypic abnormality'),
(23685, 'HP:0002916', 'Abnormality of chromosome segregation', 'XPO:0141266', 'abnormal surface breathing', 0.4444444444444444, 1.4755025719078136, 0.8098017787384251, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(23686, 'HP:0002916', 'Abnormality of chromosome segregation', 'XPO:0131513', 'absent actin cytoskeleton', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(23687, 'HP:0002916', 'Abnormality of chromosome segregation', 'XPO:0100025', 'abnormal oocyte', 0.5909090909090909, 3.6715585125471644, 1.4729417174039097, 'UPHENO:0086172', 'abnormal cell'),
(23688, 'HP:0002916', 'Abnormality of chromosome segregation', 'XPO:0131352', 'abnormally decreased number of barrier cell', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(23689, 'HP:0002916', 'Abnormality of chromosome segregation', 'XPO:0103644', 'abnormally decreased number of cilium in the multiciliated cell', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(23690, 'HP:0002916', 'Abnormality of chromosome segregation', 'XPO:0100715', 'abnormal ciliated cell', 0.6190476190476191, 3.6715585125471644, 1.5076039119696991, 'UPHENO:0086172', 'abnormal cell'),
(23691, 'HP:0002916', 'Abnormality of chromosome segregation', 'XPO:0135130', 'increased cell population proliferation in forelimb region', 0.40540540540540543, 5.835653092541957, 1.5381174557839463, 'HP:0011017', 'Abnormal cellular physiology'),
(23692, 'HP:0002916', 'Abnormality of chromosome segregation', 'XPO:0135788', 'increased cell population proliferation in intersomitic region', 0.40540540540540543, 5.835653092541957, 1.5381174557839463, 'HP:0011017', 'Abnormal cellular physiology'),
(23693, 'HP:0002916', 'Abnormality of chromosome segregation', 'XPO:0138844', 'decreased cell population proliferation in extracellular matrix', 0.40540540540540543, 5.835653092541957, 1.5381174557839463, 'HP:0011017', 'Abnormal cellular physiology'),
(23694, 'HP:0002916', 'Abnormality of chromosome segregation', 'XPO:0101187', 'abnormal dorsolateral commissural neuron', 0.48148148148148145, 3.6715585125471644, 1.3295816755533123, 'UPHENO:0086172', 'abnormal cell'),
(23695, 'HP:0002916', 'Abnormality of chromosome segregation', 'XPO:0100674', 'abnormal secondary oogonium', 0.5909090909090909, 3.6715585125471644, 1.4729417174039097, 'UPHENO:0086172', 'abnormal cell'),
(23696, 'HP:0002916', 'Abnormality of chromosome segregation', 'XPO:0100688', 'abnormal adipose tissue', 0.4230769230769231, 1.8210412618256888, 0.8777474203034321, 'HP:0000118', 'Phenotypic abnormality'),
(23697, 'HP:0002916', 'Abnormality of chromosome segregation', 'XPO:0125533', 'absent myelin accumulating cell', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(23698, 'HP:0002916', 'Abnormality of chromosome segregation', 'XPO:0100258', 'abnormal organ part', 0.47368421052631576, 1.706362323152461, 0.8990422069704646, 'UPHENO:0002536', 'abnormal anatomical entity'),
(23699, 'HP:0002916', 'Abnormality of chromosome segregation', 'XPO:0100423', 'abnormal process', 0.45, 1.706362323152461, 0.8762779498644294, 'UPHENO:0002536', 'abnormal anatomical entity'),
(23700, 'HP:0002916', 'Abnormality of chromosome segregation', 'XPO:0136524', 'increased cell population proliferation in antero-ventral region', 0.40540540540540543, 5.835653092541957, 1.5381174557839463, 'HP:0011017', 'Abnormal cellular physiology'),
(23701, 'HP:0002916', 'Abnormality of chromosome segregation', 'XPO:0131550', 'abnormally localised adherens junction', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(23702, 'HP:0002916', 'Abnormality of chromosome segregation', 'XPO:0100549', 'abnormal mitotic cell', 0.6190476190476191, 3.6715585125471644, 1.5076039119696991, 'UPHENO:0086172', 'abnormal cell'),
(23703, 'HP:0002916', 'Abnormality of chromosome segregation', 'XPO:0139623', 'decreased cell population proliferation in ventral region', 0.40540540540540543, 5.835653092541957, 1.5381174557839463, 'HP:0011017', 'Abnormal cellular physiology'),
(23704, 'HP:0002916', 'Abnormality of chromosome segregation', 'XPO:0101485', 'abnormal descending interneuron', 0.4482758620689655, 3.6715585125471644, 1.2829150624062098, 'UPHENO:0086172', 'abnormal cell'),
(23705, 'HP:0002916', 'Abnormality of chromosome segregation', 'XPO:0101302', 'abnormal subcortical cytoplasm', 0.5416666666666666, 3.6715585125471644, 1.4102343283876786, 'UPHENO:0086172', 'abnormal cell'),
(23706, 'HP:0002916', 'Abnormality of chromosome segregation', 'XPO:0101192', 'abnormal blastomere D2.1', 0.4482758620689655, 3.6715585125471644, 1.2829150624062098, 'UPHENO:0086172', 'abnormal cell'),
(23707, 'HP:0002916', 'Abnormality of chromosome segregation', 'XPO:0107325', 'abnormal adult thrombocyte', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(23708, 'HP:0002916', 'Abnormality of chromosome segregation', 'XPO:0142056', 'abnormal main body axis', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(23709, 'HP:0002916', 'Abnormality of chromosome segregation', 'XPO:0100307', 'abnormal blastomere', 0.5652173913043478, 3.6715585125471644, 1.440565418328227, 'UPHENO:0086172', 'abnormal cell'),
(23710, 'HP:0002916', 'Abnormality of chromosome segregation', 'XPO:0138585', 'decreased cell population proliferation in organism subdivision', 0.40540540540540543, 5.835653092541957, 1.5381174557839463, 'HP:0011017', 'Abnormal cellular physiology'),
(23711, 'HP:0002916', 'Abnormality of chromosome segregation', 'XPO:0142064', 'abnormal desmosome morphology', 0.4482758620689655, 3.6715585125471644, 1.2829150624062098, 'UPHENO:0086172', 'abnormal cell'),
(23712, 'HP:0002916', 'Abnormality of chromosome segregation', 'XPO:0107262', 'abnormal left-right axis', 0.45, 1.706362323152461, 0.8762779498644294, 'UPHENO:0002536', 'abnormal anatomical entity'),
(23713, 'HP:0002916', 'Abnormality of chromosome segregation', 'XPO:0100596', 'abnormal myocyte', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(23714, 'HP:0002916', 'Abnormality of chromosome segregation', 'XPO:0100872', 'abnormal neuroendocrine cell', 0.48148148148148145, 3.6715585125471644, 1.3295816755533123, 'UPHENO:0086172', 'abnormal cell'),
(23715, 'HP:0000962', 'Hyperkeratosis', 'XPO:0103640', 'increased thickness of the epidermis in forelimb bud', 0.4375, 12.720196747295123, 2.3590434665223143, 'HP:0000962', 'Hyperkeratosis'),
(23716, 'HP:0000962', 'Hyperkeratosis', 'XPO:0102139', 'abnormal skin morphology', 0.44, 11.09310877090129, 2.2092912572127217, 'UPHENO:0081431', 'abnormal skin of body morphology in the independent continuant'),
(23717, 'HP:0000962', 'Hyperkeratosis', 'XPO:0129655', 'increased size of the skin', 0.45454545454545453, 11.09310877090129, 2.24551156055619, 'UPHENO:0081431', 'abnormal skin of body morphology in the independent continuant'),
(23718, 'HP:0000962', 'Hyperkeratosis', 'XPO:0129982', 'increased size of the anatomical line', 0.41025641025641024, 5.972749669260594, 1.565362206861726, 'UPHENO:0065599', 'increased size of the anatomical entity in independent continuant'),
(23719, 'HP:0000962', 'Hyperkeratosis', 'XPO:0129582', 'increased size of the portion of organism substance', 0.41025641025641024, 5.972749669260594, 1.565362206861726, 'UPHENO:0065599', 'increased size of the anatomical entity in independent continuant'),
(23720, 'HP:0000962', 'Hyperkeratosis', 'XPO:0130281', 'increased size of the dermis', 0.42857142857142855, 7.420886955069779, 1.7833620281931915, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(23721, 'HP:0000962', 'Hyperkeratosis', 'XPO:0130126', 'increased size of the stratum compactum', 0.41379310344827586, 7.420886955069779, 1.752344670285258, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(23722, 'HP:0000962', 'Hyperkeratosis', 'XPO:0103639', 'increased thickness of the epidermis in hindlimb bud', 0.4375, 12.720196747295123, 2.3590434665223143, 'HP:0000962', 'Hyperkeratosis'),
(23723, 'HP:0000962', 'Hyperkeratosis', 'XPO:0129993', 'increased size of the Eberth-Kastschenko layer', 0.41379310344827586, 7.420886955069779, 1.752344670285258, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(23724, 'HP:0000962', 'Hyperkeratosis', 'XPO:0129487', 'increased size of the anatomical structure', 0.41025641025641024, 5.972749669260594, 1.565362206861726, 'UPHENO:0065599', 'increased size of the anatomical entity in independent continuant'),
(23725, 'HP:0000962', 'Hyperkeratosis', 'XPO:0130896', 'increased size of the skin seromucous gland', 0.4067796610169492, 7.420886955069779, 1.7374308274082122, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(23726, 'HP:0000962', 'Hyperkeratosis', 'XPO:0103914', 'increased thickness of the epidermis', 0.4666666666666667, 12.720196747295123, 2.4364096156854234, 'HP:0000962', 'Hyperkeratosis'),
(23727, 'HP:0000962', 'Hyperkeratosis', 'XPO:0130356', 'increased size of the skin gland', 0.42857142857142855, 7.420886955069779, 1.7833620281931915, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(23728, 'HP:0000962', 'Hyperkeratosis', 'XPO:0102615', 'abnormal skin gland morphology', 0.4117647058823529, 7.420886955069779, 1.7480444314835069, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(23729, 'HP:0000962', 'Hyperkeratosis', 'XPO:0128175', 'decreased size of the skin', 0.40350877192982454, 11.09310877090129, 2.1156953223539405, 'UPHENO:0081431', 'abnormal skin of body morphology in the independent continuant'),
(23730, 'HP:0000962', 'Hyperkeratosis', 'XPO:0130438', 'increased size of the granular gland', 0.4067796610169492, 7.420886955069779, 1.7374308274082122, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(23731, 'HP:0000962', 'Hyperkeratosis', 'XPO:0130706', 'increased size of the stratum spongiosum', 0.41379310344827586, 7.420886955069779, 1.752344670285258, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(23732, 'HP:0000962', 'Hyperkeratosis', 'XPO:0102561', 'abnormal dermis morphology', 0.40384615384615385, 7.420886955069779, 1.7311547172139254, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(23733, 'HP:0031017', 'Swiss cheese atrial septal defect', 'XPO:0100837', 'abnormal atrioventricular canal', 0.4166666666666667, 10.504690711543915, 2.092117220220535, 'UPHENO:0019888', 'abnormal cardiac septum morphology'),
(23734, 'HP:0010558', 'Abnormality of the clivus', 'XPO:0128034', 'decreased size of the cranium', 0.40625, 4.638757693672553, 1.3727692133255593, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(23735, 'HP:0010558', 'Abnormality of the clivus', 'XPO:0130392', 'increased size of the lagena', 0.40229885057471265, 9.012377498788434, 1.904118984913493, 'HP:0002693', 'Abnormal skull base morphology'),
(23736, 'HP:0010558', 'Abnormality of the clivus', 'XPO:0102215', 'abnormal mandibular arch skeleton morphology', 0.41935483870967744, 4.638757693672553, 1.394734915474381, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(23737, 'HP:0010558', 'Abnormality of the clivus', 'XPO:0128845', 'decreased size of the osseous labyrinth', 0.42168674698795183, 9.012377498788434, 1.9494615025928335, 'HP:0002693', 'Abnormal skull base morphology'),
(23738, 'HP:0010558', 'Abnormality of the clivus', 'XPO:0141839', 'edematous pharyngeal region', 0.40384615384615385, 4.5318002188002176, 1.3528303989641963, 'UPHENO:0087907', 'abnormal head morphology'),
(23739, 'HP:0010558', 'Abnormality of the clivus', 'XPO:0141829', 'increased width of head', 0.4626865671641791, 7.024697770424301, 1.8028403414510898, 'HP:0000929', 'Abnormal skull morphology'),
(23740, 'HP:0010558', 'Abnormality of the clivus', 'XPO:0129957', 'increased size of the neurocranium', 0.5, 8.21064164923199, 2.0261591311187765, 'UPHENO:0088115', 'abnormal neurocranium morphology'),
(23741, 'HP:0010558', 'Abnormality of the clivus', 'XPO:0115526', 'abnormally incomplete structure of head', 0.40384615384615385, 4.5318002188002176, 1.3528303989641963, 'UPHENO:0087907', 'abnormal head morphology'),
(23742, 'HP:0010558', 'Abnormality of the clivus', 'XPO:0128971', 'decreased size of the fenestra subocularis', 0.4126984126984127, 4.638757693672553, 1.3836213127410304, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(23743, 'HP:0010558', 'Abnormality of the clivus', 'XPO:0130383', 'increased size of the occipital region', 0.49230769230769234, 7.717194259133599, 1.9491624090373367, 'UPHENO:0087814', 'abnormal cranium morphology'),
(23744, 'HP:0010558', 'Abnormality of the clivus', 'XPO:0140294', 'abnormally necrotic osseous labyrinth', 0.43209876543209874, 9.012377498788434, 1.9733821704967611, 'HP:0002693', 'Abnormal skull base morphology'),
(23745, 'HP:0010558', 'Abnormality of the clivus', 'XPO:0102461', 'abnormal postcranial axial skeleton morphology', 0.40350877192982454, 6.272837960958401, 1.5909573036826314, 'UPHENO:0022529', 'abnormal postcranial axial skeleton morphology'),
(23746, 'HP:0010558', 'Abnormality of the clivus', 'XPO:0140727', 'abnormally necrotic vestibule', 0.40229885057471265, 9.012377498788434, 1.904118984913493, 'HP:0002693', 'Abnormal skull base morphology'),
(23747, 'HP:0010558', 'Abnormality of the clivus', 'XPO:0130323', 'increased size of the osseous labyrinth', 0.42168674698795183, 9.012377498788434, 1.9494615025928335, 'HP:0002693', 'Abnormal skull base morphology'),
(23748, 'HP:0010558', 'Abnormality of the clivus', 'XPO:0140560', 'abnormally necrotic orbital region', 0.4305555555555556, 7.024697770424301, 1.7391154795340382, 'HP:0000929', 'Abnormal skull morphology'),
(23749, 'HP:0010558', 'Abnormality of the clivus', 'XPO:0102401', 'abnormal neurocranium morphology', 0.5689655172413793, 8.21064164923199, 2.1613819590342866, 'UPHENO:0088115', 'abnormal neurocranium morphology'),
(23750, 'HP:0010558', 'Abnormality of the clivus', 'XPO:0102092', 'abnormal ethmoid region morphology', 0.4482758620689655, 4.638757693672553, 1.4420274283314136, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(23751, 'HP:0010558', 'Abnormality of the clivus', 'XPO:0101681', 'abnormal chondrocranium morphology', 0.4406779661016949, 4.638757693672553, 1.4297546312868548, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(23752, 'HP:0010558', 'Abnormality of the clivus', 'XPO:0140892', 'abnormally necrotic lagena', 0.4117647058823529, 9.012377498788434, 1.9263901396366612, 'HP:0002693', 'Abnormal skull base morphology'),
(23753, 'HP:0010558', 'Abnormality of the clivus', 'XPO:0102005', 'abnormal splanchnocranium morphology', 0.4406779661016949, 4.638757693672553, 1.4297546312868548, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(23754, 'HP:0010558', 'Abnormality of the clivus', 'XPO:0139784', 'abnormally necrotic cranium', 0.41935483870967744, 4.638757693672553, 1.394734915474381, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(23755, 'HP:0010558', 'Abnormality of the clivus', 'XPO:0102867', 'abnormal lagena morphology', 0.4375, 9.012377498788434, 1.985677505467577, 'HP:0002693', 'Abnormal skull base morphology'),
(23756, 'HP:0010558', 'Abnormality of the clivus', 'XPO:0130425', 'increased size of the otic region', 0.5076923076923077, 8.21064164923199, 2.0416854817853713, 'UPHENO:0088115', 'abnormal neurocranium morphology'),
(23757, 'HP:0010558', 'Abnormality of the clivus', 'XPO:0128208', 'decreased size of the olfactory region', 0.5076923076923077, 8.21064164923199, 2.0416854817853713, 'UPHENO:0088115', 'abnormal neurocranium morphology'),
(23758, 'HP:0010558', 'Abnormality of the clivus', 'XPO:0102828', 'abnormal occipital region morphology', 0.5517241379310345, 7.717194259133599, 2.063434600336733, 'UPHENO:0087814', 'abnormal cranium morphology'),
(23759, 'HP:0010558', 'Abnormality of the clivus', 'XPO:0130449', 'increased size of the fenestra subocularis', 0.4126984126984127, 4.638757693672553, 1.3836213127410304, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(23760, 'HP:0010558', 'Abnormality of the clivus', 'XPO:0102720', 'abnormal dermatocranium morphology', 0.4406779661016949, 4.638757693672553, 1.4297546312868548, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(23761, 'HP:0010558', 'Abnormality of the clivus', 'XPO:0140132', 'abnormally necrotic ethmoid region', 0.4126984126984127, 4.638757693672553, 1.3836213127410304, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(23762, 'HP:0010558', 'Abnormality of the clivus', 'XPO:0128947', 'decreased size of the otic region', 0.5076923076923077, 8.21064164923199, 2.0416854817853713, 'UPHENO:0088115', 'abnormal neurocranium morphology'),
(23763, 'HP:0010558', 'Abnormality of the clivus', 'XPO:0128905', 'decreased size of the occipital region', 0.49230769230769234, 7.717194259133599, 1.9491624090373367, 'UPHENO:0087814', 'abnormal cranium morphology'),
(23764, 'HP:0010558', 'Abnormality of the clivus', 'XPO:0141201', 'abnormally necrotic sphenoid region', 0.5238095238095238, 8.21064164923199, 2.073839987186777, 'UPHENO:0088115', 'abnormal neurocranium morphology'),
(23765, 'HP:0010558', 'Abnormality of the clivus', 'XPO:0142059', 'abnormal nasal region morphology', 0.40384615384615385, 4.5318002188002176, 1.3528303989641963, 'UPHENO:0087907', 'abnormal head morphology'),
(23766, 'HP:0010558', 'Abnormality of the clivus', 'XPO:0129291', 'decreased size of the orbital region', 0.40789473684210525, 7.024697770424301, 1.6927307076031153, 'HP:0000929', 'Abnormal skull morphology'),
(23767, 'HP:0010558', 'Abnormality of the clivus', 'XPO:0102564', 'abnormal olfactory region morphology', 0.5689655172413793, 8.21064164923199, 2.1613819590342866, 'UPHENO:0088115', 'abnormal neurocranium morphology'),
(23768, 'HP:0010558', 'Abnormality of the clivus', 'XPO:0100584', 'abnormal vertebral column', 0.41818181818181815, 6.272837960958401, 1.6196255072310737, 'UPHENO:0022529', 'abnormal postcranial axial skeleton morphology'),
(23769, 'HP:0010558', 'Abnormality of the clivus', 'XPO:0140672', 'abnormally necrotic olfactory region', 0.5238095238095238, 8.21064164923199, 2.073839987186777, 'UPHENO:0088115', 'abnormal neurocranium morphology'),
(23770, 'HP:0010558', 'Abnormality of the clivus', 'XPO:0103152', 'abnormal otic region morphology', 0.5689655172413793, 8.21064164923199, 2.1613819590342866, 'UPHENO:0088115', 'abnormal neurocranium morphology'),
(23771, 'HP:0010558', 'Abnormality of the clivus', 'XPO:0129689', 'increased size of the sphenoid region', 0.5076923076923077, 8.21064164923199, 2.0416854817853713, 'UPHENO:0088115', 'abnormal neurocranium morphology'),
(23772, 'HP:0010558', 'Abnormality of the clivus', 'XPO:0129688', 'increased size of the olfactory region', 0.5076923076923077, 8.21064164923199, 2.0416854817853713, 'UPHENO:0088115', 'abnormal neurocranium morphology'),
(23773, 'HP:0010558', 'Abnormality of the clivus', 'XPO:0128209', 'decreased size of the sphenoid region', 0.5076923076923077, 8.21064164923199, 2.0416854817853713, 'UPHENO:0088115', 'abnormal neurocranium morphology'),
(23774, 'HP:0010558', 'Abnormality of the clivus', 'XPO:0102134', 'abnormal posterior semicircular canal morphology', 0.40229885057471265, 9.012377498788434, 1.904118984913493, 'HP:0002693', 'Abnormal skull base morphology'),
(23775, 'HP:0010558', 'Abnormality of the clivus', 'XPO:0102835', 'abnormal vestibule morphology', 0.4268292682926829, 9.012377498788434, 1.9613124415516532, 'HP:0002693', 'Abnormal skull base morphology'),
(23776, 'HP:0010558', 'Abnormality of the clivus', 'XPO:0141061', 'abnormally necrotic suspensorium', 0.40625, 4.638757693672553, 1.3727692133255593, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(23777, 'HP:0010558', 'Abnormality of the clivus', 'XPO:0128914', 'decreased size of the lagena', 0.40229885057471265, 9.012377498788434, 1.904118984913493, 'HP:0002693', 'Abnormal skull base morphology'),
(23778, 'HP:0010558', 'Abnormality of the clivus', 'XPO:0101634', 'abnormal head morphology', 0.4117647058823529, 4.5318002188002176, 1.3660290568695288, 'UPHENO:0087907', 'abnormal head morphology'),
(23779, 'HP:0010558', 'Abnormality of the clivus', 'XPO:0130767', 'increased size of the orbital region', 0.40789473684210525, 7.024697770424301, 1.6927307076031153, 'HP:0000929', 'Abnormal skull morphology'),
(23780, 'HP:0010558', 'Abnormality of the clivus', 'XPO:0130324', 'increased size of the choana', 0.45714285714285713, 7.717194259133599, 1.878259894888561, 'UPHENO:0087814', 'abnormal cranium morphology'),
(23781, 'HP:0010558', 'Abnormality of the clivus', 'XPO:0129514', 'increased size of the cranium', 0.40625, 4.638757693672553, 1.3727692133255593, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(23782, 'HP:0010558', 'Abnormality of the clivus', 'XPO:0140926', 'abnormally necrotic neurocranium', 0.5238095238095238, 8.21064164923199, 2.073839987186777, 'UPHENO:0088115', 'abnormal neurocranium morphology'),
(23783, 'HP:0010558', 'Abnormality of the clivus', 'XPO:0101997', 'abnormal braincase and otic capsule skeleton morphology', 0.4262295081967213, 4.638757693672553, 1.4061206955371255, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(23784, 'HP:0010558', 'Abnormality of the clivus', 'XPO:0103015', 'abnormal anterior semicircular canal morphology', 0.40229885057471265, 9.012377498788434, 1.904118984913493, 'HP:0002693', 'Abnormal skull base morphology'),
(23785, 'HP:0010558', 'Abnormality of the clivus', 'XPO:0128668', 'decreased size of the fenestra basicranialis', 0.4126984126984127, 4.638757693672553, 1.3836213127410304, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(23786, 'HP:0010558', 'Abnormality of the clivus', 'XPO:0101852', 'abnormal semicircular canal morphology', 0.4117647058823529, 9.012377498788434, 1.9263901396366612, 'HP:0002693', 'Abnormal skull base morphology'),
(23787, 'HP:0010558', 'Abnormality of the clivus', 'XPO:0102776', 'abnormal fenestra subocularis morphology', 0.4482758620689655, 4.638757693672553, 1.4420274283314136, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(23788, 'HP:0010558', 'Abnormality of the clivus', 'XPO:0103138', 'abnormal upper jaw morphology', 0.40789473684210525, 7.024697770424301, 1.6927307076031153, 'HP:0000929', 'Abnormal skull morphology'),
(23789, 'HP:0010558', 'Abnormality of the clivus', 'XPO:0128477', 'decreased size of the neurocranium', 0.5, 8.21064164923199, 2.0261591311187765, 'UPHENO:0088115', 'abnormal neurocranium morphology'),
(23790, 'HP:0010558', 'Abnormality of the clivus', 'XPO:0102921', 'abnormal orbital region morphology', 0.4626865671641791, 7.024697770424301, 1.8028403414510898, 'HP:0000929', 'Abnormal skull morphology'),
(23791, 'HP:0010558', 'Abnormality of the clivus', 'XPO:0102259', 'abnormal pharyngeal region morphology', 0.42, 4.5318002188002176, 1.3796217205799897, 'UPHENO:0087907', 'abnormal head morphology'),
(23792, 'HP:0010558', 'Abnormality of the clivus', 'XPO:0102351', 'abnormal sphenoid region morphology', 0.5689655172413793, 8.21064164923199, 2.1613819590342866, 'UPHENO:0088115', 'abnormal neurocranium morphology'),
(23793, 'HP:0010558', 'Abnormality of the clivus', 'XPO:0101856', 'abnormal lateral semicircular canal morphology', 0.40229885057471265, 9.012377498788434, 1.904118984913493, 'HP:0002693', 'Abnormal skull base morphology'),
(23794, 'HP:0010558', 'Abnormality of the clivus', 'XPO:0103381', 'increased size of the head', 0.49206349206349204, 7.024697770424301, 1.8591926515575539, 'HP:0000929', 'Abnormal skull morphology'),
(23795, 'HP:0010558', 'Abnormality of the clivus', 'XPO:0102052', 'abnormal choana morphology', 0.5, 7.717194259133599, 1.9643312168691918, 'UPHENO:0087814', 'abnormal cranium morphology'),
(23796, 'HP:0010558', 'Abnormality of the clivus', 'XPO:0128846', 'decreased size of the choana', 0.45714285714285713, 7.717194259133599, 1.878259894888561, 'UPHENO:0087814', 'abnormal cranium morphology'),
(23797, 'HP:0010558', 'Abnormality of the clivus', 'XPO:0102485', 'abnormal osseous labyrinth morphology', 0.4605263157894737, 9.012377498788434, 2.037262134832184, 'HP:0002693', 'Abnormal skull base morphology'),
(23798, 'HP:0010558', 'Abnormality of the clivus', 'XPO:0100420', 'abnormal choana', 0.4067796610169492, 4.5318002188002176, 1.3577349361344757, 'UPHENO:0087907', 'abnormal head morphology'),
(23799, 'HP:0010558', 'Abnormality of the clivus', 'XPO:0141185', 'abnormally necrotic occipital region', 0.5079365079365079, 7.717194259133599, 1.9798597685321015, 'UPHENO:0087814', 'abnormal cranium morphology'),
(23800, 'HP:0010558', 'Abnormality of the clivus', 'XPO:0101764', 'abnormal cranium morphology', 0.45614035087719296, 4.638757693672553, 1.4546217934659431, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(23801, 'HP:0010558', 'Abnormality of the clivus', 'XPO:0102665', 'abnormal suspensorium morphology', 0.4406779661016949, 4.638757693672553, 1.4297546312868548, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(23802, 'HP:0010558', 'Abnormality of the clivus', 'XPO:0103176', 'abnormal fenestra basicranialis morphology', 0.4482758620689655, 4.638757693672553, 1.4420274283314136, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(23803, 'HP:0010558', 'Abnormality of the clivus', 'XPO:0140644', 'abnormally necrotic otic region', 0.5238095238095238, 8.21064164923199, 2.073839987186777, 'UPHENO:0088115', 'abnormal neurocranium morphology'),
(23804, 'HP:0010558', 'Abnormality of the clivus', 'XPO:0130147', 'increased size of the fenestra basicranialis', 0.4126984126984127, 4.638757693672553, 1.3836213127410304, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(23805, 'HP:0010558', 'Abnormality of the clivus', 'XPO:0101659', 'abnormal lower jaw morphology', 0.4189189189189189, 7.024697770424301, 1.7154529418548001, 'HP:0000929', 'Abnormal skull morphology'),
(23806, 'HP:0034304', 'Epsilon wave', 'XPO:0100076', 'abnormal artery', 0.4117647058823529, 5.249153838287537, 1.4701755971154233, 'UPHENO:0080362', 'abnormal cardiovascular system'),
(23807, 'HP:0034304', 'Epsilon wave', 'XPO:0100043', 'abnormal vein', 0.4117647058823529, 5.249153838287537, 1.4701755971154233, 'UPHENO:0080362', 'abnormal cardiovascular system'),
(23808, 'HP:0034304', 'Epsilon wave', 'XPO:0100054', 'abnormal blood vessel', 0.42424242424242425, 5.249153838287537, 1.4922847414540332, 'UPHENO:0080362', 'abnormal cardiovascular system'),
(23809, 'HP:0034304', 'Epsilon wave', 'XPO:0100004', 'abnormal cell', 0.4074074074074074, 1.8210412618256888, 0.861339479684008, 'HP:0000118', 'Phenotypic abnormality'),
(23810, 'HP:0034304', 'Epsilon wave', 'XPO:0100981', 'abnormal dorsal longitudinal anastomosing vessel', 0.4117647058823529, 5.249153838287537, 1.4701755971154233, 'UPHENO:0080362', 'abnormal cardiovascular system'),
(23811, 'HP:0034304', 'Epsilon wave', 'XPO:0101583', 'abnormal truncus arteriosus', 0.4117647058823529, 5.249153838287537, 1.4701755971154233, 'UPHENO:0080362', 'abnormal cardiovascular system'),
(23812, 'HP:0034304', 'Epsilon wave', 'XPO:0100792', 'abnormal capillary', 0.4117647058823529, 5.249153838287537, 1.4701755971154233, 'UPHENO:0080362', 'abnormal cardiovascular system'),
(23813, 'HP:0034304', 'Epsilon wave', 'XPO:0100780', 'abnormal vascular plexus', 0.4117647058823529, 5.249153838287537, 1.4701755971154233, 'UPHENO:0080362', 'abnormal cardiovascular system'),
(23814, 'HP:0011089', 'Double tooth', 'XPO:0101506', 'abnormal upper jaw', 0.43333333333333335, 7.0866363731414825, 1.752391440773049, 'HP:0000153', 'Abnormality of the mouth'),
(23815, 'HP:0011089', 'Double tooth', 'XPO:0103828', 'decreased width of the mouth', 0.45454545454545453, 7.884497199543557, 1.8931091789510952, 'UPHENO:0076786', 'abnormal oral cavity morphology'),
(23816, 'HP:0011089', 'Double tooth', 'XPO:0102279', 'abnormal mouth morphology', 0.5238095238095238, 7.312692920701687, 1.9571556393291838, 'UPHENO:0076800', 'abnormal mouth morphology'),
(23817, 'HP:0011089', 'Double tooth', 'XPO:0139736', 'abnormally necrotic tooth', 0.5625, 9.872199840740173, 2.356504277614693, 'HP:0006482', 'Abnormal dental morphology'),
(23818, 'HP:0011089', 'Double tooth', 'XPO:0102899', 'abnormal branchial arch skeleton 4 morphology', 0.4050632911392405, 5.725717590856133, 1.5229175983900207, 'UPHENO:0076803', 'abnormal digestive system morphology'),
(23819, 'HP:0011089', 'Double tooth', 'XPO:0130923', 'increased size of the dentine', 0.4787234042553192, 9.872199840740173, 2.1739487379531184, 'HP:0006482', 'Abnormal dental morphology'),
(23820, 'HP:0011089', 'Double tooth', 'XPO:0130358', 'increased size of the lower jaw', 0.475, 7.312692920701687, 1.8637406303810895, 'UPHENO:0076800', 'abnormal mouth morphology'),
(23821, 'HP:0011089', 'Double tooth', 'XPO:0141830', 'increased width of mouth', 0.45454545454545453, 7.884497199543557, 1.8931091789510952, 'UPHENO:0076786', 'abnormal oral cavity morphology'),
(23822, 'HP:0011089', 'Double tooth', 'XPO:0131611', 'increased size of the roof of mouth', 0.4520547945205479, 7.312692920701687, 1.8181688303509294, 'UPHENO:0076800', 'abnormal mouth morphology'),
(23823, 'HP:0011089', 'Double tooth', 'XPO:0102823', 'abnormal palatoquadrate morphology', 0.4266666666666667, 5.725717590856133, 1.5630012280114445, 'UPHENO:0076803', 'abnormal digestive system morphology'),
(23824, 'HP:0011089', 'Double tooth', 'XPO:0130466', 'increased size of the tooth', 0.5357142857142857, 9.872199840740173, 2.2997126964277097, 'HP:0006482', 'Abnormal dental morphology'),
(23825, 'HP:0011089', 'Double tooth', 'XPO:0140639', 'abnormally necrotic upper jaw', 0.475, 7.312692920701687, 1.8637406303810895, 'UPHENO:0076800', 'abnormal mouth morphology'),
(23826, 'HP:0011089', 'Double tooth', 'XPO:0130132', 'increased size of the oral epithelium', 0.4074074074074074, 7.312692920701687, 1.7260490329042149, 'UPHENO:0076800', 'abnormal mouth morphology'),
(23827, 'HP:0011089', 'Double tooth', 'XPO:0102926', 'abnormal branchial arch skeleton 2 morphology', 0.4050632911392405, 5.725717590856133, 1.5229175983900207, 'UPHENO:0076803', 'abnormal digestive system morphology'),
(23828, 'HP:0011089', 'Double tooth', 'XPO:0102563', 'abnormal hyoid arch skeleton morphology', 0.42105263157894735, 5.725717590856133, 1.5526842754751673, 'UPHENO:0076803', 'abnormal digestive system morphology'),
(23829, 'HP:0011089', 'Double tooth', 'XPO:0102735', 'abnormal pharyngeal mesenchyme morphology', 0.40298507462686567, 5.725717590856133, 1.5190058362769763, 'UPHENO:0076803', 'abnormal digestive system morphology'),
(23830, 'HP:0011089', 'Double tooth', 'XPO:0102861', 'abnormal cementum morphology', 0.5555555555555556, 9.872199840740173, 2.34191277956244, 'HP:0006482', 'Abnormal dental morphology'),
(23831, 'HP:0011089', 'Double tooth', 'XPO:0129449', 'decreased size of the dentine', 0.4787234042553192, 9.872199840740173, 2.1739487379531184, 'HP:0006482', 'Abnormal dental morphology'),
(23832, 'HP:0011089', 'Double tooth', 'XPO:0140897', 'abnormally necrotic lower jaw', 0.48717948717948717, 7.312692920701687, 1.8874835064202586, 'UPHENO:0076800', 'abnormal mouth morphology'),
(23833, 'HP:0011089', 'Double tooth', 'XPO:0102776', 'abnormal fenestra subocularis morphology', 0.40625, 4.638757693672553, 1.3727692133255593, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(23834, 'HP:0011089', 'Double tooth', 'XPO:0101567', 'abnormal tongue', 0.5614035087719298, 7.884497199543557, 2.103897429231332, 'UPHENO:0076786', 'abnormal oral cavity morphology'),
(23835, 'HP:0011089', 'Double tooth', 'XPO:0141311', 'abnormal roof of mouth morphology', 0.5, 7.312692920701687, 1.9121575406725366, 'UPHENO:0076800', 'abnormal mouth morphology'),
(23836, 'HP:0011089', 'Double tooth', 'XPO:0130701', 'increased size of the upper jaw', 0.4634146341463415, 7.312692920701687, 1.8408717811057655, 'UPHENO:0076800', 'abnormal mouth morphology'),
(23837, 'HP:0011089', 'Double tooth', 'XPO:0102551', 'abnormal branchial arch skeleton 1 morphology', 0.4050632911392405, 5.725717590856133, 1.5229175983900207, 'UPHENO:0076803', 'abnormal digestive system morphology'),
(23838, 'HP:0011089', 'Double tooth', 'XPO:0103352', 'decreased size of the mouth', 0.4861111111111111, 7.884497199543557, 1.9577389239177327, 'UPHENO:0076786', 'abnormal oral cavity morphology'),
(23839, 'HP:0011089', 'Double tooth', 'XPO:0129990', 'increased size of the cementum', 0.4945054945054945, 9.872199840740173, 2.209492490166528, 'HP:0006482', 'Abnormal dental morphology'),
(23840, 'HP:0011089', 'Double tooth', 'XPO:0102445', 'abnormal branchial arch 3 morphology', 0.40298507462686567, 5.725717590856133, 1.5190058362769763, 'UPHENO:0076803', 'abnormal digestive system morphology'),
(23841, 'HP:0011089', 'Double tooth', 'XPO:0130628', 'increased size of the oral cavity', 0.5147058823529411, 7.884497199543557, 2.0144967331818533, 'UPHENO:0076786', 'abnormal oral cavity morphology'),
(23842, 'HP:0011089', 'Double tooth', 'XPO:0129152', 'decreased size of the oral cavity', 0.5147058823529411, 7.884497199543557, 2.0144967331818533, 'UPHENO:0076786', 'abnormal oral cavity morphology'),
(23843, 'HP:0011089', 'Double tooth', 'XPO:0140626', 'abnormally necrotic tongue', 0.5147058823529411, 7.884497199543557, 2.0144967331818533, 'UPHENO:0076786', 'abnormal oral cavity morphology'),
(23844, 'HP:0011089', 'Double tooth', 'XPO:0128510', 'decreased size of the cementum', 0.4945054945054945, 9.872199840740173, 2.209492490166528, 'HP:0006482', 'Abnormal dental morphology'),
(23845, 'HP:0011089', 'Double tooth', 'XPO:0101816', 'abnormal tooth morphology', 0.625, 9.872199840740173, 2.4839736110640565, 'HP:0006482', 'Abnormal dental morphology'),
(23846, 'HP:0011089', 'Double tooth', 'XPO:0102552', 'abnormal branchial arch skeleton morphology', 0.4266666666666667, 5.725717590856133, 1.5630012280114445, 'UPHENO:0076803', 'abnormal digestive system morphology'),
(23847, 'HP:0011089', 'Double tooth', 'XPO:0100027', 'abnormal lower jaw', 0.43333333333333335, 7.0866363731414825, 1.752391440773049, 'HP:0000153', 'Abnormality of the mouth'),
(23848, 'HP:0011089', 'Double tooth', 'XPO:0115558', 'abnormally incomplete structure of mouth', 0.515625, 7.312692920701687, 1.9418051620172418, 'UPHENO:0076800', 'abnormal mouth morphology'),
(23849, 'HP:0011089', 'Double tooth', 'XPO:0140789', 'abnormally necrotic roof of mouth', 0.4647887323943662, 7.312692920701687, 1.8435990000545652, 'UPHENO:0076800', 'abnormal mouth morphology'),
(23850, 'HP:0011089', 'Double tooth', 'XPO:0102890', 'abnormal dentine morphology', 0.5421686746987951, 9.872199840740173, 2.3135249088816305, 'HP:0006482', 'Abnormal dental morphology'),
(23851, 'HP:0011089', 'Double tooth', 'XPO:0115393', 'abnormally decreased volume of oral cavity', 0.5, 7.884497199543557, 1.9855096574360394, 'UPHENO:0076786', 'abnormal oral cavity morphology'),
(23852, 'HP:0011089', 'Double tooth', 'XPO:0102690', 'abnormal dorsal hyoid arch skeleton morphology', 0.41025641025641024, 5.725717590856133, 1.5326488002692003, 'UPHENO:0076803', 'abnormal digestive system morphology'),
(23853, 'HP:0011089', 'Double tooth', 'XPO:0128989', 'decreased size of the tooth', 0.5357142857142857, 9.872199840740173, 2.2997126964277097, 'HP:0006482', 'Abnormal dental morphology'),
(23854, 'HP:0011089', 'Double tooth', 'XPO:0127750', 'abnormally localised tongue', 0.4925373134328358, 7.884497199543557, 1.970636716503552, 'UPHENO:0076786', 'abnormal oral cavity morphology'),
(23855, 'HP:0011089', 'Double tooth', 'XPO:0103096', 'abnormal oral cavity morphology', 0.5555555555555556, 7.884497199543557, 2.0929109445861864, 'UPHENO:0076786', 'abnormal oral cavity morphology'),
(23856, 'HP:0011089', 'Double tooth', 'XPO:0102092', 'abnormal ethmoid region morphology', 0.40625, 4.638757693672553, 1.3727692133255593, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(23857, 'HP:0011089', 'Double tooth', 'XPO:0102960', 'abnormal oral epithelium morphology', 0.4583333333333333, 7.312692920701687, 1.830751463740579, 'UPHENO:0076800', 'abnormal mouth morphology'),
(23858, 'HP:0011089', 'Double tooth', 'XPO:0102103', 'abnormal mandibular arch morphology', 0.4383561643835616, 5.725717590856133, 1.584267528377446, 'UPHENO:0076803', 'abnormal digestive system morphology'),
(23859, 'HP:0011089', 'Double tooth', 'XPO:0128105', 'decreased size of the tongue', 0.4605263157894737, 7.884497199543557, 1.9055231426456665, 'UPHENO:0076786', 'abnormal oral cavity morphology'),
(23860, 'HP:0011089', 'Double tooth', 'XPO:0139862', 'abnormally necrotic mandibular arch', 0.4050632911392405, 5.725717590856133, 1.5229175983900207, 'UPHENO:0076803', 'abnormal digestive system morphology'),
(23861, 'HP:0011089', 'Double tooth', 'XPO:0140890', 'abnormally necrotic dentine', 0.4891304347826087, 9.872199840740173, 2.197451569514569, 'HP:0006482', 'Abnormal dental morphology'),
(23862, 'HP:0011089', 'Double tooth', 'XPO:0103138', 'abnormal upper jaw morphology', 0.5066666666666667, 7.312692920701687, 1.9248630461642862, 'UPHENO:0076800', 'abnormal mouth morphology'),
(23863, 'HP:0011089', 'Double tooth', 'XPO:0102525', 'abnormal hyoid arch morphology', 0.4090909090909091, 5.725717590856133, 1.5304701939081158, 'UPHENO:0076803', 'abnormal digestive system morphology'),
(23864, 'HP:0011089', 'Double tooth', 'XPO:0128880', 'decreased size of the lower jaw', 0.475, 7.312692920701687, 1.8637406303810895, 'UPHENO:0076800', 'abnormal mouth morphology'),
(23865, 'HP:0011089', 'Double tooth', 'XPO:0128653', 'decreased size of the oral epithelium', 0.4074074074074074, 7.312692920701687, 1.7260490329042149, 'UPHENO:0076800', 'abnormal mouth morphology'),
(23866, 'HP:0011089', 'Double tooth', 'XPO:0100420', 'abnormal choana', 0.4126984126984127, 5.0624614801082695, 1.445430668412546, 'UPHENO:0002910', 'abnormal face'),
(23867, 'HP:0011089', 'Double tooth', 'XPO:0102985', 'abnormal branchial arch skeleton 3 morphology', 0.41025641025641024, 5.725717590856133, 1.5326488002692003, 'UPHENO:0076803', 'abnormal digestive system morphology'),
(23868, 'HP:0011089', 'Double tooth', 'XPO:0103176', 'abnormal fenestra basicranialis morphology', 0.40625, 4.638757693672553, 1.3727692133255593, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(23869, 'HP:0011089', 'Double tooth', 'XPO:0141006', 'abnormally necrotic cementum', 0.5056179775280899, 9.872199840740173, 2.2341803233463895, 'HP:0006482', 'Abnormal dental morphology'),
(23870, 'HP:0011089', 'Double tooth', 'XPO:0103224', 'abnormal ventral hyoid arch skeleton morphology', 0.41025641025641024, 5.725717590856133, 1.5326488002692003, 'UPHENO:0076803', 'abnormal digestive system morphology'),
(23871, 'HP:0011089', 'Double tooth', 'XPO:0141009', 'abnormally necrotic oral epithelium', 0.4177215189873418, 7.312692920701687, 1.7477611949930372, 'UPHENO:0076800', 'abnormal mouth morphology'),
(23872, 'HP:0011089', 'Double tooth', 'XPO:0131573', 'decreased size of the roof of mouth', 0.4520547945205479, 7.312692920701687, 1.8181688303509294, 'UPHENO:0076800', 'abnormal mouth morphology'),
(23873, 'HP:0011089', 'Double tooth', 'XPO:0129585', 'increased size of the tongue', 0.45, 7.884497199543557, 1.8836198501275678, 'UPHENO:0076786', 'abnormal oral cavity morphology'),
(23874, 'HP:0011089', 'Double tooth', 'XPO:0101659', 'abnormal lower jaw morphology', 0.5205479452054794, 7.312692920701687, 1.951052862889655, 'UPHENO:0076800', 'abnormal mouth morphology'),
(23875, 'HP:0011089', 'Double tooth', 'XPO:0102204', 'abnormal branchial arch morphology', 0.4153846153846154, 5.725717590856133, 1.5421981063659433, 'UPHENO:0076803', 'abnormal digestive system morphology'),
(23876, 'HP:0011089', 'Double tooth', 'XPO:0101764', 'abnormal cranium morphology', 0.4126984126984127, 4.638757693672553, 1.3836213127410304, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(23877, 'HP:0011089', 'Double tooth', 'XPO:0103199', 'abnormal tongue morphology', 0.5555555555555556, 7.884497199543557, 2.0929109445861864, 'UPHENO:0076786', 'abnormal oral cavity morphology'),
(23878, 'HP:0011089', 'Double tooth', 'XPO:0126046', 'absent tooth', 0.4175824175824176, 9.181382707377857, 1.9580561758275088, 'UPHENO:0002826', 'abnormal dentition'),
(23879, 'HP:0011089', 'Double tooth', 'XPO:0126089', 'absent tongue', 0.4782608695652174, 7.884497199543557, 1.9418667530853457, 'UPHENO:0076786', 'abnormal oral cavity morphology'),
(23880, 'HP:0011089', 'Double tooth', 'XPO:0103735', 'increased size of the mouth', 0.4861111111111111, 7.884497199543557, 1.9577389239177327, 'UPHENO:0076786', 'abnormal oral cavity morphology'),
(23881, 'HP:0011089', 'Double tooth', 'XPO:0102223', 'abnormal pharyngeal arch morphology', 0.42857142857142855, 5.725717590856133, 1.5664861849086864, 'UPHENO:0076803', 'abnormal digestive system morphology'),
(23882, 'HP:0011089', 'Double tooth', 'XPO:0129225', 'decreased size of the upper jaw', 0.4634146341463415, 7.312692920701687, 1.8408717811057655, 'UPHENO:0076800', 'abnormal mouth morphology'),
(23883, 'HP:0010522', 'Dyslexia', 'XPO:0100427', 'abnormal olfactory system', 0.4482758620689655, 3.94131651835137, 1.3292091859262085, 'UPHENO:0004523', 'abnormal nervous system'),
(23884, 'HP:0010522', 'Dyslexia', 'XPO:0101187', 'abnormal dorsolateral commissural neuron', 0.40625, 3.94131651835137, 1.2653694462805098, 'UPHENO:0004523', 'abnormal nervous system'),
(23885, 'HP:0010522', 'Dyslexia', 'XPO:0100164', 'abnormal neural nucleus', 0.43333333333333335, 3.94131651835137, 1.3068679445984308, 'UPHENO:0004523', 'abnormal nervous system'),
(23886, 'HP:0010522', 'Dyslexia', 'XPO:0101501', 'abnormal parabrachial area', 0.41935483870967744, 3.94131651835137, 1.2856166430382838, 'UPHENO:0004523', 'abnormal nervous system'),
(23887, 'HP:0010522', 'Dyslexia', 'XPO:0100274', 'abnormal sensory system', 0.4642857142857143, 3.94131651835137, 1.3527368387638634, 'UPHENO:0004523', 'abnormal nervous system'),
(23888, 'HP:0010522', 'Dyslexia', 'XPO:0100701', 'abnormal microglial cell', 0.40625, 3.94131651835137, 1.2653694462805098, 'UPHENO:0004523', 'abnormal nervous system'),
(23889, 'HP:0010522', 'Dyslexia', 'XPO:0100734', 'abnormal lateral line system', 0.40625, 3.94131651835137, 1.2653694462805098, 'UPHENO:0004523', 'abnormal nervous system'),
(23890, 'HP:0010522', 'Dyslexia', 'XPO:0100587', 'abnormal vestibuloauditory system', 0.4482758620689655, 3.94131651835137, 1.3292091859262085, 'UPHENO:0004523', 'abnormal nervous system'),
(23891, 'HP:0010522', 'Dyslexia', 'XPO:0100864', 'abnormal dorsolateral ascending neuron', 0.40625, 3.94131651835137, 1.2653694462805098, 'UPHENO:0004523', 'abnormal nervous system'),
(23892, 'HP:0010522', 'Dyslexia', 'XPO:0100032', 'abnormal nervous system', 0.48148148148148145, 3.94131651835137, 1.3775597686645948, 'UPHENO:0004523', 'abnormal nervous system'),
(23893, 'HP:0010522', 'Dyslexia', 'XPO:0100537', 'abnormal medium cavity', 0.41935483870967744, 3.94131651835137, 1.2856166430382838, 'UPHENO:0004523', 'abnormal nervous system'),
(23894, 'HP:0010522', 'Dyslexia', 'XPO:0100158', 'abnormal neuromere', 0.41935483870967744, 3.94131651835137, 1.2856166430382838, 'UPHENO:0004523', 'abnormal nervous system'),
(23895, 'HP:0010522', 'Dyslexia', 'XPO:0100175', 'abnormal migrating neuroblast', 0.41935483870967744, 3.94131651835137, 1.2856166430382838, 'UPHENO:0004523', 'abnormal nervous system'),
(23896, 'HP:0010522', 'Dyslexia', 'XPO:0100031', 'abnormal central nervous system', 0.4642857142857143, 3.94131651835137, 1.3527368387638634, 'UPHENO:0004523', 'abnormal nervous system'),
(23897, 'HP:0010522', 'Dyslexia', 'XPO:0100760', 'abnormal Stirnorgan', 0.40625, 3.94131651835137, 1.2653694462805098, 'UPHENO:0004523', 'abnormal nervous system'),
(23898, 'HP:0010522', 'Dyslexia', 'XPO:0100004', 'abnormal cell', 0.4074074074074074, 1.8210412618256888, 0.861339479684008, 'HP:0000118', 'Phenotypic abnormality'),
(23899, 'HP:0010522', 'Dyslexia', 'XPO:0100858', 'abnormal presumptive midbrain-hindbrain boundary', 0.41935483870967744, 3.94131651835137, 1.2856166430382838, 'UPHENO:0004523', 'abnormal nervous system'),
(23900, 'HP:0010522', 'Dyslexia', 'XPO:0101133', 'abnormal motor neuron', 0.40625, 3.94131651835137, 1.2653694462805098, 'UPHENO:0004523', 'abnormal nervous system'),
(23901, 'HP:0010522', 'Dyslexia', 'XPO:0100642', 'abnormal gustatory system', 0.4482758620689655, 3.94131651835137, 1.3292091859262085, 'UPHENO:0004523', 'abnormal nervous system'),
(23902, 'HP:0010522', 'Dyslexia', 'XPO:0142051', 'abnormal cerebrospinal fluid', 0.43333333333333335, 3.94131651835137, 1.3068679445984308, 'UPHENO:0004523', 'abnormal nervous system'),
(23903, 'HP:0010522', 'Dyslexia', 'XPO:0100702', 'abnormal glial cell', 0.41935483870967744, 3.94131651835137, 1.2856166430382838, 'UPHENO:0004523', 'abnormal nervous system'),
(23904, 'HP:0010522', 'Dyslexia', 'XPO:0100916', 'abnormal principal cavity', 0.41935483870967744, 3.94131651835137, 1.2856166430382838, 'UPHENO:0004523', 'abnormal nervous system'),
(23905, 'HP:0010522', 'Dyslexia', 'XPO:0100954', 'abnormal neural progenitor cell', 0.40625, 3.94131651835137, 1.2653694462805098, 'UPHENO:0004523', 'abnormal nervous system'),
(23906, 'HP:0010522', 'Dyslexia', 'XPO:0100196', 'abnormal neuron', 0.41935483870967744, 3.94131651835137, 1.2856166430382838, 'UPHENO:0004523', 'abnormal nervous system'),
(23907, 'HP:0010522', 'Dyslexia', 'XPO:0100114', 'abnormal peripheral nervous system', 0.43333333333333335, 3.94131651835137, 1.3068679445984308, 'UPHENO:0004523', 'abnormal nervous system'),
(23908, 'HP:0010522', 'Dyslexia', 'XPO:0107253', 'abnormal enteric nervous system', 0.4642857142857143, 3.94131651835137, 1.3527368387638634, 'UPHENO:0004523', 'abnormal nervous system'),
(23909, 'HP:0010522', 'Dyslexia', 'XPO:0100273', 'abnormal visual system', 0.4482758620689655, 3.94131651835137, 1.3292091859262085, 'UPHENO:0004523', 'abnormal nervous system'),
(23910, 'HP:0041236', 'Fractured middle phalanx of manus', 'XPO:0102787', 'abnormal forelimb digit 5 morphology', 0.41228070175438597, 7.492661022682715, 1.7575777491876043, 'HP:0001167', 'Abnormal finger morphology'),
(23911, 'HP:0041236', 'Fractured middle phalanx of manus', 'XPO:0103609', 'abnormally increased number of forelimb digit in the regenerating forelimb', 0.4351145038167939, 7.774297771301195, 1.839214429391996, 'HP:0005918', 'Abnormal finger phalanx morphology'),
(23912, 'HP:0041236', 'Fractured middle phalanx of manus', 'XPO:0102214', 'abnormal forelimb digit morphology', 0.41964285714285715, 7.492661022682715, 1.7732009697610411, 'HP:0001167', 'Abnormal finger morphology'),
(23913, 'HP:0041236', 'Fractured middle phalanx of manus', 'XPO:0102746', 'abnormal forelimb digit 2 morphology', 0.41228070175438597, 7.492661022682715, 1.7575777491876043, 'HP:0001167', 'Abnormal finger morphology'),
(23914, 'HP:0041236', 'Fractured middle phalanx of manus', 'XPO:0103634', 'abnormally increased number of forelimb digit', 0.456, 7.774297771301195, 1.8828382255821516, 'HP:0005918', 'Abnormal finger phalanx morphology'),
(23915, 'HP:0041236', 'Fractured middle phalanx of manus', 'XPO:0115789', 'duplicated forelimb digit 5 in regenerating forelimb', 0.41911764705882354, 7.774297771301195, 1.805088748356272, 'HP:0005918', 'Abnormal finger phalanx morphology'),
(23916, 'HP:0041236', 'Fractured middle phalanx of manus', 'XPO:0102529', 'abnormal forelimb digit 4 morphology', 0.41228070175438597, 7.492661022682715, 1.7575777491876043, 'HP:0001167', 'Abnormal finger morphology'),
(23917, 'HP:0041236', 'Fractured middle phalanx of manus', 'XPO:0115787', 'duplicated forelimb digit 3 in regenerating forelimb', 0.41911764705882354, 7.774297771301195, 1.805088748356272, 'HP:0005918', 'Abnormal finger phalanx morphology'),
(23918, 'HP:0041236', 'Fractured middle phalanx of manus', 'XPO:0115788', 'duplicated forelimb digit 4 in regenerating forelimb', 0.41911764705882354, 7.774297771301195, 1.805088748356272, 'HP:0005918', 'Abnormal finger phalanx morphology'),
(23919, 'HP:0041236', 'Fractured middle phalanx of manus', 'XPO:0115786', 'duplicated forelimb digit 2 in regenerating forelimb', 0.41911764705882354, 7.774297771301195, 1.805088748356272, 'HP:0005918', 'Abnormal finger phalanx morphology'),
(23920, 'HP:0041236', 'Fractured middle phalanx of manus', 'XPO:0102598', 'abnormal forelimb digit 3 morphology', 0.41228070175438597, 7.492661022682715, 1.7575777491876043, 'HP:0001167', 'Abnormal finger morphology'),
(23921, 'HP:0041117', 'Fractured lower limb segment', 'XPO:0102773', 'abnormal Keller explant morphology', 0.41935483870967744, 2.786899518863159, 1.0810641970914296, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(23922, 'HP:0041117', 'Fractured lower limb segment', 'XPO:0103201', 'abnormal activin-induced ectoderm morphology', 0.41935483870967744, 2.786899518863159, 1.0810641970914296, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(23923, 'HP:0041117', 'Fractured lower limb segment', 'XPO:0141321', 'edematous hindlimb', 0.4666666666666667, 7.333232559010569, 1.849912212567108, 'UPHENO:0084767', 'abnormal anatomical entity morphology in the pelvic complex'),
(23924, 'HP:0041117', 'Fractured lower limb segment', 'XPO:0129777', 'increased size of the limb', 0.41304347826086957, 5.914846961127896, 1.563038375154302, 'UPHENO:0084763', 'abnormal anatomical entity morphology in the appendage girdle complex'),
(23925, 'HP:0041117', 'Fractured lower limb segment', 'XPO:0139872', 'abnormally necrotic zeugopod', 0.41304347826086957, 5.914846961127896, 1.563038375154302, 'UPHENO:0084763', 'abnormal anatomical entity morphology in the appendage girdle complex'),
(23926, 'HP:0041117', 'Fractured lower limb segment', 'XPO:0102896', 'abnormal mitotic spindle morphology', 0.40540540540540543, 2.786899518863159, 1.0629318554210558, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(23927, 'HP:0041117', 'Fractured lower limb segment', 'XPO:0139895', 'abnormally necrotic limb segment', 0.4418604651162791, 5.914846961127896, 1.6166437546149683, 'UPHENO:0084763', 'abnormal anatomical entity morphology in the appendage girdle complex'),
(23928, 'HP:0041117', 'Fractured lower limb segment', 'XPO:0102526', 'abnormal nucleus morphology', 0.40540540540540543, 2.786899518863159, 1.0629318554210558, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(23929, 'HP:0041117', 'Fractured lower limb segment', 'XPO:0101837', 'abnormal limb segment morphology', 0.5, 5.914846961127896, 1.7197161046416785, 'UPHENO:0084763', 'abnormal anatomical entity morphology in the appendage girdle complex'),
(23930, 'HP:0041117', 'Fractured lower limb segment', 'XPO:0141507', 'abnormal autopod morphology in the regenerating limb', 0.4222222222222222, 5.914846961127896, 1.5803100417423723, 'UPHENO:0084763', 'abnormal anatomical entity morphology in the appendage girdle complex'),
(23931, 'HP:0041117', 'Fractured lower limb segment', 'XPO:0102703', 'abnormal endoplasmic reticulum morphology', 0.40540540540540543, 2.786899518863159, 1.0629318554210558, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(23932, 'HP:0041117', 'Fractured lower limb segment', 'XPO:0133355', 'hindlimb fused with trunk', 0.45652173913043476, 7.333232559010569, 1.829693985694721, 'UPHENO:0084767', 'abnormal anatomical entity morphology in the pelvic complex'),
(23933, 'HP:0041117', 'Fractured lower limb segment', 'XPO:0102353', 'abnormal centromere morphology', 0.40540540540540543, 2.786899518863159, 1.0629318554210558, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(23934, 'HP:0041117', 'Fractured lower limb segment', 'XPO:0102693', 'abnormal plasma membrane morphology', 0.40540540540540543, 2.786899518863159, 1.0629318554210558, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(23935, 'HP:0041117', 'Fractured lower limb segment', 'XPO:0140371', 'abnormally necrotic autopod', 0.41304347826086957, 5.914846961127896, 1.563038375154302, 'UPHENO:0084763', 'abnormal anatomical entity morphology in the appendage girdle complex'),
(23936, 'HP:0041117', 'Fractured lower limb segment', 'XPO:0101871', 'abnormal acellular anatomical structure morphology', 0.40625, 2.786899518863159, 1.0640385000262718, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(23937, 'HP:0041117', 'Fractured lower limb segment', 'XPO:0141316', 'abnormal anatomical region morphology', 0.41935483870967744, 2.786899518863159, 1.0810641970914296, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(23938, 'HP:0041117', 'Fractured lower limb segment', 'XPO:0140214', 'abnormally necrotic foot', 0.40384615384615385, 7.333232559010569, 1.7209002772432245, 'UPHENO:0084767', 'abnormal anatomical entity morphology in the pelvic complex'),
(23939, 'HP:0041117', 'Fractured lower limb segment', 'XPO:0140041', 'abnormally necrotic stylopod', 0.41304347826086957, 5.914846961127896, 1.563038375154302, 'UPHENO:0084763', 'abnormal anatomical entity morphology in the appendage girdle complex'),
(23940, 'HP:0041117', 'Fractured lower limb segment', 'XPO:0142064', 'abnormal desmosome morphology', 0.40540540540540543, 2.786899518863159, 1.0629318554210558, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(23941, 'HP:0041117', 'Fractured lower limb segment', 'XPO:0102742', 'abnormal cell-free extract morphology', 0.41935483870967744, 2.786899518863159, 1.0810641970914296, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(23942, 'HP:0041117', 'Fractured lower limb segment', 'XPO:0102035', 'abnormal forelimb morphology', 0.4318181818181818, 5.914846961127896, 1.5981672191879817, 'UPHENO:0084763', 'abnormal anatomical entity morphology in the appendage girdle complex'),
(23943, 'HP:0041117', 'Fractured lower limb segment', 'XPO:0133356', 'forelimb fused with trunk', 0.40425531914893614, 5.914846961127896, 1.5463209065352097, 'UPHENO:0084763', 'abnormal anatomical entity morphology in the appendage girdle complex'),
(23944, 'HP:0041117', 'Fractured lower limb segment', 'XPO:0140049', 'abnormally necrotic limb', 0.4318181818181818, 5.914846961127896, 1.5981672191879817, 'UPHENO:0084763', 'abnormal anatomical entity morphology in the appendage girdle complex'),
(23945, 'HP:0041117', 'Fractured lower limb segment', 'XPO:0103073', 'abnormal interdigital webbing morphology', 0.4318181818181818, 5.914846961127896, 1.5981672191879817, 'UPHENO:0084763', 'abnormal anatomical entity morphology in the appendage girdle complex'),
(23946, 'HP:0041117', 'Fractured lower limb segment', 'XPO:0141540', 'inverted dorsal-ventral axis in hindlimb zeugopod', 0.42857142857142855, 7.333232559010569, 1.7727983398744687, 'UPHENO:0084767', 'abnormal anatomical entity morphology in the pelvic complex'),
(23947, 'HP:0041117', 'Fractured lower limb segment', 'XPO:0140040', 'abnormally necrotic hindlimb stylopod', 0.40384615384615385, 7.333232559010569, 1.7209002772432245, 'UPHENO:0084767', 'abnormal anatomical entity morphology in the pelvic complex'),
(23948, 'HP:0041117', 'Fractured lower limb segment', 'XPO:0102356', 'abnormal kinetochore morphology', 0.40540540540540543, 2.786899518863159, 1.0629318554210558, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(23949, 'HP:0041117', 'Fractured lower limb segment', 'XPO:0103145', 'abnormal basal body morphology', 0.40540540540540543, 2.786899518863159, 1.0629318554210558, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(23950, 'HP:0041117', 'Fractured lower limb segment', 'XPO:0141574', 'abnormal muscle morphology in the hindlimb', 0.40384615384615385, 7.333232559010569, 1.7209002772432245, 'UPHENO:0084767', 'abnormal anatomical entity morphology in the pelvic complex'),
(23951, 'HP:0041117', 'Fractured lower limb segment', 'XPO:0139718', 'abnormally necrotic anatomical structure', 0.41935483870967744, 2.786899518863159, 1.0810641970914296, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(23952, 'HP:0041117', 'Fractured lower limb segment', 'XPO:0102530', 'abnormal hindlimb stylopod morphology', 0.4666666666666667, 7.333232559010569, 1.849912212567108, 'UPHENO:0084767', 'abnormal anatomical entity morphology in the pelvic complex'),
(23953, 'HP:0041117', 'Fractured lower limb segment', 'XPO:0140621', 'abnormally necrotic hindlimb zeugopod', 0.40384615384615385, 7.333232559010569, 1.7209002772432245, 'UPHENO:0084767', 'abnormal anatomical entity morphology in the pelvic complex'),
(23954, 'HP:0041117', 'Fractured lower limb segment', 'XPO:0102113', 'abnormal anatomical line morphology', 0.4482758620689655, 2.786899518863159, 1.1177207989108764, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(23955, 'HP:0041117', 'Fractured lower limb segment', 'XPO:0141277', 'abnormal actin cytoskeleton morphology', 0.40540540540540543, 2.786899518863159, 1.0629318554210558, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(23956, 'HP:0041117', 'Fractured lower limb segment', 'XPO:0141296', 'abnormal adherens junction morphology', 0.40540540540540543, 2.786899518863159, 1.0629318554210558, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(23957, 'HP:0041117', 'Fractured lower limb segment', 'XPO:0101740', 'abnormal cell part morphology', 0.42857142857142855, 2.786899518863159, 1.092879457252359, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(23958, 'HP:0041117', 'Fractured lower limb segment', 'XPO:0101973', 'abnormal hand morphology', 0.40425531914893614, 5.914846961127896, 1.5463209065352097, 'UPHENO:0084763', 'abnormal anatomical entity morphology in the appendage girdle complex'),
(23959, 'HP:0041117', 'Fractured lower limb segment', 'XPO:0102142', 'abnormal forelimb stylopod morphology', 0.40425531914893614, 5.914846961127896, 1.5463209065352097, 'UPHENO:0084763', 'abnormal anatomical entity morphology in the appendage girdle complex'),
(23960, 'HP:0041117', 'Fractured lower limb segment', 'XPO:0102588', 'abnormal centrosome morphology', 0.40540540540540543, 2.786899518863159, 1.0629318554210558, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(23961, 'HP:0041117', 'Fractured lower limb segment', 'XPO:0102055', 'abnormal process morphology', 0.40625, 2.786899518863159, 1.0640385000262718, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(23962, 'HP:0041117', 'Fractured lower limb segment', 'XPO:0102178', 'abnormal whole organism morphology', 0.41935483870967744, 2.786899518863159, 1.0810641970914296, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(23963, 'HP:0041117', 'Fractured lower limb segment', 'XPO:0103179', 'abnormal lampbrush chromosome morphology', 0.40540540540540543, 2.786899518863159, 1.0629318554210558, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(23964, 'HP:0041117', 'Fractured lower limb segment', 'XPO:0141508', 'abnormal stylopod morphology in the regenerating limb', 0.4222222222222222, 5.914846961127896, 1.5803100417423723, 'UPHENO:0084763', 'abnormal anatomical entity morphology in the appendage girdle complex'),
(23965, 'HP:0041117', 'Fractured lower limb segment', 'XPO:0101694', 'abnormal anatomical space morphology', 0.41935483870967744, 2.786899518863159, 1.0810641970914296, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(23966, 'HP:0041117', 'Fractured lower limb segment', 'XPO:0140269', 'abnormally necrotic anatomical line', 0.41935483870967744, 2.786899518863159, 1.0810641970914296, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(23967, 'HP:0041117', 'Fractured lower limb segment', 'XPO:0141552', 'abnormal nervous system morphology in the hindlimb', 0.4375, 7.333232559010569, 1.791169797804531, 'UPHENO:0084767', 'abnormal anatomical entity morphology in the pelvic complex'),
(23968, 'HP:0041117', 'Fractured lower limb segment', 'XPO:0101890', 'abnormal organ part morphology', 0.41935483870967744, 2.786899518863159, 1.0810641970914296, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(23969, 'HP:0041117', 'Fractured lower limb segment', 'XPO:0141541', 'inverted joint region in hindlimb', 0.4772727272727273, 7.333232559010569, 1.8708158389227239, 'UPHENO:0084767', 'abnormal anatomical entity morphology in the pelvic complex'),
(23970, 'HP:0041117', 'Fractured lower limb segment', 'XPO:0103383', 'increased size of the hindlimb', 0.4117647058823529, 7.333232559010569, 1.7376899458268962, 'UPHENO:0084767', 'abnormal anatomical entity morphology in the pelvic complex'),
(23971, 'HP:0041117', 'Fractured lower limb segment', 'XPO:0101642', 'abnormal multicellular anatomical structure morphology', 0.40625, 2.786899518863159, 1.0640385000262718, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(23972, 'HP:0041117', 'Fractured lower limb segment', 'XPO:0102360', 'abnormal cell condensation morphology', 0.40625, 2.786899518863159, 1.0640385000262718, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(23973, 'HP:0041117', 'Fractured lower limb segment', 'XPO:0141565', 'abnormal hindlimb stylopod morphology in the regenerating hindlimb', 0.40384615384615385, 7.333232559010569, 1.7209002772432245, 'UPHENO:0084767', 'abnormal anatomical entity morphology in the pelvic complex'),
(23974, 'HP:0041117', 'Fractured lower limb segment', 'XPO:0102478', 'abnormal hindlimb morphology', 0.5, 7.333232559010569, 1.91484105854906, 'UPHENO:0084767', 'abnormal anatomical entity morphology in the pelvic complex'),
(23975, 'HP:0041117', 'Fractured lower limb segment', 'XPO:0130219', 'increased size of the interdigital region', 0.4634146341463415, 5.914846961127896, 1.6556046147926393, 'UPHENO:0084763', 'abnormal anatomical entity morphology in the appendage girdle complex'),
(23976, 'HP:0041117', 'Fractured lower limb segment', 'XPO:0107399', 'abnormal filopodium morphology', 0.40540540540540543, 2.786899518863159, 1.0629318554210558, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(23977, 'HP:0041117', 'Fractured lower limb segment', 'XPO:0102302', 'abnormal forelimb zeugopod morphology', 0.40425531914893614, 5.914846961127896, 1.5463209065352097, 'UPHENO:0084763', 'abnormal anatomical entity morphology in the appendage girdle complex'),
(23978, 'HP:0041117', 'Fractured lower limb segment', 'XPO:0115510', 'abnormal degeneration of whole organism', 0.40625, 2.786899518863159, 1.0640385000262718, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(23979, 'HP:0041117', 'Fractured lower limb segment', 'XPO:0102090', 'abnormal autopod morphology', 0.475, 5.914846961127896, 1.676171920339841, 'UPHENO:0084763', 'abnormal anatomical entity morphology in the appendage girdle complex'),
(23980, 'HP:0041117', 'Fractured lower limb segment', 'XPO:0101638', 'abnormal anatomical structure morphology', 0.4482758620689655, 2.786899518863159, 1.1177207989108764, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(23981, 'HP:0041117', 'Fractured lower limb segment', 'XPO:0141578', 'abnormal joint region morphology in the hindlimb', 0.5121951219512195, 7.333232559010569, 1.9380521006565, 'UPHENO:0084767', 'abnormal anatomical entity morphology in the pelvic complex'),
(23982, 'HP:0041117', 'Fractured lower limb segment', 'XPO:0107345', 'abnormal anatomical axis morphology', 0.41935483870967744, 2.786899518863159, 1.0810641970914296, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(23983, 'HP:0041117', 'Fractured lower limb segment', 'XPO:0128056', 'decreased size of the limb segment', 0.4222222222222222, 5.914846961127896, 1.5803100417423723, 'UPHENO:0084763', 'abnormal anatomical entity morphology in the appendage girdle complex'),
(23984, 'HP:0041117', 'Fractured lower limb segment', 'XPO:0101636', 'abnormal cell morphology', 0.4166666666666667, 2.786899518863159, 1.0775936770692605, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(23985, 'HP:0041117', 'Fractured lower limb segment', 'XPO:0102089', 'abnormal foot morphology', 0.4666666666666667, 7.333232559010569, 1.849912212567108, 'UPHENO:0084767', 'abnormal anatomical entity morphology in the pelvic complex'),
(23986, 'HP:0041117', 'Fractured lower limb segment', 'XPO:0140144', 'abnormally necrotic portion of organism substance', 0.41935483870967744, 2.786899518863159, 1.0810641970914296, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(23987, 'HP:0041117', 'Fractured lower limb segment', 'XPO:0140236', 'abnormally necrotic hindlimb', 0.42857142857142855, 7.333232559010569, 1.7727983398744687, 'UPHENO:0084767', 'abnormal anatomical entity morphology in the pelvic complex'),
(23988, 'HP:0041117', 'Fractured lower limb segment', 'XPO:0100852', 'abnormal interdigital region', 0.41935483870967744, 5.504475013697824, 1.5193183443737854, 'HP:0040064', 'Abnormality of limbs'),
(23989, 'HP:0041117', 'Fractured lower limb segment', 'XPO:0101976', 'abnormal portion of organism substance morphology', 0.4482758620689655, 2.786899518863159, 1.1177207989108764, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(23990, 'HP:0041117', 'Fractured lower limb segment', 'XPO:0102520', 'abnormal microtubule morphology', 0.40540540540540543, 2.786899518863159, 1.0629318554210558, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(23991, 'HP:0041117', 'Fractured lower limb segment', 'XPO:0103345', 'decreased size of the hindlimb', 0.4117647058823529, 7.333232559010569, 1.7376899458268962, 'UPHENO:0084767', 'abnormal anatomical entity morphology in the pelvic complex'),
(23992, 'HP:0041117', 'Fractured lower limb segment', 'XPO:0141322', 'edematous forelimb', 0.40425531914893614, 5.914846961127896, 1.5463209065352097, 'UPHENO:0084763', 'abnormal anatomical entity morphology in the appendage girdle complex'),
(23993, 'HP:0041117', 'Fractured lower limb segment', 'XPO:0115721', 'abnormally inverted hindlimb zeugopod', 0.45652173913043476, 7.333232559010569, 1.829693985694721, 'UPHENO:0084767', 'abnormal anatomical entity morphology in the pelvic complex'),
(23994, 'HP:0041117', 'Fractured lower limb segment', 'XPO:0102018', 'abnormal limb morphology', 0.5, 5.914846961127896, 1.7197161046416785, 'UPHENO:0084763', 'abnormal anatomical entity morphology in the appendage girdle complex'),
(23995, 'HP:0041117', 'Fractured lower limb segment', 'XPO:0141509', 'abnormal zeugopod morphology in the regenerating limb', 0.4222222222222222, 5.914846961127896, 1.5803100417423723, 'UPHENO:0084763', 'abnormal anatomical entity morphology in the appendage girdle complex'),
(23996, 'HP:0041117', 'Fractured lower limb segment', 'XPO:0101713', 'abnormal anatomical entity in vitro morphology', 0.4482758620689655, 2.786899518863159, 1.1177207989108764, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(23997, 'HP:0041117', 'Fractured lower limb segment', 'XPO:0102484', 'abnormal interdigital region morphology', 0.5428571428571428, 5.914846961127896, 1.7919031563550367, 'UPHENO:0084763', 'abnormal anatomical entity morphology in the appendage girdle complex'),
(23998, 'HP:0041117', 'Fractured lower limb segment', 'XPO:0141579', 'abnormal joint region morphology in the hindlimb zeugopod', 0.4666666666666667, 7.333232559010569, 1.849912212567108, 'UPHENO:0084767', 'abnormal anatomical entity morphology in the pelvic complex'),
(23999, 'HP:0041117', 'Fractured lower limb segment', 'XPO:0140528', 'abnormally necrotic interdigital region', 0.48717948717948717, 5.914846961127896, 1.6975252897283848, 'UPHENO:0084763', 'abnormal anatomical entity morphology in the appendage girdle complex'),
(24000, 'HP:0041117', 'Fractured lower limb segment', 'XPO:0102034', 'abnormal zeugopod morphology', 0.475, 5.914846961127896, 1.676171920339841, 'UPHENO:0084763', 'abnormal anatomical entity morphology in the appendage girdle complex'),
(24001, 'HP:0041117', 'Fractured lower limb segment', 'XPO:0141571', 'abnormal dorsal-ventral axis morphology in the hindlimb zeugopod', 0.45652173913043476, 7.333232559010569, 1.829693985694721, 'UPHENO:0084767', 'abnormal anatomical entity morphology in the pelvic complex'),
(24002, 'HP:0041117', 'Fractured lower limb segment', 'XPO:0102601', 'abnormal disaggregated/reaggregated ectoderm treated with activin morphology', 0.41935483870967744, 2.786899518863159, 1.0810641970914296, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(24003, 'HP:0041117', 'Fractured lower limb segment', 'XPO:0101716', 'abnormal anatomical group morphology', 0.40625, 2.786899518863159, 1.0640385000262718, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(24004, 'HP:0041117', 'Fractured lower limb segment', 'XPO:0102143', 'abnormal stylopod morphology', 0.475, 5.914846961127896, 1.676171920339841, 'UPHENO:0084763', 'abnormal anatomical entity morphology in the appendage girdle complex'),
(24005, 'HP:0041117', 'Fractured lower limb segment', 'XPO:0141548', 'abnormal foot morphology in the regenerating hindlimb', 0.40384615384615385, 7.333232559010569, 1.7209002772432245, 'UPHENO:0084767', 'abnormal anatomical entity morphology in the pelvic complex'),
(24006, 'HP:0041117', 'Fractured lower limb segment', 'XPO:0129536', 'increased size of the limb segment', 0.4222222222222222, 5.914846961127896, 1.5803100417423723, 'UPHENO:0084763', 'abnormal anatomical entity morphology in the appendage girdle complex'),
(24007, 'HP:0041117', 'Fractured lower limb segment', 'XPO:0102454', 'abnormal hindlimb zeugopod morphology', 0.4666666666666667, 7.333232559010569, 1.849912212567108, 'UPHENO:0084767', 'abnormal anatomical entity morphology in the pelvic complex'),
(24008, 'HP:0041117', 'Fractured lower limb segment', 'XPO:0102539', 'abnormal cytoplasm morphology', 0.40540540540540543, 2.786899518863159, 1.0629318554210558, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(24009, 'HP:0041117', 'Fractured lower limb segment', 'XPO:0128297', 'decreased size of the limb', 0.41304347826086957, 5.914846961127896, 1.563038375154302, 'UPHENO:0084763', 'abnormal anatomical entity morphology in the appendage girdle complex'),
(24010, 'HP:0041117', 'Fractured lower limb segment', 'XPO:0128741', 'decreased size of the interdigital region', 0.4634146341463415, 5.914846961127896, 1.6556046147926393, 'UPHENO:0084763', 'abnormal anatomical entity morphology in the appendage girdle complex'),
(24011, 'HP:0006201', 'Hypermobility of distal interphalangeal joints', 'XPO:0126603', 'abnormally localised digit', 0.43283582089552236, 6.393467666143939, 1.6635269236307513, 'HP:0011297', 'Abnormal digit morphology'),
(24012, 'HP:0006201', 'Hypermobility of distal interphalangeal joints', 'XPO:0103632', 'abnormally increased number of digit', 0.43283582089552236, 6.393467666143939, 1.6635269236307513, 'HP:0011297', 'Abnormal digit morphology'),
(24013, 'HP:0006201', 'Hypermobility of distal interphalangeal joints', 'XPO:0141208', 'abnormally necrotic digit-joint region', 0.4084507042253521, 6.393467666143939, 1.6159877384059913, 'HP:0011297', 'Abnormal digit morphology'),
(24014, 'HP:0006201', 'Hypermobility of distal interphalangeal joints', 'XPO:0101248', 'abnormal digit-joint region', 0.4745762711864407, 6.393467666143939, 1.7418920876304784, 'UPHENO:0002905', 'abnormal digit'),
(24015, 'HP:0006201', 'Hypermobility of distal interphalangeal joints', 'XPO:0101810', 'abnormal digit morphology', 0.43283582089552236, 6.393467666143939, 1.6635269236307513, 'UPHENO:0002905', 'abnormal digit'),
(24016, 'HP:0006201', 'Hypermobility of distal interphalangeal joints', 'XPO:0100240', 'abnormal hindlimb digit 1', 0.4057971014492754, 6.393467666143939, 1.6107298492083872, 'UPHENO:0002905', 'abnormal digit'),
(24017, 'HP:0006201', 'Hypermobility of distal interphalangeal joints', 'XPO:0100419', 'abnormal hindlimb digit 2', 0.4057971014492754, 6.393467666143939, 1.6107298492083872, 'UPHENO:0002905', 'abnormal digit'),
(24018, 'HP:0006201', 'Hypermobility of distal interphalangeal joints', 'XPO:0127078', 'abnormally localised digit-joint region', 0.4393939393939394, 6.393467666143939, 1.6760820219233785, 'UPHENO:0002905', 'abnormal digit'),
(24019, 'HP:0006201', 'Hypermobility of distal interphalangeal joints', 'XPO:0103833', 'abnormally decreased number of digit-joint region in the regenerating forelimb', 0.4027777777777778, 6.393467666143939, 1.6047263626124957, 'UPHENO:0002905', 'abnormal digit'),
(24020, 'HP:0006201', 'Hypermobility of distal interphalangeal joints', 'XPO:0101244', 'abnormal hindlimb digit 4', 0.4057971014492754, 6.393467666143939, 1.6107298492083872, 'HP:0011297', 'Abnormal digit morphology'),
(24021, 'HP:0006201', 'Hypermobility of distal interphalangeal joints', 'XPO:0103613', 'abnormal number of hindlimb digits', 0.4084507042253521, 6.393467666143939, 1.6159877384059913, 'HP:0011297', 'Abnormal digit morphology'),
(24022, 'HP:0006201', 'Hypermobility of distal interphalangeal joints', 'XPO:0125443', 'absent digit-joint region', 0.4264705882352941, 6.393467666143939, 1.6512498043735655, 'HP:0011297', 'Abnormal digit morphology'),
(24023, 'HP:0006201', 'Hypermobility of distal interphalangeal joints', 'XPO:0101316', 'abnormal hindlimb digit 5', 0.4057971014492754, 6.393467666143939, 1.6107298492083872, 'HP:0011297', 'Abnormal digit morphology'),
(24024, 'HP:0006201', 'Hypermobility of distal interphalangeal joints', 'XPO:0124986', 'absent digit', 0.42028985507246375, 6.393467666143939, 1.6392405555055425, 'HP:0011297', 'Abnormal digit morphology'),
(24025, 'HP:0006201', 'Hypermobility of distal interphalangeal joints', 'XPO:0100548', 'abnormal hindlimb digit 3', 0.4057971014492754, 6.393467666143939, 1.6107298492083872, 'HP:0011297', 'Abnormal digit morphology'),
(24026, 'HP:0006201', 'Hypermobility of distal interphalangeal joints', 'XPO:0102880', 'abnormal digit-joint region morphology', 0.43283582089552236, 6.393467666143939, 1.6635269236307513, 'HP:0011297', 'Abnormal digit morphology'),
(24027, 'HP:0006201', 'Hypermobility of distal interphalangeal joints', 'XPO:0100178', 'abnormal digit', 0.5, 6.393467666143939, 1.7879412275217466, 'UPHENO:0002905', 'abnormal digit'),
(24028, 'HP:0006201', 'Hypermobility of distal interphalangeal joints', 'XPO:0103839', 'abnormally decreased number of digit-joint region in the regenerating hindlimb', 0.4027777777777778, 6.393467666143939, 1.6047263626124957, 'UPHENO:0002905', 'abnormal digit'),
(24029, 'HP:0006201', 'Hypermobility of distal interphalangeal joints', 'XPO:0100177', 'abnormal hindlimb digit', 0.4117647058823529, 6.393467666143939, 1.622530225640833, 'UPHENO:0002905', 'abnormal digit'),
(24030, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0127364', 'abnormally localised multiciliated cell', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(24031, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0100417', 'abnormal dense regular connective tissue', 0.4074074074074074, 1.8210412618256888, 0.861339479684008, 'HP:0000118', 'Phenotypic abnormality'),
(24032, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0141497', 'abnormal lymphoblast', 0.48148148148148145, 3.6715585125471644, 1.3295816755533123, 'UPHENO:0086172', 'abnormal cell'),
(24033, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0115509', 'abnormally semi-viable whole organism', 0.42857142857142855, 1.706362323152461, 0.8551597151958877, 'UPHENO:0002536', 'abnormal anatomical entity'),
(24034, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0101569', 'abnormal activin-induced ectoderm', 0.45, 1.706362323152461, 0.8762779498644294, 'UPHENO:0002536', 'abnormal anatomical entity'),
(24035, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0102896', 'abnormal mitotic spindle morphology', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(24036, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0100317', 'abnormal respiratory system', 0.44, 1.8210412618256888, 0.8951302448265857, 'HP:0000118', 'Phenotypic abnormality'),
(24037, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0142064', 'abnormal desmosome morphology', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(24038, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0101378', 'abnormal blastomere D1', 0.52, 3.6715585125471644, 1.3817418089225373, 'UPHENO:0086172', 'abnormal cell'),
(24039, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0126159', 'absent apoptotic cell', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(24040, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0131075', 'abnormally increased number of mucus secreting cell', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(24041, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0100551', 'abnormal oocyte cortex', 0.52, 3.6715585125471644, 1.3817418089225373, 'UPHENO:0086172', 'abnormal cell'),
(24042, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0126983', 'abnormally localised primordial germ cell', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(24043, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0101162', 'abnormal stromal cell', 0.4642857142857143, 3.6715585125471644, 1.305623286610558, 'UPHENO:0086172', 'abnormal cell'),
(24044, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0101450', 'abnormal myeloid cell', 0.48148148148148145, 3.6715585125471644, 1.3295816755533123, 'UPHENO:0086172', 'abnormal cell'),
(24045, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0102356', 'abnormal kinetochore morphology', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(24046, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0141285', 'abnormal cortical actin cytoskeleton morphology', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(24047, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0100225', 'abnormal endocrine system', 0.44, 1.8210412618256888, 0.8951302448265857, 'HP:0000118', 'Phenotypic abnormality'),
(24048, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0130986', 'abnormally increased number of germ cell', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(24049, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0100917', 'abnormal stage III oocyte', 0.5416666666666666, 3.6715585125471644, 1.4102343283876786, 'UPHENO:0086172', 'abnormal cell'),
(24050, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0102636', 'abnormal acid secreting cell morphology', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(24051, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0101009', 'abnormal blastomere D1.1.1', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(24052, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0131089', 'abnormally increased number of mitotic cell', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(24053, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0100852', 'abnormal interdigital region', 0.4583333333333333, 1.8210412618256888, 0.9135884804823818, 'HP:0000118', 'Phenotypic abnormality'),
(24054, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0127824', 'abnormally localised alkali secreting cell', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(24055, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0100081', 'abnormal anatomical entity in vitro', 0.47368421052631576, 1.706362323152461, 0.8990422069704646, 'UPHENO:0002536', 'abnormal anatomical entity'),
(24056, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0101004', 'abnormal acid secreting cell', 0.5909090909090909, 3.6715585125471644, 1.4729417174039097, 'UPHENO:0086172', 'abnormal cell'),
(24057, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0131551', 'abnormally localised actin cytoskeleton', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(24058, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0101158', 'abnormal blastomere V2.2.2', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(24059, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0131706', 'abnormal ciliary basal body organization', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(24060, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0100732', 'abnormal tendon fibroblast', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(24061, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0107325', 'abnormal adult thrombocyte', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(24062, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0100993', 'abnormal ligament cell', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(24063, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0100026', 'abnormal germ cell', 0.5909090909090909, 3.6715585125471644, 1.4729417174039097, 'UPHENO:0086172', 'abnormal cell'),
(24064, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0101409', 'abnormal perivitelline space', 0.5416666666666666, 3.6715585125471644, 1.4102343283876786, 'UPHENO:0086172', 'abnormal cell'),
(24065, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0100549', 'abnormal mitotic cell', 0.5909090909090909, 3.6715585125471644, 1.4729417174039097, 'UPHENO:0086172', 'abnormal cell'),
(24066, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0141277', 'abnormal actin cytoskeleton morphology', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(24067, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0100010', 'abnormal multicellular anatomical structure', 0.42857142857142855, 1.706362323152461, 0.8551597151958877, 'UPHENO:0002536', 'abnormal anatomical entity'),
(24068, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0131675', 'abnormal spindle microtubule', 0.5416666666666666, 3.6715585125471644, 1.4102343283876786, 'UPHENO:0086172', 'abnormal cell'),
(24069, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0100232', 'abnormal lymphatic system', 0.44, 1.8210412618256888, 0.8951302448265857, 'HP:0000118', 'Phenotypic abnormality'),
(24070, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0141770', 'abnormal urate homeostasis', 0.42105263157894735, 1.4755025719078136, 0.7882031722869998, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(24071, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0100956', 'abnormal centrosome', 0.5652173913043478, 3.6715585125471644, 1.440565418328227, 'UPHENO:0086172', 'abnormal cell'),
(24072, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0125854', 'absent barrier epithelial cell', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(24073, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0100337', 'abnormal zygote', 0.5909090909090909, 3.6715585125471644, 1.4729417174039097, 'UPHENO:0086172', 'abnormal cell'),
(24074, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0100899', 'abnormal secondary spermatogonium', 0.5652173913043478, 3.6715585125471644, 1.440565418328227, 'UPHENO:0086172', 'abnormal cell'),
(24075, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0101534', 'abnormal blastomere V2.1.1', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(24076, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0125833', 'absent kinetochore', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(24077, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0100626', 'abnormal primordial germ cell', 0.5652173913043478, 3.6715585125471644, 1.440565418328227, 'UPHENO:0086172', 'abnormal cell'),
(24078, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0131677', 'abnormal actin filament', 0.5416666666666666, 3.6715585125471644, 1.4102343283876786, 'UPHENO:0086172', 'abnormal cell'),
(24079, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0133441', 'abnormally increased number of cilium in the ciliated cell', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(24080, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0103167', 'abnormal absorptive cell morphology', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(24081, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0107270', 'abnormal proximal-distal axis', 0.42857142857142855, 1.706362323152461, 0.8551597151958877, 'UPHENO:0002536', 'abnormal anatomical entity'),
(24082, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0141299', 'abnormal actin filament morphology', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(24083, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0100308', 'abnormal early embryonic cell', 0.5652173913043478, 3.6715585125471644, 1.440565418328227, 'UPHENO:0086172', 'abnormal cell'),
(24084, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0127513', 'abnormally localised nucleate erythrocyte', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(24085, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0101452', 'abnormal blastomere V1.1.1', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(24086, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0131082', 'abnormally increased number of alkali secreting cell', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(24087, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0101347', 'abnormal hindlimb region', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(24088, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0100307', 'abnormal blastomere', 0.5416666666666666, 3.6715585125471644, 1.4102343283876786, 'UPHENO:0086172', 'abnormal cell'),
(24089, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0125115', 'absent paracrine cell', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(24090, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0101166', 'abnormal premigratory neural crest cell', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(24091, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0125530', 'absent chondroblast', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(24092, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0100175', 'abnormal migrating neuroblast', 0.48148148148148145, 3.6715585125471644, 1.3295816755533123, 'UPHENO:0086172', 'abnormal cell'),
(24093, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0100239', 'abnormal acellular anatomical structure', 0.42857142857142855, 1.706362323152461, 0.8551597151958877, 'UPHENO:0002536', 'abnormal anatomical entity'),
(24094, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0100762', 'abnormal intersomitic region', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(24095, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0125698', 'absent filopodium', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(24096, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0107287', 'abnormal afferent neuron', 0.4482758620689655, 3.6715585125471644, 1.2829150624062098, 'UPHENO:0086172', 'abnormal cell'),
(24097, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0100108', 'abnormal cell part', 0.5909090909090909, 3.6715585125471644, 1.4729417174039097, 'UPHENO:0086172', 'abnormal cell'),
(24098, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0100035', 'abnormal ventral animal hemisphere blastomere', 0.4482758620689655, 3.6715585125471644, 1.2829150624062098, 'UPHENO:0086172', 'abnormal cell'),
(24099, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0141743', 'abnormal chemical homeostasis within a tissue', 0.42105263157894735, 1.4755025719078136, 0.7882031722869998, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(24100, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0127508', 'abnormally localised barrier epithelial cell', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(24101, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0103021', 'abnormal wedge region morphology', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(24102, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0100025', 'abnormal oocyte', 0.5652173913043478, 3.6715585125471644, 1.440565418328227, 'UPHENO:0086172', 'abnormal cell'),
(24103, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0125868', 'absent cementoblast', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(24104, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0107324', 'abnormal embryonic thrombocyte', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(24105, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0101283', 'abnormal left-ventral blastomere', 0.52, 3.6715585125471644, 1.3817418089225373, 'UPHENO:0086172', 'abnormal cell'),
(24106, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0101157', 'abnormal female organism', 0.42857142857142855, 1.706362323152461, 0.8551597151958877, 'UPHENO:0002536', 'abnormal anatomical entity'),
(24107, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0127171', 'abnormally localised myelin accumulating cell', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(24108, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0101074', 'abnormal germinal vesicle', 0.5, 3.6715585125471644, 1.3549093166236559, 'UPHENO:0086172', 'abnormal cell'),
(24109, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0125859', 'absent nucleate erythrocyte', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(24110, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0131725', 'abnormal phosphorylation of RNA polymerase II C-terminal domain', 0.42105263157894735, 1.4755025719078136, 0.7882031722869998, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(24111, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0101220', 'abnormal centriole', 0.5416666666666666, 3.6715585125471644, 1.4102343283876786, 'UPHENO:0086172', 'abnormal cell'),
(24112, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0100704', 'abnormal Merkel cell', 0.5909090909090909, 3.6715585125471644, 1.4729417174039097, 'UPHENO:0086172', 'abnormal cell'),
(24113, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0103005', 'abnormal oxygen accumulating cell morphology', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(24114, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0131569', 'abnormally localised cortical actin cytoskeleton', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(24115, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0131066', 'abnormally increased number of myoblast', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(24116, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0100960', 'abnormal postmigratory neural crest cell', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(24117, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0100501', 'abnormal urogenital system', 0.44, 1.8210412618256888, 0.8951302448265857, 'HP:0000118', 'Phenotypic abnormality'),
(24118, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0102693', 'abnormal plasma membrane morphology', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(24119, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0141314', 'abnormal Roux spot morphology', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(24120, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0131707', 'abnormal cilium assembly', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(24121, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0100070', 'abnormal anatomical system', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(24122, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0100674', 'abnormal secondary oogonium', 0.5652173913043478, 3.6715585125471644, 1.440565418328227, 'UPHENO:0086172', 'abnormal cell'),
(24123, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0100702', 'abnormal glial cell', 0.48148148148148145, 3.6715585125471644, 1.3295816755533123, 'UPHENO:0086172', 'abnormal cell'),
(24124, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0131687', 'abnormal astral microtubule', 0.52, 3.6715585125471644, 1.3817418089225373, 'UPHENO:0086172', 'abnormal cell'),
(24125, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0103099', 'abnormal alkali secreting cell morphology', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(24126, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0102434', 'abnormal exocrine cell morphology', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(24127, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0127821', 'abnormally localised apoptotic cell', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(24128, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0126783', 'abnormally localised exocrine cell', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(24129, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0102768', 'abnormal ooplasm morphology', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(24130, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0125750', 'absent melanoblast', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(24131, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0101917', 'abnormal progenitor cell morphology', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(24132, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0103093', 'abnormal sperm entry point morphology', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(24133, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0130979', 'abnormally increased number of Merkel cell', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(24134, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0107272', 'abnormal axial region', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(24135, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0100028', 'abnormal anatomical cluster', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(24136, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0101362', 'abnormal vegetal cortex', 0.5, 3.6715585125471644, 1.3549093166236559, 'UPHENO:0086172', 'abnormal cell'),
(24137, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0131090', 'abnormally increased number of oxygen accumulating cell', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(24138, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0101192', 'abnormal blastomere D2.1', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(24139, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0101326', 'abnormal cementoblast', 0.5909090909090909, 3.6715585125471644, 1.4729417174039097, 'UPHENO:0086172', 'abnormal cell'),
(24140, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0101022', 'abnormal blastomere V1.2', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(24141, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0100907', 'abnormal cytoplasm', 0.5652173913043478, 3.6715585125471644, 1.440565418328227, 'UPHENO:0086172', 'abnormal cell'),
(24142, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0100547', 'abnormal blastomere V2', 0.52, 3.6715585125471644, 1.3817418089225373, 'UPHENO:0086172', 'abnormal cell'),
(24143, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0100203', 'abnormal endocrine cell', 0.48148148148148145, 3.6715585125471644, 1.3295816755533123, 'UPHENO:0086172', 'abnormal cell'),
(24144, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0107323', 'abnormal thrombocyte', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(24145, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0100569', 'abnormal motor axon', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(24146, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0131131', 'abnormally increased number of absorptive cell', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(24147, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0141499', 'abnormal tadpole', 0.42857142857142855, 1.706362323152461, 0.8551597151958877, 'UPHENO:0002536', 'abnormal anatomical entity'),
(24148, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0125785', 'absent mitotic spindle', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(24149, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0101468', 'abnormal stage I oocyte', 0.5416666666666666, 3.6715585125471644, 1.4102343283876786, 'UPHENO:0086172', 'abnormal cell'),
(24150, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0127794', 'abnormally localised mitotic cell', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(24151, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0100864', 'abnormal dorsolateral ascending neuron', 0.4642857142857143, 3.6715585125471644, 1.305623286610558, 'UPHENO:0086172', 'abnormal cell'),
(24152, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0126697', 'abnormally localised proepicardium', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(24153, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0107311', 'abnormal apical junction complex', 0.48148148148148145, 3.6715585125471644, 1.3295816755533123, 'UPHENO:0086172', 'abnormal cell'),
(24154, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0101072', 'abnormal mitochondrial cloud', 0.52, 3.6715585125471644, 1.3817418089225373, 'UPHENO:0086172', 'abnormal cell'),
(24155, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0142066', 'abnormally increased number of desmosome', 0.4482758620689655, 3.6715585125471644, 1.2829150624062098, 'UPHENO:0086172', 'abnormal cell'),
(24156, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0127196', 'abnormally localised electrically active cell', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(24157, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0100031', 'abnormal central nervous system', 0.4230769230769231, 1.8210412618256888, 0.8777474203034321, 'HP:0000118', 'Phenotypic abnormality'),
(24158, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0102336', 'abnormal Merkel cell morphology', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(24159, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0100503', 'abnormal blastomere D2', 0.52, 3.6715585125471644, 1.3817418089225373, 'UPHENO:0086172', 'abnormal cell'),
(24160, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0102965', 'abnormal barrier epithelial cell morphology', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(24161, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0125061', 'absent basal body', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(24162, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0141776', 'abnormal metabolic process', 0.43478260869565216, 1.8210412618256888, 0.8898073220416851, 'HP:0000118', 'Phenotypic abnormality'),
(24163, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0100372', 'abnormal hematological system', 0.44, 1.8210412618256888, 0.8951302448265857, 'HP:0000118', 'Phenotypic abnormality'),
(24164, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0100754', 'abnormal electrically active cell', 0.5909090909090909, 3.6715585125471644, 1.4729417174039097, 'UPHENO:0086172', 'abnormal cell'),
(24165, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0131669', 'abnormal Roux spot', 0.52, 3.6715585125471644, 1.3817418089225373, 'UPHENO:0086172', 'abnormal cell'),
(24166, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0101200', 'abnormal joint region', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(24167, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0101411', 'abnormal marginal zone (sensu neural)', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(24168, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0131171', 'abnormally increased number of barrier epithelial cell', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(24169, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0100823', 'abnormal blood', 0.4074074074074074, 1.8210412618256888, 0.861339479684008, 'HP:0000118', 'Phenotypic abnormality'),
(24170, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0141265', 'abnormal escape behavior', 0.42105263157894735, 1.4755025719078136, 0.7882031722869998, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(24171, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0125384', 'absent ciliated cell', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(24172, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0127363', 'abnormally localised barrier cell', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(24173, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0101504', 'abnormal blastomere D2.2.1', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(24174, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0101570', 'abnormal forelimb region', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(24175, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0101239', 'abnormal olfactory epithelial support cell', 0.4482758620689655, 3.6715585125471644, 1.2829150624062098, 'UPHENO:0086172', 'abnormal cell'),
(24176, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0127522', 'abnormally localised cementoblast', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(24177, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0102109', 'abnormal pericyte morphology', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(24178, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0107261', 'abnormal dorsal-ventral axis', 0.42857142857142855, 1.706362323152461, 0.8551597151958877, 'UPHENO:0002536', 'abnormal anatomical entity'),
(24179, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0100533', 'abnormal melanoblast', 0.5909090909090909, 3.6715585125471644, 1.4729417174039097, 'UPHENO:0086172', 'abnormal cell'),
(24180, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0102764', 'abnormal apoptotic cell morphology', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(24181, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0100675', 'abnormal dorsal vegetal hemisphere blastomere', 0.4482758620689655, 3.6715585125471644, 1.2829150624062098, 'UPHENO:0086172', 'abnormal cell'),
(24182, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0100713', 'abnormal monociliated cell', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(24183, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0101547', 'abnormal lampbrush chromosome', 0.5652173913043478, 3.6715585125471644, 1.440565418328227, 'UPHENO:0086172', 'abnormal cell'),
(24184, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0133443', 'abnormally increased number of cilium in the multiciliated cell', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(24185, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0102323', 'abnormal keratin accumulating cell morphology', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(24186, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0131061', 'abnormally increased number of keratin accumulating cell', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(24187, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0100688', 'abnormal adipose tissue', 0.4074074074074074, 1.8210412618256888, 0.861339479684008, 'HP:0000118', 'Phenotypic abnormality'),
(24188, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0100872', 'abnormal neuroendocrine cell', 0.4642857142857143, 3.6715585125471644, 1.305623286610558, 'UPHENO:0086172', 'abnormal cell'),
(24189, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0101132', 'abnormal apoptotic cell', 0.5909090909090909, 3.6715585125471644, 1.4729417174039097, 'UPHENO:0086172', 'abnormal cell'),
(24190, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0101576', 'abnormal blastomere V1.2.2', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(24191, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0100570', 'abnormal axon', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(24192, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0100643', 'abnormal thoracic region', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(24193, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0101136', 'abnormal ooplasm', 0.52, 3.6715585125471644, 1.3817418089225373, 'UPHENO:0086172', 'abnormal cell'),
(24194, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0124984', 'absent progenitor cell', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(24195, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0107426', 'abnormal yolk platelet morphology', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(24196, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:00000000', 'Xenopus phenotype', 0.4444444444444444, 1.4755025719078136, 0.8098017787384251, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(24197, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0141264', 'abnormal schooling behavior', 0.42105263157894735, 1.4755025719078136, 0.7882031722869998, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(24198, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0101094', 'abnormal blastomere V2.2.1', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(24199, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0103631', 'abnormally increased number of apoptotic cell', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(24200, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0101302', 'abnormal subcortical cytoplasm', 0.52, 3.6715585125471644, 1.3817418089225373, 'UPHENO:0086172', 'abnormal cell'),
(24201, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0141315', 'abnormal anatomical region', 0.42857142857142855, 1.706362323152461, 0.8551597151958877, 'UPHENO:0002536', 'abnormal anatomical entity'),
(24202, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0100006', 'abnormal anatomical structure', 0.47368421052631576, 1.706362323152461, 0.8990422069704646, 'UPHENO:0002536', 'abnormal anatomical entity'),
(24203, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0100638', 'abnormal polar body', 0.5909090909090909, 3.6715585125471644, 1.4729417174039097, 'UPHENO:0086172', 'abnormal cell'),
(24204, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0100642', 'abnormal gustatory system', 0.4074074074074074, 1.8210412618256888, 0.861339479684008, 'HP:0000118', 'Phenotypic abnormality'),
(24205, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0133471', 'abnormally decreased number of cilium in the ciliated cell', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(24206, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0116091', 'abnormally increased variability of size of cell in endoderm', 0.4642857142857143, 3.6715585125471644, 1.305623286610558, 'UPHENO:0086172', 'abnormal cell'),
(24207, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0126454', 'abnormally localised stem cell', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(24208, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0103894', 'abnormally decreased number of spindle microtubule', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(24209, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0100395', 'abnormal blastomere D1.1', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(24210, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0101333', 'abnormal barrier epithelial cell', 0.5909090909090909, 3.6715585125471644, 1.4729417174039097, 'UPHENO:0086172', 'abnormal cell'),
(24211, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0131153', 'abnormally increased number of electrically active cell', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(24212, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0100176', 'abnormal stage VI oocyte', 0.5416666666666666, 3.6715585125471644, 1.4102343283876786, 'UPHENO:0086172', 'abnormal cell'),
(24213, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0100545', 'abnormal male organism', 0.42857142857142855, 1.706362323152461, 0.8551597151958877, 'UPHENO:0002536', 'abnormal anatomical entity'),
(24214, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0103642', 'increased cell population proliferation', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(24215, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0102347', 'abnormal ciliated cell morphology', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(24216, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0100791', 'abnormal multiciliated cell precursor', 0.5909090909090909, 3.6715585125471644, 1.4729417174039097, 'UPHENO:0086172', 'abnormal cell'),
(24217, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0124864', 'absent germ cell', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(24218, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0102958', 'abnormal cementoblast morphology', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(24219, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0127743', 'abnormally localised perivitelline space', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(24220, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0141296', 'abnormal adherens junction morphology', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(24221, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0100715', 'abnormal ciliated cell', 0.5909090909090909, 3.6715585125471644, 1.4729417174039097, 'UPHENO:0086172', 'abnormal cell'),
(24222, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0101463', 'abnormal right-ventral blastomere', 0.52, 3.6715585125471644, 1.3817418089225373, 'UPHENO:0086172', 'abnormal cell'),
(24223, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0100332', 'abnormal germinal granule', 0.4642857142857143, 3.6715585125471644, 1.305623286610558, 'UPHENO:0086172', 'abnormal cell'),
(24224, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0100336', 'abnormal interneuron', 0.4482758620689655, 3.6715585125471644, 1.2829150624062098, 'UPHENO:0086172', 'abnormal cell'),
(24225, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0103041', 'abnormal perivitelline space morphology', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(24226, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0127683', 'abnormally localised centromere', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(24227, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0100258', 'abnormal organ part', 0.45, 1.706362323152461, 0.8762779498644294, 'UPHENO:0002536', 'abnormal anatomical entity'),
(24228, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0102353', 'abnormal centromere morphology', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(24229, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0127428', 'abnormally localised endoplasmic reticulum', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(24230, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0101113', 'abnormal stage IV oocyte', 0.5416666666666666, 3.6715585125471644, 1.4102343283876786, 'UPHENO:0086172', 'abnormal cell'),
(24231, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0142023', 'absent desmosome', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(24232, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0100392', 'abnormal cilium', 0.5416666666666666, 3.6715585125471644, 1.4102343283876786, 'UPHENO:0086172', 'abnormal cell'),
(24233, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0107284', 'abnormal migrating myoblast', 0.5652173913043478, 3.6715585125471644, 1.440565418328227, 'UPHENO:0086172', 'abnormal cell'),
(24234, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0107312', 'abnormal filopodium', 0.5652173913043478, 3.6715585125471644, 1.440565418328227, 'UPHENO:0086172', 'abnormal cell'),
(24235, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0115505', 'dead whole organism', 0.42857142857142855, 1.706362323152461, 0.8551597151958877, 'UPHENO:0002536', 'abnormal anatomical entity'),
(24236, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0127533', 'abnormally localised spermatocyte', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(24237, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0125160', 'absent exocrine cell', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(24238, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0101513', 'abnormal basal body', 0.5652173913043478, 3.6715585125471644, 1.440565418328227, 'UPHENO:0086172', 'abnormal cell'),
(24239, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0127337', 'abnormally localised oxygen accumulating cell', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(24240, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0100285', 'abnormal progenitor cell', 0.5909090909090909, 3.6715585125471644, 1.4729417174039097, 'UPHENO:0086172', 'abnormal cell'),
(24241, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0115508', 'abnormally peramorphic growth of whole organism', 0.42857142857142855, 1.706362323152461, 0.8551597151958877, 'UPHENO:0002536', 'abnormal anatomical entity'),
(24242, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0131666', 'abnormal adherens junction', 0.5652173913043478, 3.6715585125471644, 1.440565418328227, 'UPHENO:0086172', 'abnormal cell'),
(24243, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0127435', 'abnormally localised mitotic spindle', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(24244, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0100465', 'abnormal skeletal system', 0.4074074074074074, 1.8210412618256888, 0.861339479684008, 'HP:0000118', 'Phenotypic abnormality'),
(24245, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0125997', 'absent Merkel cell', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(24246, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0100316', 'abnormal gamete', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(24247, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0127806', 'abnormally localised spermatid', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(24248, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0100084', 'abnormal anatomical group', 0.42857142857142855, 1.706362323152461, 0.8551597151958877, 'UPHENO:0002536', 'abnormal anatomical entity'),
(24249, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0131685', 'abnormal cortical actin cytoskeleton', 0.5416666666666666, 3.6715585125471644, 1.4102343283876786, 'UPHENO:0086172', 'abnormal cell'),
(24250, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0102520', 'abnormal microtubule morphology', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(24251, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0127089', 'abnormally localised myoblast', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(24252, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0125559', 'absent electrically active cell', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(24253, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0127343', 'abnormally localised filopodium', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(24254, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0100581', 'abnormal immune system', 0.44, 1.8210412618256888, 0.8951302448265857, 'HP:0000118', 'Phenotypic abnormality'),
(24255, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0131130', 'abnormally increased number of myelin accumulating cell', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(24256, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0100265', 'abnormal sensory epithelial cell', 0.5, 3.6715585125471644, 1.3549093166236559, 'UPHENO:0086172', 'abnormal cell'),
(24257, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0100104', 'abnormal embryonic structure', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(24258, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0131165', 'abnormally increased number of cementoblast', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(24259, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0100521', 'abnormal animal blastomere', 0.4642857142857143, 3.6715585125471644, 1.305623286610558, 'UPHENO:0086172', 'abnormal cell'),
(24260, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0127979', 'abnormally localised absorptive cell', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(24261, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0130973', 'abnormally increased number of stem cell', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(24262, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0100989', 'abnormal right blastomere', 0.52, 3.6715585125471644, 1.3817418089225373, 'UPHENO:0086172', 'abnormal cell'),
(24263, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0100509', 'abnormal germ plasm', 0.48148148148148145, 3.6715585125471644, 1.3295816755533123, 'UPHENO:0086172', 'abnormal cell'),
(24264, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0126162', 'absent alkali secreting cell', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(24265, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0127643', 'abnormally localised somatic stem cell', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(24266, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0126737', 'abnormally localised mesenchymal stem cell', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(24267, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0142030', 'abnormally localised desmosome', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(24268, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0102165', 'abnormal melanoblast morphology', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(24269, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0102526', 'abnormal nucleus morphology', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(24270, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0100842', 'abnormal left-dorsal blastomere', 0.52, 3.6715585125471644, 1.3817418089225373, 'UPHENO:0086172', 'abnormal cell'),
(24271, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0101061', 'abnormal plasma membrane', 0.5652173913043478, 3.6715585125471644, 1.440565418328227, 'UPHENO:0086172', 'abnormal cell'),
(24272, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0101535', 'abnormal absorptive cell', 0.5909090909090909, 3.6715585125471644, 1.4729417174039097, 'UPHENO:0086172', 'abnormal cell'),
(24273, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0126473', 'abnormally localised germ cell', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(24274, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0101472', 'abnormal zygote cortex', 0.5416666666666666, 3.6715585125471644, 1.4102343283876786, 'UPHENO:0086172', 'abnormal cell'),
(24275, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0115512', 'abnormally semi-erect whole organism', 0.42857142857142855, 1.706362323152461, 0.8551597151958877, 'UPHENO:0002536', 'abnormal anatomical entity'),
(24276, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0131180', 'abnormally decreased number of cell', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(24277, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0100859', 'abnormal blastomere V1.1.2', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(24278, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0125779', 'absent endoplasmic reticulum', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(24279, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0101110', 'abnormal cell-free extract', 0.45, 1.706362323152461, 0.8762779498644294, 'UPHENO:0002536', 'abnormal anatomical entity'),
(24280, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0101109', 'abnormal egg cell-free extract', 0.42857142857142855, 1.706362323152461, 0.8551597151958877, 'UPHENO:0002536', 'abnormal anatomical entity'),
(24281, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0127653', 'abnormally localised Merkel cell', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(24282, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0100676', 'abnormal blastomere D2.2', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(24283, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0125693', 'absent mucus secreting cell', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(24284, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0101187', 'abnormal dorsolateral commissural neuron', 0.4642857142857143, 3.6715585125471644, 1.305623286610558, 'UPHENO:0086172', 'abnormal cell'),
(24285, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0100654', 'abnormal blastomere V2.1', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(24286, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0103179', 'abnormal lampbrush chromosome morphology', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(24287, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0101350', 'abnormal blastomere D2.1.2', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(24288, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0100649', 'abnormal growth cone', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(24289, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0126133', 'absent mitotic cell', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(24290, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0142057', 'abnormal desmosome', 0.5652173913043478, 3.6715585125471644, 1.440565418328227, 'UPHENO:0086172', 'abnormal cell'),
(24291, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0102181', 'abnormal mitotic cell morphology', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(24292, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0102423', 'abnormal multiciliated cell precursor morphology', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(24293, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0100172', 'abnormal stem cell', 0.5909090909090909, 3.6715585125471644, 1.4729417174039097, 'UPHENO:0086172', 'abnormal cell'),
(24294, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0100003', 'abnormal organism subdivision', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(24295, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0101311', 'abnormal bottle cell', 0.52, 3.6715585125471644, 1.3817418089225373, 'UPHENO:0086172', 'abnormal cell'),
(24296, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0131136', 'abnormally increased number of multiciliated cell precursor', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(24297, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0139717', 'abnormally necrotic cell', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(24298, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0100976', 'abnormal multiciliated cell', 0.5652173913043478, 3.6715585125471644, 1.440565418328227, 'UPHENO:0086172', 'abnormal cell'),
(24299, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0100924', 'abnormal spermatozoon', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(24300, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0100437', 'abnormal proepicardium', 0.5652173913043478, 3.6715585125471644, 1.440565418328227, 'UPHENO:0086172', 'abnormal cell'),
(24301, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0100189', 'abnormal enteroendocrine cell', 0.4642857142857143, 3.6715585125471644, 1.305623286610558, 'UPHENO:0086172', 'abnormal cell'),
(24302, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0100817', 'abnormal intersomitic neuron', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(24303, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0101366', 'abnormal morula cell', 0.5416666666666666, 3.6715585125471644, 1.4102343283876786, 'UPHENO:0086172', 'abnormal cell'),
(24304, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0101480', 'abnormal stage V oocyte', 0.5416666666666666, 3.6715585125471644, 1.4102343283876786, 'UPHENO:0086172', 'abnormal cell'),
(24305, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0127168', 'abnormally localised chondroblast', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(24306, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0102873', 'abnormal nucleate erythrocyte morphology', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(24307, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0127338', 'abnormally localised mucus secreting cell', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(24308, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0125454', 'absent myoblast', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(24309, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0100665', 'abnormal egg jelly', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(24310, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0100814', 'abnormal natural killer cell', 0.4482758620689655, 3.6715585125471644, 1.2829150624062098, 'UPHENO:0086172', 'abnormal cell'),
(24311, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0126495', 'abnormally localised keratin accumulating cell', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(24312, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0107258', 'abnormal anatomical axis', 0.45, 1.706362323152461, 0.8762779498644294, 'UPHENO:0002536', 'abnormal anatomical entity'),
(24313, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0131031', 'abnormally increased number of nucleate erythrocyte', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(24314, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0101405', 'abnormal ring structure', 0.52, 3.6715585125471644, 1.3817418089225373, 'UPHENO:0086172', 'abnormal cell'),
(24315, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0100397', 'abnormal ventral vegetal hemisphere blastomere', 0.4482758620689655, 3.6715585125471644, 1.2829150624062098, 'UPHENO:0086172', 'abnormal cell'),
(24316, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0126314', 'absent absorptive cell', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(24317, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0100289', 'abnormal chondroblast', 0.5909090909090909, 3.6715585125471644, 1.4729417174039097, 'UPHENO:0086172', 'abnormal cell'),
(24318, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0100429', 'abnormal spermatid', 0.5652173913043478, 3.6715585125471644, 1.440565418328227, 'UPHENO:0086172', 'abnormal cell'),
(24319, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0100396', 'abnormal dorsal animal hemisphere blastomere', 0.4482758620689655, 3.6715585125471644, 1.2829150624062098, 'UPHENO:0086172', 'abnormal cell'),
(24320, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0127815', 'abnormally localised ciliated non-epidermal cell', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(24321, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0100520', 'abnormal blastomere D1.2', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(24322, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0101497', 'abnormal ciliary axoneme', 0.52, 3.6715585125471644, 1.3817418089225373, 'UPHENO:0086172', 'abnormal cell'),
(24323, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0100014', 'abnormal tissue', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(24324, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0100861', 'abnormal blastomere D2.2.2', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(24325, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0100546', 'abnormal whole organism', 0.45, 1.706362323152461, 0.8762779498644294, 'UPHENO:0002536', 'abnormal anatomical entity'),
(24326, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0131096', 'abnormally increased number of exocrine cell', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(24327, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0130988', 'abnormally increased number of pericyte', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(24328, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0103145', 'abnormal basal body morphology', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(24329, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0103104', 'abnormal zygote cortex morphology', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(24330, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0131550', 'abnormally localised adherens junction', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(24331, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0126214', 'absent microtubule', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(24332, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0101264', 'abnormal mitotic spindle', 0.5652173913043478, 3.6715585125471644, 1.440565418328227, 'UPHENO:0086172', 'abnormal cell'),
(24333, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0127486', 'abnormally localised kinetochore', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(24334, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0100900', 'abnormal angioblast', 0.5, 3.6715585125471644, 1.3549093166236559, 'UPHENO:0086172', 'abnormal cell'),
(24335, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0101141', 'abnormal Keller explant', 0.45, 1.706362323152461, 0.8762779498644294, 'UPHENO:0002536', 'abnormal anatomical entity'),
(24336, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0131513', 'absent actin cytoskeleton', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(24337, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0124934', 'absent centrosome', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(24338, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0101269', 'abnormal mesodermal cell', 0.4642857142857143, 3.6715585125471644, 1.305623286610558, 'UPHENO:0086172', 'abnormal cell'),
(24339, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0127399', 'abnormally localised melanoblast', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(24340, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0103636', 'abnormally increased number of melanoblast', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(24341, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0131129', 'abnormally increased number of chondroblast', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(24342, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0127160', 'abnormally localised acid secreting cell', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(24343, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0124884', 'absent keratin accumulating cell', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(24344, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0100032', 'abnormal nervous system', 0.44, 1.8210412618256888, 0.8951302448265857, 'HP:0000118', 'Phenotypic abnormality'),
(24345, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0101466', 'abnormal secondary myofiber', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(24346, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0100802', 'abnormal exocrine cell', 0.5909090909090909, 3.6715585125471644, 1.4729417174039097, 'UPHENO:0086172', 'abnormal cell'),
(24347, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0107276', 'abnormal dorsal region', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(24348, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0100386', 'abnormal limb', 0.4230769230769231, 1.8210412618256888, 0.8777474203034321, 'HP:0000118', 'Phenotypic abnormality'),
(24349, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0100273', 'abnormal visual system', 0.4074074074074074, 1.8210412618256888, 0.861339479684008, 'HP:0000118', 'Phenotypic abnormality'),
(24350, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0101345', 'abnormal ascending interneuron', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(24351, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0100733', 'abnormal fibroblast', 0.4482758620689655, 3.6715585125471644, 1.2829150624062098, 'UPHENO:0086172', 'abnormal cell'),
(24352, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0100205', 'abnormal limb segment', 0.4074074074074074, 1.8210412618256888, 0.861339479684008, 'HP:0000118', 'Phenotypic abnormality'),
(24353, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0100415', 'abnormal secretory epithelial cell', 0.5, 3.6715585125471644, 1.3549093166236559, 'UPHENO:0086172', 'abnormal cell'),
(24354, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0126630', 'abnormally localised early embryonic cell', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(24355, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0102703', 'abnormal endoplasmic reticulum morphology', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(24356, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0101168', 'abnormal circulating cell', 0.5, 3.6715585125471644, 1.3549093166236559, 'UPHENO:0086172', 'abnormal cell'),
(24357, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0100202', 'abnormal embryo', 0.42857142857142855, 1.706362323152461, 0.8551597151958877, 'UPHENO:0002536', 'abnormal anatomical entity'),
(24358, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0101435', 'abnormal paracrine cell', 0.5909090909090909, 3.6715585125471644, 1.4729417174039097, 'UPHENO:0086172', 'abnormal cell'),
(24359, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0100477', 'abnormal pericyte', 0.5909090909090909, 3.6715585125471644, 1.4729417174039097, 'UPHENO:0086172', 'abnormal cell'),
(24360, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0103080', 'abnormal myelin accumulating cell morphology', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(24361, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0107278', 'abnormal medial region', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(24362, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0125692', 'absent oxygen accumulating cell', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(24363, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0126388', 'abnormally localised oocyte', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(24364, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0100335', 'abnormal commissural interneuron', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(24365, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0127018', 'abnormally localised ciliated cell', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(24366, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0131110', 'abnormally increased number of paracrine cell', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(24367, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0100515', 'abnormal somatic stem cell', 0.5652173913043478, 3.6715585125471644, 1.440565418328227, 'UPHENO:0086172', 'abnormal cell'),
(24368, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0100377', 'abnormal connective tissue', 0.4230769230769231, 1.8210412618256888, 0.8777474203034321, 'HP:0000118', 'Phenotypic abnormality'),
(24369, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0141748', 'abnormal gas homeostasis', 0.42105263157894735, 1.4755025719078136, 0.7882031722869998, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(24370, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0101461', 'abnormal sperm entry point', 0.5416666666666666, 3.6715585125471644, 1.4102343283876786, 'UPHENO:0086172', 'abnormal cell'),
(24371, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0125053', 'absent zygote', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(24372, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0141738', 'abnormal carbon dioxide homeostasis', 0.42105263157894735, 1.4755025719078136, 0.7882031722869998, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(24373, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0126738', 'abnormally localised paracrine cell', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(24374, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0100295', 'abnormal extracellular matrix', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(24375, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0101297', 'abnormal barrier cell', 0.5909090909090909, 3.6715585125471644, 1.4729417174039097, 'UPHENO:0086172', 'abnormal cell'),
(24376, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0126671', 'abnormally localised zygote', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(24377, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0141771', 'abnormal urea homeostasis', 0.42105263157894735, 1.4755025719078136, 0.7882031722869998, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(24378, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0100967', 'abnormal blastomere V2.1.2', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(24379, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0107271', 'abnormal apical region', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(24380, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0101467', 'abnormal alkali secreting cell', 0.5909090909090909, 3.6715585125471644, 1.4729417174039097, 'UPHENO:0086172', 'abnormal cell'),
(24381, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0103067', 'abnormal paracrine cell morphology', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(24382, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0130964', 'abnormally increased number of cell', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(24383, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0102024', 'abnormal cilium morphology', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(24384, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0124716', 'absent cell', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(24385, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0126472', 'abnormally localised secondary spermatogonium', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(24386, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0101485', 'abnormal descending interneuron', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(24387, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0124845', 'absent stem cell', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(24388, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0100398', 'abnormal vegetal blastomere', 0.4642857142857143, 3.6715585125471644, 1.305623286610558, 'UPHENO:0086172', 'abnormal cell'),
(24389, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0131723', 'abnormal pathway-restricted SMAD protein phosphorylation', 0.42105263157894735, 1.4755025719078136, 0.7882031722869998, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(24390, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0100894', 'abnormal nucleus', 0.5652173913043478, 3.6715585125471644, 1.440565418328227, 'UPHENO:0086172', 'abnormal cell'),
(24391, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0100954', 'abnormal neural progenitor cell', 0.4642857142857143, 3.6715585125471644, 1.305623286610558, 'UPHENO:0086172', 'abnormal cell'),
(24392, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0127631', 'abnormally localised centriole', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(24393, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0101921', 'abnormal chondroblast morphology', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(24394, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0107263', 'abnormal anatomical side', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(24395, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0126548', 'abnormally localised centrosome', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(24396, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0100902', 'abnormal spermatocyte', 0.5652173913043478, 3.6715585125471644, 1.440565418328227, 'UPHENO:0086172', 'abnormal cell'),
(24397, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0101494', 'abnormal blastomere D1.2.1', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(24398, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0100843', 'abnormal fasciculated network of fibrils', 0.48148148148148145, 3.6715585125471644, 1.3295816755533123, 'UPHENO:0086172', 'abnormal cell'),
(24399, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0100585', 'abnormal elastica externa', 0.4230769230769231, 1.8210412618256888, 0.8777474203034321, 'HP:0000118', 'Phenotypic abnormality'),
(24400, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0127339', 'abnormally localised migrating myoblast', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(24401, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0101448', 'abnormal myelin accumulating cell', 0.5909090909090909, 3.6715585125471644, 1.4729417174039097, 'UPHENO:0086172', 'abnormal cell'),
(24402, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0101373', 'abnormal oxygen accumulating cell', 0.5909090909090909, 3.6715585125471644, 1.4729417174039097, 'UPHENO:0086172', 'abnormal cell'),
(24403, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0101240', 'abnormal ciliated non-epidermal cell', 0.5652173913043478, 3.6715585125471644, 1.440565418328227, 'UPHENO:0086172', 'abnormal cell'),
(24404, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0100691', 'abnormal keratin accumulating cell', 0.5909090909090909, 3.6715585125471644, 1.4729417174039097, 'UPHENO:0086172', 'abnormal cell'),
(24405, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0125644', 'absent pericyte', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(24406, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0100728', 'abnormal cell condensation', 0.42857142857142855, 1.706362323152461, 0.8551597151958877, 'UPHENO:0002536', 'abnormal anatomical entity'),
(24407, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0101658', 'abnormal germ cell morphology', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(24408, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0101037', 'abnormal hatching gland cell', 0.4482758620689655, 3.6715585125471644, 1.2829150624062098, 'UPHENO:0086172', 'abnormal cell'),
(24409, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0102934', 'abnormal subcortical cytoplasm morphology', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(24410, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0101228', 'abnormal mesenchymal stem cell', 0.5652173913043478, 3.6715585125471644, 1.440565418328227, 'UPHENO:0086172', 'abnormal cell'),
(24411, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0100277', 'abnormal blastocoel', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(24412, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0101575', 'abnormal vitelline membrane', 0.52, 3.6715585125471644, 1.3817418089225373, 'UPHENO:0086172', 'abnormal cell'),
(24413, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0127391', 'abnormally localised lampbrush chromosome', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(24414, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0101740', 'abnormal cell part morphology', 0.4642857142857143, 3.6715585125471644, 1.305623286610558, 'UPHENO:0086172', 'abnormal cell'),
(24415, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0126681', 'abnormally localised basal body', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(24416, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0126413', 'abnormally localised cell part', 0.4482758620689655, 3.6715585125471644, 1.2829150624062098, 'UPHENO:0086172', 'abnormal cell'),
(24417, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0102588', 'abnormal centrosome morphology', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(24418, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0102183', 'abnormal oocyte cortex morphology', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(24419, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0141289', 'abnormal spindle microtubule morphology', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(24420, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0100574', 'abnormal gastrula cell', 0.5416666666666666, 3.6715585125471644, 1.4102343283876786, 'UPHENO:0086172', 'abnormal cell'),
(24421, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0130989', 'abnormally increased number of ciliated cell', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(24422, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0100481', 'abnormal anatomical line', 0.47368421052631576, 1.706362323152461, 0.8990422069704646, 'UPHENO:0002536', 'abnormal anatomical entity'),
(24423, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0125715', 'absent barrier cell', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(24424, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0142065', 'abnormally decreased number of desmosome', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(24425, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0101490', 'abnormal ectodermal cell', 0.4642857142857143, 3.6715585125471644, 1.305623286610558, 'UPHENO:0086172', 'abnormal cell'),
(24426, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0107253', 'abnormal enteric nervous system', 0.4230769230769231, 1.8210412618256888, 0.8777474203034321, 'HP:0000118', 'Phenotypic abnormality'),
(24427, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0102929', 'abnormal barrier cell morphology', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(24428, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0102704', 'abnormal mitochondrial cloud morphology', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(24429, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0101241', 'abnormal nucleate erythrocyte', 0.5909090909090909, 3.6715585125471644, 1.4729417174039097, 'UPHENO:0086172', 'abnormal cell'),
(24430, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0125743', 'absent lampbrush chromosome', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(24431, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0102386', 'abnormal electrically active cell morphology', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(24432, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0107262', 'abnormal left-right axis', 0.42857142857142855, 1.706362323152461, 0.8551597151958877, 'UPHENO:0002536', 'abnormal anatomical entity'),
(24433, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0100888', 'abnormal microtubule', 0.5652173913043478, 3.6715585125471644, 1.440565418328227, 'UPHENO:0086172', 'abnormal cell'),
(24434, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0125523', 'absent acid secreting cell', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(24435, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0101636', 'abnormal cell morphology', 0.4482758620689655, 3.6715585125471644, 1.2829150624062098, 'UPHENO:0086172', 'abnormal cell'),
(24436, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0100034', 'abnormal blastomere V1.1', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(24437, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0141745', 'abnormal creatinine homeostasis', 0.42105263157894735, 1.4755025719078136, 0.7882031722869998, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(24438, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0100596', 'abnormal myocyte', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(24439, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0100599', 'abnormal adult immune system', 0.4230769230769231, 1.8210412618256888, 0.8777474203034321, 'HP:0000118', 'Phenotypic abnormality'),
(24440, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0131512', 'absent adherens junction', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(24441, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0101221', 'abnormal larval immune system', 0.4230769230769231, 1.8210412618256888, 0.8777474203034321, 'HP:0000118', 'Phenotypic abnormality'),
(24442, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0141498', 'abnormal axon microtubule bundle', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(24443, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0100344', 'abnormal portion of organism substance', 0.47368421052631576, 1.706362323152461, 0.8990422069704646, 'UPHENO:0002536', 'abnormal anatomical entity'),
(24444, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0100882', 'abnormal perichondrial cell', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(24445, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0101498', 'abnormal stage II oocyte', 0.5416666666666666, 3.6715585125471644, 1.4102343283876786, 'UPHENO:0086172', 'abnormal cell'),
(24446, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0126318', 'abnormally localised cell', 0.4642857142857143, 3.6715585125471644, 1.305623286610558, 'UPHENO:0086172', 'abnormal cell'),
(24447, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0103129', 'abnormal ciliary axoneme morphology', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(24448, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0101514', 'abnormal dendrite', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(24449, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0100196', 'abnormal neuron', 0.48148148148148145, 3.6715585125471644, 1.3295816755533123, 'UPHENO:0086172', 'abnormal cell'),
(24450, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0127217', 'abnormally localised cilium', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(24451, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0127029', 'abnormally localised multiciliated cell precursor', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(24452, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0100274', 'abnormal sensory system', 0.4230769230769231, 1.8210412618256888, 0.8777474203034321, 'HP:0000118', 'Phenotypic abnormality'),
(24453, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0131667', 'abnormal actin cytoskeleton', 0.5652173913043478, 3.6715585125471644, 1.440565418328227, 'UPHENO:0086172', 'abnormal cell'),
(24454, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0100423', 'abnormal process', 0.42857142857142855, 1.706362323152461, 0.8551597151958877, 'UPHENO:0002536', 'abnormal anatomical entity'),
(24455, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0107399', 'abnormal filopodium morphology', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(24456, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0100449', 'abnormal lymphocyte', 0.48148148148148145, 3.6715585125471644, 1.3295816755533123, 'UPHENO:0086172', 'abnormal cell'),
(24457, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0101374', 'abnormal migratory neural crest cell', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(24458, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0107273', 'abnormal basal region', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(24459, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0107260', 'abnormal anterior-posterior axis', 0.42857142857142855, 1.706362323152461, 0.8551597151958877, 'UPHENO:0002536', 'abnormal anatomical entity'),
(24460, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0101518', 'abnormal B cell', 0.4642857142857143, 3.6715585125471644, 1.305623286610558, 'UPHENO:0086172', 'abnormal cell'),
(24461, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0101587', 'abnormal hemangioblast', 0.48148148148148145, 3.6715585125471644, 1.3295816755533123, 'UPHENO:0086172', 'abnormal cell'),
(24462, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0127476', 'abnormally localised nucleus', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(24463, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0141263', 'abnormal visually guided collision avoidance behavior', 0.42105263157894735, 1.4755025719078136, 0.7882031722869998, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(24464, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0141772', 'abnormal water homeostasis', 0.42105263157894735, 1.4755025719078136, 0.7882031722869998, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(24465, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0102869', 'abnormal mucus secreting cell morphology', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(24466, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0141266', 'abnormal surface breathing', 0.42105263157894735, 1.4755025719078136, 0.7882031722869998, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(24467, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0126600', 'abnormally localised progenitor cell', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(24468, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0100784', 'abnormal left blastomere', 0.52, 3.6715585125471644, 1.3817418089225373, 'UPHENO:0086172', 'abnormal cell'),
(24469, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0141267', 'abnormal resting posture', 0.42105263157894735, 1.4755025719078136, 0.7882031722869998, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(24470, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0126982', 'abnormally localised secondary oogonium', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(24471, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0125824', 'absent nucleus', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(24472, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0101107', 'abnormal erythroid cell', 0.48148148148148145, 3.6715585125471644, 1.3295816755533123, 'UPHENO:0086172', 'abnormal cell'),
(24473, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0125533', 'absent myelin accumulating cell', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(24474, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0100427', 'abnormal olfactory system', 0.4074074074074074, 1.8210412618256888, 0.861339479684008, 'HP:0000118', 'Phenotypic abnormality'),
(24475, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0101071', 'abnormal endoplasmic reticulum', 0.5652173913043478, 3.6715585125471644, 1.440565418328227, 'UPHENO:0086172', 'abnormal cell'),
(24476, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0107339', 'abnormal yolk platelet', 0.52, 3.6715585125471644, 1.3817418089225373, 'UPHENO:0086172', 'abnormal cell'),
(24477, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0100062', 'abnormal anatomical space', 0.42857142857142855, 1.706362323152461, 0.8551597151958877, 'UPHENO:0002536', 'abnormal anatomical entity'),
(24478, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0100653', 'abnormal myoblast', 0.5909090909090909, 3.6715585125471644, 1.4729417174039097, 'UPHENO:0086172', 'abnormal cell'),
(24479, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0100969', 'abnormal disaggregated/reaggregated ectoderm treated with activin', 0.45, 1.706362323152461, 0.8762779498644294, 'UPHENO:0002536', 'abnormal anatomical entity'),
(24480, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0101198', 'abnormal digestive enzyme secreting cell', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(24481, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0131561', 'abnormally localised actin filament', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(24482, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0100422', 'abnormal notochord', 0.4074074074074074, 1.8210412618256888, 0.861339479684008, 'HP:0000118', 'Phenotypic abnormality'),
(24483, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0100901', 'abnormal blastomere D1.2.2', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(24484, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0100587', 'abnormal vestibuloauditory system', 0.4074074074074074, 1.8210412618256888, 0.861339479684008, 'HP:0000118', 'Phenotypic abnormality'),
(24485, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0131032', 'abnormally increased number of acid secreting cell', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(24486, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0100862', 'abnormal blastomere V1', 0.52, 3.6715585125471644, 1.3817418089225373, 'UPHENO:0086172', 'abnormal cell'),
(24487, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0101176', 'abnormal non-ciliated epithelial cell', 0.5, 3.6715585125471644, 1.3549093166236559, 'UPHENO:0086172', 'abnormal cell'),
(24488, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0100152', 'abnormal alimentary system', 0.4074074074074074, 1.8210412618256888, 0.861339479684008, 'HP:0000118', 'Phenotypic abnormality'),
(24489, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0101327', 'abnormal blastomere V1.2.1', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(24490, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0124807', 'absent cell part', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(24491, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0127372', 'abnormally localised polar body', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(24492, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0100009', 'abnormal multi-tissue structure', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(24493, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0100701', 'abnormal microglial cell', 0.4642857142857143, 3.6715585125471644, 1.305623286610558, 'UPHENO:0086172', 'abnormal cell'),
(24494, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0103037', 'abnormal ring structure morphology', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(24495, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0141272', 'absent surface breathing', 0.42105263157894735, 1.4755025719078136, 0.7882031722869998, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(24496, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0101083', 'abnormal T cell', 0.4642857142857143, 3.6715585125471644, 1.305623286610558, 'UPHENO:0086172', 'abnormal cell'),
(24497, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0102539', 'abnormal cytoplasm morphology', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(24498, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0100724', 'abnormal kinetochore', 0.5652173913043478, 3.6715585125471644, 1.440565418328227, 'UPHENO:0086172', 'abnormal cell'),
(24499, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0100218', 'abnormal epithelial cell', 0.52, 3.6715585125471644, 1.3817418089225373, 'UPHENO:0086172', 'abnormal cell'),
(24500, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0101969', 'abnormal zygote morphology', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(24501, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0100965', 'abnormal blastomere V2.2', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(24502, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0101500', 'abnormal endodermal cell', 0.4642857142857143, 3.6715585125471644, 1.305623286610558, 'UPHENO:0086172', 'abnormal cell'),
(24503, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0102852', 'abnormal centriole morphology', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(24504, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0100887', 'abnormal right-dorsal blastomere', 0.52, 3.6715585125471644, 1.3817418089225373, 'UPHENO:0086172', 'abnormal cell'),
(24505, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0125394', 'absent multiciliated cell precursor', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(24506, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0100004', 'abnormal cell', 0.6190476190476191, 3.6715585125471644, 1.5076039119696991, 'UPHENO:0086172', 'abnormal cell'),
(24507, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0101451', 'abnormal dorsal lymph space', 0.4074074074074074, 1.8210412618256888, 0.861339479684008, 'HP:0000118', 'Phenotypic abnormality'),
(24508, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0101358', 'abnormal endothelial cell', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(24509, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0101120', 'abnormal cardiac progenitor cell', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(24510, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0131145', 'abnormally increased number of polar body', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(24511, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0107259', 'abnormal animal-vegetal axis', 0.42857142857142855, 1.706362323152461, 0.8551597151958877, 'UPHENO:0002536', 'abnormal anatomical entity'),
(24512, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0101237', 'abnormal mucus secreting cell', 0.5909090909090909, 3.6715585125471644, 1.4729417174039097, 'UPHENO:0086172', 'abnormal cell'),
(24513, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0101016', 'abnormal egg', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(24514, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0133445', 'abnormally increased number of cilium in the ciliated non-epidermal cell', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(24515, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0102285', 'abnormal myoblast morphology', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(24516, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0107286', 'abnormal efferent neuron', 0.4482758620689655, 3.6715585125471644, 1.2829150624062098, 'UPHENO:0086172', 'abnormal cell'),
(24517, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0101804', 'abnormal stem cell morphology', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(24518, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0101389', 'abnormal wedge region', 0.52, 3.6715585125471644, 1.3817418089225373, 'UPHENO:0086172', 'abnormal cell'),
(24519, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0100573', 'abnormal extraembryonic structure', 0.42857142857142855, 1.706362323152461, 0.8551597151958877, 'UPHENO:0002536', 'abnormal anatomical entity'),
(24520, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0100721', 'abnormal centromere', 0.5652173913043478, 3.6715585125471644, 1.440565418328227, 'UPHENO:0086172', 'abnormal cell'),
(24521, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0131708', 'abnormal cilium disassembly', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(24522, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0141784', 'abnormal cellular hormone metabolic process', 0.42105263157894735, 1.4755025719078136, 0.7882031722869998, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(24523, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0131134', 'abnormally increased number of barrier cell', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(24524, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0101133', 'abnormal motor neuron', 0.4642857142857143, 3.6715585125471644, 1.305623286610558, 'UPHENO:0086172', 'abnormal cell'),
(24525, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0101079', 'abnormal blastomere D1.1.2', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(24526, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0127288', 'abnormally localised pericyte', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(24527, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0131654', 'abnormal neuron projection', 0.4482758620689655, 3.6715585125471644, 1.2829150624062098, 'UPHENO:0086172', 'abnormal cell'),
(24528, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0115758', 'abnormally decreased mobility of melanoblast', 0.5, 3.6715585125471644, 1.3549093166236559, 'UPHENO:0086172', 'abnormal cell'),
(24529, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0127876', 'abnormally localised microtubule', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(24530, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0101325', 'abnormal blastomere D2.1.1', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(24531, 'HP:0031557', 'Reduced fibroblast CD55 level', 'XPO:0131735', 'abnormal spindle assembly', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(24532, 'HP:0002694', 'Sclerosis of skull base', 'XPO:0129688', 'increased size of the olfactory region', 0.4782608695652174, 8.21064164923199, 1.9816227226316523, 'UPHENO:0088115', 'abnormal neurocranium morphology'),
(24533, 'HP:0002694', 'Sclerosis of skull base', 'XPO:0102005', 'abnormal splanchnocranium morphology', 0.4126984126984127, 4.638757693672553, 1.3836213127410304, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(24534, 'HP:0002694', 'Sclerosis of skull base', 'XPO:0128477', 'decreased size of the neurocranium', 0.4714285714285714, 8.21064164923199, 1.967417358673387, 'UPHENO:0088115', 'abnormal neurocranium morphology'),
(24535, 'HP:0002694', 'Sclerosis of skull base', 'XPO:0102776', 'abnormal fenestra subocularis morphology', 0.41935483870967744, 4.638757693672553, 1.394734915474381, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(24536, 'HP:0002694', 'Sclerosis of skull base', 'XPO:0140294', 'abnormally necrotic osseous labyrinth', 0.4117647058823529, 9.012377498788434, 1.9263901396366612, 'HP:0002693', 'Abnormal skull base morphology'),
(24537, 'HP:0002694', 'Sclerosis of skull base', 'XPO:0141201', 'abnormally necrotic sphenoid region', 0.4925373134328358, 8.21064164923199, 2.0109816954593276, 'UPHENO:0088115', 'abnormal neurocranium morphology'),
(24538, 'HP:0002694', 'Sclerosis of skull base', 'XPO:0102092', 'abnormal ethmoid region morphology', 0.41935483870967744, 4.638757693672553, 1.394734915474381, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(24539, 'HP:0002694', 'Sclerosis of skull base', 'XPO:0102052', 'abnormal choana morphology', 0.47058823529411764, 7.717194259133599, 1.9056811978469999, 'UPHENO:0087814', 'abnormal cranium morphology'),
(24540, 'HP:0002694', 'Sclerosis of skull base', 'XPO:0128208', 'decreased size of the olfactory region', 0.4782608695652174, 8.21064164923199, 1.9816227226316523, 'UPHENO:0088115', 'abnormal neurocranium morphology'),
(24541, 'HP:0002694', 'Sclerosis of skull base', 'XPO:0102401', 'abnormal neurocranium morphology', 0.532258064516129, 8.21064164923199, 2.090497604077971, 'UPHENO:0088115', 'abnormal neurocranium morphology'),
(24542, 'HP:0002694', 'Sclerosis of skull base', 'XPO:0102828', 'abnormal occipital region morphology', 0.5161290322580645, 7.717194259133599, 1.9957625121026088, 'UPHENO:0087814', 'abnormal cranium morphology'),
(24543, 'HP:0002694', 'Sclerosis of skull base', 'XPO:0130324', 'increased size of the choana', 0.43243243243243246, 7.717194259133599, 1.8267909253745338, 'UPHENO:0087814', 'abnormal cranium morphology'),
(24544, 'HP:0002694', 'Sclerosis of skull base', 'XPO:0128845', 'decreased size of the osseous labyrinth', 0.40229885057471265, 9.012377498788434, 1.904118984913493, 'HP:0002693', 'Abnormal skull base morphology'),
(24545, 'HP:0002694', 'Sclerosis of skull base', 'XPO:0103381', 'increased size of the head', 0.4626865671641791, 7.024697770424301, 1.8028403414510898, 'HP:0000929', 'Abnormal skull morphology'),
(24546, 'HP:0002694', 'Sclerosis of skull base', 'XPO:0141829', 'increased width of head', 0.43661971830985913, 7.024697770424301, 1.7513199484202062, 'HP:0000929', 'Abnormal skull morphology'),
(24547, 'HP:0002694', 'Sclerosis of skull base', 'XPO:0102835', 'abnormal vestibule morphology', 0.4069767441860465, 9.012377498788434, 1.9151574483139766, 'HP:0002693', 'Abnormal skull base morphology'),
(24548, 'HP:0002694', 'Sclerosis of skull base', 'XPO:0102351', 'abnormal sphenoid region morphology', 0.532258064516129, 8.21064164923199, 2.090497604077971, 'UPHENO:0088115', 'abnormal neurocranium morphology'),
(24549, 'HP:0002694', 'Sclerosis of skull base', 'XPO:0101764', 'abnormal cranium morphology', 0.4262295081967213, 4.638757693672553, 1.4061206955371255, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(24550, 'HP:0002694', 'Sclerosis of skull base', 'XPO:0102485', 'abnormal osseous labyrinth morphology', 0.4375, 9.012377498788434, 1.985677505467577, 'HP:0002693', 'Abnormal skull base morphology'),
(24551, 'HP:0002694', 'Sclerosis of skull base', 'XPO:0130425', 'increased size of the otic region', 0.4782608695652174, 8.21064164923199, 1.9816227226316523, 'UPHENO:0088115', 'abnormal neurocranium morphology'),
(24552, 'HP:0002694', 'Sclerosis of skull base', 'XPO:0102921', 'abnormal orbital region morphology', 0.43661971830985913, 7.024697770424301, 1.7513199484202062, 'HP:0000929', 'Abnormal skull morphology'),
(24553, 'HP:0002694', 'Sclerosis of skull base', 'XPO:0129689', 'increased size of the sphenoid region', 0.4782608695652174, 8.21064164923199, 1.9816227226316523, 'UPHENO:0088115', 'abnormal neurocranium morphology'),
(24554, 'HP:0002694', 'Sclerosis of skull base', 'XPO:0102665', 'abnormal suspensorium morphology', 0.4126984126984127, 4.638757693672553, 1.3836213127410304, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(24555, 'HP:0002694', 'Sclerosis of skull base', 'XPO:0128905', 'decreased size of the occipital region', 0.463768115942029, 7.717194259133599, 1.891821514286438, 'UPHENO:0087814', 'abnormal cranium morphology'),
(24556, 'HP:0002694', 'Sclerosis of skull base', 'XPO:0128947', 'decreased size of the otic region', 0.4782608695652174, 8.21064164923199, 1.9816227226316523, 'UPHENO:0088115', 'abnormal neurocranium morphology'),
(24557, 'HP:0002694', 'Sclerosis of skull base', 'XPO:0101681', 'abnormal chondrocranium morphology', 0.4126984126984127, 4.638757693672553, 1.3836213127410304, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(24558, 'HP:0002694', 'Sclerosis of skull base', 'XPO:0102564', 'abnormal olfactory region morphology', 0.532258064516129, 8.21064164923199, 2.090497604077971, 'UPHENO:0088115', 'abnormal neurocranium morphology'),
(24559, 'HP:0002694', 'Sclerosis of skull base', 'XPO:0103176', 'abnormal fenestra basicranialis morphology', 0.41935483870967744, 4.638757693672553, 1.394734915474381, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(24560, 'HP:0002694', 'Sclerosis of skull base', 'XPO:0130383', 'increased size of the occipital region', 0.463768115942029, 7.717194259133599, 1.891821514286438, 'UPHENO:0087814', 'abnormal cranium morphology'),
(24561, 'HP:0002694', 'Sclerosis of skull base', 'XPO:0140926', 'abnormally necrotic neurocranium', 0.4925373134328358, 8.21064164923199, 2.0109816954593276, 'UPHENO:0088115', 'abnormal neurocranium morphology'),
(24562, 'HP:0002694', 'Sclerosis of skull base', 'XPO:0102720', 'abnormal dermatocranium morphology', 0.4126984126984127, 4.638757693672553, 1.3836213127410304, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(24563, 'HP:0002694', 'Sclerosis of skull base', 'XPO:0102867', 'abnormal lagena morphology', 0.4166666666666667, 9.012377498788434, 1.93782282243807, 'HP:0002693', 'Abnormal skull base morphology'),
(24564, 'HP:0002694', 'Sclerosis of skull base', 'XPO:0140560', 'abnormally necrotic orbital region', 0.40789473684210525, 7.024697770424301, 1.6927307076031153, 'HP:0000929', 'Abnormal skull morphology'),
(24565, 'HP:0002694', 'Sclerosis of skull base', 'XPO:0141185', 'abnormally necrotic occipital region', 0.47761194029850745, 7.717194259133599, 1.9198500263732323, 'UPHENO:0087814', 'abnormal cranium morphology'),
(24566, 'HP:0002694', 'Sclerosis of skull base', 'XPO:0103152', 'abnormal otic region morphology', 0.532258064516129, 8.21064164923199, 2.090497604077971, 'UPHENO:0088115', 'abnormal neurocranium morphology'),
(24567, 'HP:0002694', 'Sclerosis of skull base', 'XPO:0129957', 'increased size of the neurocranium', 0.4714285714285714, 8.21064164923199, 1.967417358673387, 'UPHENO:0088115', 'abnormal neurocranium morphology'),
(24568, 'HP:0002694', 'Sclerosis of skull base', 'XPO:0128209', 'decreased size of the sphenoid region', 0.4782608695652174, 8.21064164923199, 1.9816227226316523, 'UPHENO:0088115', 'abnormal neurocranium morphology'),
(24569, 'HP:0002694', 'Sclerosis of skull base', 'XPO:0130323', 'increased size of the osseous labyrinth', 0.40229885057471265, 9.012377498788434, 1.904118984913493, 'HP:0002693', 'Abnormal skull base morphology'),
(24570, 'HP:0002694', 'Sclerosis of skull base', 'XPO:0140672', 'abnormally necrotic olfactory region', 0.4925373134328358, 8.21064164923199, 2.0109816954593276, 'UPHENO:0088115', 'abnormal neurocranium morphology'),
(24571, 'HP:0002694', 'Sclerosis of skull base', 'XPO:0140644', 'abnormally necrotic otic region', 0.4925373134328358, 8.21064164923199, 2.0109816954593276, 'UPHENO:0088115', 'abnormal neurocranium morphology'),
(24572, 'HP:0002694', 'Sclerosis of skull base', 'XPO:0128846', 'decreased size of the choana', 0.43243243243243246, 7.717194259133599, 1.8267909253745338, 'UPHENO:0087814', 'abnormal cranium morphology'),
(24573, 'HP:0001045', 'Vitiligo', 'XPO:0102945', 'abnormal Eberth-Kastschenko layer morphology', 0.42857142857142855, 7.420886955069779, 1.7833620281931915, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(24574, 'HP:0001045', 'Vitiligo', 'XPO:0100006', 'abnormal anatomical structure', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(24575, 'HP:0001045', 'Vitiligo', 'XPO:0100081', 'abnormal anatomical entity in vitro', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(24576, 'HP:0001045', 'Vitiligo', 'XPO:0100983', 'abnormal skin gland', 0.4838709677419355, 6.8660902472206855, 1.8227182263109507, 'HP:0000951', 'Abnormality of the skin'),
(24577, 'HP:0001045', 'Vitiligo', 'XPO:0100172', 'abnormal stem cell', 0.4074074074074074, 1.8210412618256888, 0.861339479684008, 'HP:0000118', 'Phenotypic abnormality'),
(24578, 'HP:0001045', 'Vitiligo', 'XPO:0103147', 'abnormal neuromast mantle cell morphology', 0.42857142857142855, 7.420886955069779, 1.7833620281931915, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(24579, 'HP:0001045', 'Vitiligo', 'XPO:0103019', 'abnormal melanophore morphology', 0.4090909090909091, 7.420886955069779, 1.7423597190908553, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(24580, 'HP:0001045', 'Vitiligo', 'XPO:0100026', 'abnormal germ cell', 0.4074074074074074, 1.8210412618256888, 0.861339479684008, 'HP:0000118', 'Phenotypic abnormality'),
(24581, 'HP:0001045', 'Vitiligo', 'XPO:0101004', 'abnormal acid secreting cell', 0.4074074074074074, 1.8210412618256888, 0.861339479684008, 'HP:0000118', 'Phenotypic abnormality'),
(24582, 'HP:0001045', 'Vitiligo', 'XPO:0101333', 'abnormal barrier epithelial cell', 0.4074074074074074, 1.8210412618256888, 0.861339479684008, 'HP:0000118', 'Phenotypic abnormality'),
(24583, 'HP:0001045', 'Vitiligo', 'XPO:0101313', 'abnormal Eberth-Kastschenko layer', 0.4411764705882353, 6.8660902472206855, 1.740447489012273, 'HP:0000951', 'Abnormality of the skin'),
(24584, 'HP:0001045', 'Vitiligo', 'XPO:0101208', 'abnormal stratum spongiosum', 0.4411764705882353, 6.8660902472206855, 1.740447489012273, 'HP:0000951', 'Abnormality of the skin'),
(24585, 'HP:0001045', 'Vitiligo', 'XPO:0100754', 'abnormal electrically active cell', 0.4074074074074074, 1.8210412618256888, 0.861339479684008, 'HP:0000118', 'Phenotypic abnormality'),
(24586, 'HP:0001045', 'Vitiligo', 'XPO:0101241', 'abnormal nucleate erythrocyte', 0.4074074074074074, 1.8210412618256888, 0.861339479684008, 'HP:0000118', 'Phenotypic abnormality'),
(24587, 'HP:0001045', 'Vitiligo', 'XPO:0100533', 'abnormal melanoblast', 0.4074074074074074, 1.8210412618256888, 0.861339479684008, 'HP:0000118', 'Phenotypic abnormality'),
(24588, 'HP:0001045', 'Vitiligo', 'XPO:0100802', 'abnormal exocrine cell', 0.4074074074074074, 1.8210412618256888, 0.861339479684008, 'HP:0000118', 'Phenotypic abnormality'),
(24589, 'HP:0001045', 'Vitiligo', 'XPO:0100852', 'abnormal interdigital region', 0.4074074074074074, 1.8210412618256888, 0.861339479684008, 'HP:0000118', 'Phenotypic abnormality'),
(24590, 'HP:0001045', 'Vitiligo', 'XPO:0101297', 'abnormal barrier cell', 0.4074074074074074, 1.8210412618256888, 0.861339479684008, 'HP:0000118', 'Phenotypic abnormality'),
(24591, 'HP:0001045', 'Vitiligo', 'XPO:0100004', 'abnormal cell', 0.4230769230769231, 1.8210412618256888, 0.8777474203034321, 'HP:0000118', 'Phenotypic abnormality'),
(24592, 'HP:0001045', 'Vitiligo', 'XPO:0101467', 'abnormal alkali secreting cell', 0.4074074074074074, 1.8210412618256888, 0.861339479684008, 'HP:0000118', 'Phenotypic abnormality'),
(24593, 'HP:0001045', 'Vitiligo', 'XPO:0100791', 'abnormal multiciliated cell precursor', 0.4074074074074074, 1.8210412618256888, 0.861339479684008, 'HP:0000118', 'Phenotypic abnormality'),
(24594, 'HP:0001045', 'Vitiligo', 'XPO:0101254', 'abnormal stratum compactum', 0.4411764705882353, 6.8660902472206855, 1.740447489012273, 'HP:0000951', 'Abnormality of the skin'),
(24595, 'HP:0001045', 'Vitiligo', 'XPO:0101278', 'abnormal pigment cell', 0.4411764705882353, 6.8660902472206855, 1.740447489012273, 'HP:0000951', 'Abnormality of the skin'),
(24596, 'HP:0001045', 'Vitiligo', 'XPO:0101448', 'abnormal myelin accumulating cell', 0.4074074074074074, 1.8210412618256888, 0.861339479684008, 'HP:0000118', 'Phenotypic abnormality'),
(24597, 'HP:0001045', 'Vitiligo', 'XPO:0102561', 'abnormal dermis morphology', 0.45, 7.420886955069779, 1.8274022900777487, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(24598, 'HP:0001045', 'Vitiligo', 'XPO:0100638', 'abnormal polar body', 0.4074074074074074, 1.8210412618256888, 0.861339479684008, 'HP:0000118', 'Phenotypic abnormality'),
(24599, 'HP:0001045', 'Vitiligo', 'XPO:0102139', 'abnormal skin morphology', 0.46153846153846156, 7.420886955069779, 1.8506822386605823, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(24600, 'HP:0001045', 'Vitiligo', 'XPO:0100929', 'abnormal dermis', 0.46875, 6.8660902472206855, 1.7940122082596586, 'HP:0000951', 'Abnormality of the skin'),
(24601, 'HP:0001045', 'Vitiligo', 'XPO:0100549', 'abnormal mitotic cell', 0.4074074074074074, 1.8210412618256888, 0.861339479684008, 'HP:0000118', 'Phenotypic abnormality'),
(24602, 'HP:0001045', 'Vitiligo', 'XPO:0100704', 'abnormal Merkel cell', 0.4074074074074074, 1.8210412618256888, 0.861339479684008, 'HP:0000118', 'Phenotypic abnormality'),
(24603, 'HP:0001045', 'Vitiligo', 'XPO:0101322', 'abnormal iridophore', 0.42857142857142855, 6.8660902472206855, 1.7154037734456928, 'HP:0000951', 'Abnormality of the skin'),
(24604, 'HP:0001045', 'Vitiligo', 'XPO:0100994', 'abnormal granular gland', 0.46875, 6.8660902472206855, 1.7940122082596586, 'HP:0000951', 'Abnormality of the skin'),
(24605, 'HP:0001045', 'Vitiligo', 'XPO:0101132', 'abnormal apoptotic cell', 0.4074074074074074, 1.8210412618256888, 0.861339479684008, 'HP:0000118', 'Phenotypic abnormality'),
(24606, 'HP:0001045', 'Vitiligo', 'XPO:0101535', 'abnormal absorptive cell', 0.4074074074074074, 1.8210412618256888, 0.861339479684008, 'HP:0000118', 'Phenotypic abnormality'),
(24607, 'HP:0001045', 'Vitiligo', 'XPO:0101435', 'abnormal paracrine cell', 0.4074074074074074, 1.8210412618256888, 0.861339479684008, 'HP:0000118', 'Phenotypic abnormality'),
(24608, 'HP:0001045', 'Vitiligo', 'XPO:0100715', 'abnormal ciliated cell', 0.4074074074074074, 1.8210412618256888, 0.861339479684008, 'HP:0000118', 'Phenotypic abnormality'),
(24609, 'HP:0001045', 'Vitiligo', 'XPO:0102954', 'abnormal iridophore morphology', 0.4090909090909091, 7.420886955069779, 1.7423597190908553, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(24610, 'HP:0001045', 'Vitiligo', 'XPO:0101237', 'abnormal mucus secreting cell', 0.4074074074074074, 1.8210412618256888, 0.861339479684008, 'HP:0000118', 'Phenotypic abnormality'),
(24611, 'HP:0001045', 'Vitiligo', 'XPO:0101373', 'abnormal oxygen accumulating cell', 0.4074074074074074, 1.8210412618256888, 0.861339479684008, 'HP:0000118', 'Phenotypic abnormality'),
(24612, 'HP:0001045', 'Vitiligo', 'XPO:0100285', 'abnormal progenitor cell', 0.4074074074074074, 1.8210412618256888, 0.861339479684008, 'HP:0000118', 'Phenotypic abnormality'),
(24613, 'HP:0001045', 'Vitiligo', 'XPO:0101326', 'abnormal cementoblast', 0.4074074074074074, 1.8210412618256888, 0.861339479684008, 'HP:0000118', 'Phenotypic abnormality'),
(24614, 'HP:0001045', 'Vitiligo', 'XPO:0102910', 'abnormal pigment cell morphology', 0.42857142857142855, 7.420886955069779, 1.7833620281931915, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(24615, 'HP:0001045', 'Vitiligo', 'XPO:0100344', 'abnormal portion of organism substance', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(24616, 'HP:0001045', 'Vitiligo', 'XPO:0103223', 'abnormal xanthophore morphology', 0.4090909090909091, 7.420886955069779, 1.7423597190908553, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(24617, 'HP:0001045', 'Vitiligo', 'XPO:0101014', 'abnormal goblet cell', 0.40540540540540543, 6.8660902472206855, 1.6683974647021622, 'HP:0000951', 'Abnormality of the skin'),
(24618, 'HP:0001045', 'Vitiligo', 'XPO:0100481', 'abnormal anatomical line', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(24619, 'HP:0001045', 'Vitiligo', 'XPO:0100653', 'abnormal myoblast', 0.4074074074074074, 1.8210412618256888, 0.861339479684008, 'HP:0000118', 'Phenotypic abnormality'),
(24620, 'HP:0001045', 'Vitiligo', 'XPO:0100289', 'abnormal chondroblast', 0.4074074074074074, 1.8210412618256888, 0.861339479684008, 'HP:0000118', 'Phenotypic abnormality'),
(24621, 'HP:0001045', 'Vitiligo', 'XPO:0101529', 'abnormal skin mucous gland', 0.4411764705882353, 6.8660902472206855, 1.740447489012273, 'HP:0000951', 'Abnormality of the skin'),
(24622, 'HP:0001045', 'Vitiligo', 'XPO:0100691', 'abnormal keratin accumulating cell', 0.4074074074074074, 1.8210412618256888, 0.861339479684008, 'HP:0000118', 'Phenotypic abnormality'),
(24623, 'HP:0001045', 'Vitiligo', 'XPO:0100108', 'abnormal cell part', 0.4074074074074074, 1.8210412618256888, 0.861339479684008, 'HP:0000118', 'Phenotypic abnormality'),
(24624, 'HP:0001045', 'Vitiligo', 'XPO:0101515', 'abnormal neuromast mantle cell', 0.4411764705882353, 6.8660902472206855, 1.740447489012273, 'HP:0000951', 'Abnormality of the skin'),
(24625, 'HP:0001045', 'Vitiligo', 'XPO:0102886', 'abnormal stratum compactum morphology', 0.42857142857142855, 7.420886955069779, 1.7833620281931915, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(24626, 'HP:0001045', 'Vitiligo', 'XPO:0100337', 'abnormal zygote', 0.4074074074074074, 1.8210412618256888, 0.861339479684008, 'HP:0000118', 'Phenotypic abnormality'),
(24627, 'HP:0001045', 'Vitiligo', 'XPO:0100507', 'abnormal skin', 0.5, 6.8660902472206855, 1.8528478414619864, 'HP:0000951', 'Abnormality of the skin'),
(24628, 'HP:0001045', 'Vitiligo', 'XPO:0102840', 'abnormal stratum spongiosum morphology', 0.42857142857142855, 7.420886955069779, 1.7833620281931915, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(24629, 'HP:0001045', 'Vitiligo', 'XPO:0102176', 'abnormal neuromast support cell morphology', 0.42857142857142855, 7.420886955069779, 1.7833620281931915, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(24630, 'HP:0001045', 'Vitiligo', 'XPO:0102615', 'abnormal skin gland morphology', 0.46153846153846156, 7.420886955069779, 1.8506822386605823, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(24631, 'HP:0001045', 'Vitiligo', 'XPO:0101095', 'abnormal skin seromucous gland', 0.46875, 6.8660902472206855, 1.7940122082596586, 'HP:0000951', 'Abnormality of the skin'),
(24632, 'HP:0001045', 'Vitiligo', 'XPO:0102626', 'abnormal granular gland morphology', 0.43902439024390244, 7.420886955069779, 1.8049793268950312, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(24633, 'HP:0001045', 'Vitiligo', 'XPO:0101387', 'abnormal melanophore', 0.42857142857142855, 6.8660902472206855, 1.7154037734456928, 'HP:0000951', 'Abnormality of the skin'),
(24634, 'HP:0001045', 'Vitiligo', 'XPO:0100477', 'abnormal pericyte', 0.4074074074074074, 1.8210412618256888, 0.861339479684008, 'HP:0000118', 'Phenotypic abnormality'),
(24635, 'HP:0001045', 'Vitiligo', 'XPO:0102727', 'abnormal skin seromucous gland morphology', 0.43902439024390244, 7.420886955069779, 1.8049793268950312, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(24636, 'HP:0001045', 'Vitiligo', 'XPO:0101591', 'abnormal xanthophore', 0.42857142857142855, 6.8660902472206855, 1.7154037734456928, 'HP:0000951', 'Abnormality of the skin'),
(24637, 'HP:0001045', 'Vitiligo', 'XPO:0100544', 'abnormal neuromast support cell', 0.4411764705882353, 6.8660902472206855, 1.740447489012273, 'HP:0000951', 'Abnormality of the skin'),
(24638, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0102336', 'abnormal Merkel cell morphology', 0.40540540540540543, 2.786899518863159, 1.0629318554210558, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(24639, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0130299', 'increased size of the dorsolateral neural tube', 0.4117647058823529, 5.483278994082134, 1.502604659339613, 'HP:0002011', 'Morphological central nervous system abnormality'),
(24640, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0103202', 'abnormal forelimb region morphology', 0.40625, 2.786899518863159, 1.0640385000262718, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(24641, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0107357', 'abnormal proximal-distal axis morphology', 0.40625, 2.786899518863159, 1.0640385000262718, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(24642, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0102334', 'abnormal glial cell morphology', 0.475, 4.7814666189787065, 1.5070489852738316, 'HP:0012639', 'Abnormal nervous system morphology'),
(24643, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0129431', 'decreased size of the growth cone', 0.40425531914893614, 4.7814666189787065, 1.3902997209433732, 'HP:0012639', 'Abnormal nervous system morphology'),
(24644, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0102693', 'abnormal plasma membrane morphology', 0.4166666666666667, 2.786899518863159, 1.0775936770692605, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(24645, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0102742', 'abnormal cell-free extract morphology', 0.43333333333333335, 2.786899518863159, 1.0989342374200721, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(24646, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0141504', 'abnormal axon microtubule bundle morphology', 0.4523809523809524, 4.7814666189787065, 1.4707292146657451, 'HP:0012639', 'Abnormal nervous system morphology'),
(24647, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0103179', 'abnormal lampbrush chromosome morphology', 0.4166666666666667, 2.786899518863159, 1.0775936770692605, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(24648, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0102506', 'abnormal occipital lateral line morphology', 0.40425531914893614, 4.7814666189787065, 1.3902997209433732, 'HP:0012639', 'Abnormal nervous system morphology'),
(24649, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0133368', 'fused olfactory epithelia', 0.41304347826086957, 4.7814666189787065, 1.405330425021534, 'HP:0012639', 'Abnormal nervous system morphology'),
(24650, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0128126', 'decreased size of the anterior neural tube', 0.4117647058823529, 5.483278994082134, 1.502604659339613, 'HP:0002011', 'Morphological central nervous system abnormality'),
(24651, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0102832', 'abnormal joint region morphology', 0.40625, 2.786899518863159, 1.0640385000262718, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(24652, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0102495', 'abnormal spinal neuron morphology', 0.42, 5.483278994082134, 1.5175563177406288, 'HP:0002011', 'Morphological central nervous system abnormality'),
(24653, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0101642', 'abnormal multicellular anatomical structure morphology', 0.41935483870967744, 2.786899518863159, 1.0810641970914296, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(24654, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0129808', 'increased size of the olfactory system', 0.40425531914893614, 4.7814666189787065, 1.3902997209433732, 'HP:0012639', 'Abnormal nervous system morphology'),
(24655, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0102177', 'abnormal male organism morphology', 0.40625, 2.786899518863159, 1.0640385000262718, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(24656, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0139852', 'abnormally necrotic neuromere', 0.4772727272727273, 5.483278994082134, 1.617720470261422, 'HP:0002011', 'Morphological central nervous system abnormality'),
(24657, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0101636', 'abnormal cell morphology', 0.42857142857142855, 2.786899518863159, 1.092879457252359, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(24658, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0130905', 'increased size of the growth cone', 0.40425531914893614, 4.7814666189787065, 1.3902997209433732, 'HP:0012639', 'Abnormal nervous system morphology'),
(24659, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0100032', 'abnormal nervous system', 0.41935483870967744, 3.94131651835137, 1.2856166430382838, 'UPHENO:0004523', 'abnormal nervous system'),
(24660, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0102133', 'abnormal urogenital system morphology', 0.40540540540540543, 2.786899518863159, 1.0629318554210558, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(24661, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0102526', 'abnormal nucleus morphology', 0.4166666666666667, 2.786899518863159, 1.0775936770692605, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(24662, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0102741', 'abnormal egg cell-free extract morphology', 0.40625, 2.786899518863159, 1.0640385000262718, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(24663, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0102965', 'abnormal barrier epithelial cell morphology', 0.40540540540540543, 2.786899518863159, 1.0629318554210558, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(24664, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0140929', 'abnormally necrotic parabrachial area', 0.45652173913043476, 5.483278994082134, 1.5821618319614958, 'HP:0002011', 'Morphological central nervous system abnormality'),
(24665, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0129739', 'increased size of the nervous system', 0.4523809523809524, 4.7814666189787065, 1.4707292146657451, 'HP:0012639', 'Abnormal nervous system morphology'),
(24666, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0107359', 'abnormal axial region morphology', 0.40625, 2.786899518863159, 1.0640385000262718, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(24667, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0140286', 'abnormally necrotic gustatory system', 0.4222222222222222, 4.7814666189787065, 1.4208594094232423, 'HP:0012639', 'Abnormal nervous system morphology'),
(24668, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0139865', 'abnormally necrotic anterior neural tube', 0.42857142857142855, 5.483278994082134, 1.5329633758669794, 'HP:0002011', 'Morphological central nervous system abnormality'),
(24669, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0141239', 'abnormally necrotic neural progenitor cell', 0.40425531914893614, 4.7814666189787065, 1.3902997209433732, 'HP:0012639', 'Abnormal nervous system morphology'),
(24670, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0101790', 'abnormal neuromere morphology', 0.5384615384615384, 5.483278994082134, 1.718294166598753, 'HP:0002011', 'Morphological central nervous system abnormality'),
(24671, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0102165', 'abnormal melanoblast morphology', 0.40540540540540543, 2.786899518863159, 1.0629318554210558, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(24672, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0140397', 'abnormally necrotic ventrolateral neural tube', 0.42857142857142855, 5.483278994082134, 1.5329633758669794, 'HP:0002011', 'Morphological central nervous system abnormality'),
(24673, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0107373', 'abnormal efferent neuron morphology', 0.4418604651162791, 4.7814666189787065, 1.4535271116150168, 'HP:0012639', 'Abnormal nervous system morphology'),
(24674, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0102285', 'abnormal myoblast morphology', 0.40540540540540543, 2.786899518863159, 1.0629318554210558, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(24675, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0102773', 'abnormal Keller explant morphology', 0.43333333333333335, 2.786899518863159, 1.0989342374200721, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(24676, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0131614', 'increased size of the neuron projection', 0.41304347826086957, 4.7814666189787065, 1.405330425021534, 'HP:0012639', 'Abnormal nervous system morphology'),
(24677, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0128066', 'decreased size of the enteric nervous system', 0.4222222222222222, 4.7814666189787065, 1.4208594094232423, 'HP:0012639', 'Abnormal nervous system morphology'),
(24678, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0107347', 'abnormal anterior-posterior axis morphology', 0.40625, 2.786899518863159, 1.0640385000262718, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(24679, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0102178', 'abnormal whole organism morphology', 0.43333333333333335, 2.786899518863159, 1.0989342374200721, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(24680, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0101688', 'abnormal olfactory epithelium morphology', 0.4418604651162791, 4.7814666189787065, 1.4535271116150168, 'HP:0012639', 'Abnormal nervous system morphology'),
(24681, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0141285', 'abnormal cortical actin cytoskeleton morphology', 0.40540540540540543, 2.786899518863159, 1.0629318554210558, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(24682, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0140637', 'abnormally necrotic motor neuron', 0.40425531914893614, 4.7814666189787065, 1.3902997209433732, 'HP:0012639', 'Abnormal nervous system morphology'),
(24683, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0102392', 'abnormal Stirnorgan morphology', 0.475, 4.7814666189787065, 1.5070489852738316, 'HP:0012639', 'Abnormal nervous system morphology'),
(24684, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0102169', 'abnormal medium cavity morphology', 0.5, 4.7814666189787065, 1.5461996344228495, 'HP:0012639', 'Abnormal nervous system morphology'),
(24685, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0107349', 'abnormal left-right axis morphology', 0.40625, 2.786899518863159, 1.0640385000262718, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(24686, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0129818', 'increased size of the gustatory system', 0.40425531914893614, 4.7814666189787065, 1.3902997209433732, 'HP:0012639', 'Abnormal nervous system morphology'),
(24687, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0102995', 'abnormal infraorbital lateral line morphology', 0.40425531914893614, 4.7814666189787065, 1.3902997209433732, 'HP:0012639', 'Abnormal nervous system morphology'),
(24688, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0128259', 'decreased size of the nervous system', 0.4523809523809524, 4.7814666189787065, 1.4707292146657451, 'HP:0012639', 'Abnormal nervous system morphology'),
(24689, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0141241', 'abnormally necrotic olfactory epithelial support cell', 0.40425531914893614, 4.7814666189787065, 1.3902997209433732, 'HP:0012639', 'Abnormal nervous system morphology'),
(24690, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0102958', 'abnormal cementoblast morphology', 0.40540540540540543, 2.786899518863159, 1.0629318554210558, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(24691, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0129546', 'increased size of the enteric nervous system', 0.4222222222222222, 4.7814666189787065, 1.4208594094232423, 'HP:0012639', 'Abnormal nervous system morphology'),
(24692, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0139888', 'abnormally necrotic glial cell', 0.4318181818181818, 4.7814666189787065, 1.4369148276191301, 'HP:0012639', 'Abnormal nervous system morphology'),
(24693, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0130145', 'increased size of the posterior neural tube', 0.4117647058823529, 5.483278994082134, 1.502604659339613, 'HP:0002011', 'Morphological central nervous system abnormality'),
(24694, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0103104', 'abnormal zygote cortex morphology', 0.40540540540540543, 2.786899518863159, 1.0629318554210558, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(24695, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0102703', 'abnormal endoplasmic reticulum morphology', 0.4166666666666667, 2.786899518863159, 1.0775936770692605, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(24696, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0107340', 'abnormal enteric nervous system morphology', 0.5135135135135135, 4.7814666189787065, 1.56695492062131, 'HP:0012639', 'Abnormal nervous system morphology'),
(24697, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0102764', 'abnormal apoptotic cell morphology', 0.40540540540540543, 2.786899518863159, 1.0629318554210558, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(24698, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0101967', 'abnormal commissural interneuron morphology', 0.4222222222222222, 4.7814666189787065, 1.4208594094232423, 'HP:0012639', 'Abnormal nervous system morphology'),
(24699, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0102942', 'abnormal pigment layer morphology', 0.4222222222222222, 4.7814666189787065, 1.4208594094232423, 'HP:0012639', 'Abnormal nervous system morphology'),
(24700, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0139781', 'abnormally necrotic enteric nervous system', 0.4418604651162791, 4.7814666189787065, 1.4535271116150168, 'HP:0012639', 'Abnormal nervous system morphology'),
(24701, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0128716', 'decreased size of the Stirnorgan', 0.40425531914893614, 4.7814666189787065, 1.3902997209433732, 'HP:0012639', 'Abnormal nervous system morphology'),
(24702, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0141207', 'abnormally necrotic lateral funiculus', 0.42, 5.483278994082134, 1.5175563177406288, 'HP:0002011', 'Morphological central nervous system abnormality'),
(24703, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0140468', 'abnormally necrotic central nervous system', 0.4883720930232558, 5.483278994082134, 1.6364230623437035, 'HP:0002011', 'Morphological central nervous system abnormality'),
(24704, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0131746', 'abnormal neural tube closure', 0.525, 5.483278994082134, 1.696679543076158, 'HP:0002011', 'Morphological central nervous system abnormality'),
(24705, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0128102', 'decreased size of the portion of organism substance', 0.40625, 2.786899518863159, 1.0640385000262718, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(24706, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0102275', 'abnormal thoracic region morphology', 0.40625, 2.786899518863159, 1.0640385000262718, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(24707, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0129251', 'decreased size of the medium cavity', 0.4418604651162791, 4.7814666189787065, 1.4535271116150168, 'HP:0012639', 'Abnormal nervous system morphology'),
(24708, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0130727', 'increased size of the medium cavity', 0.4418604651162791, 4.7814666189787065, 1.4535271116150168, 'HP:0012639', 'Abnormal nervous system morphology'),
(24709, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0102873', 'abnormal nucleate erythrocyte morphology', 0.40540540540540543, 2.786899518863159, 1.0629318554210558, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(24710, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0102539', 'abnormal cytoplasm morphology', 0.4166666666666667, 2.786899518863159, 1.0775936770692605, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(24711, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0102202', 'abnormal axon morphology', 0.4523809523809524, 4.7814666189787065, 1.4707292146657451, 'HP:0012639', 'Abnormal nervous system morphology'),
(24712, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0139914', 'abnormally necrotic sensory system', 0.4634146341463415, 4.7814666189787065, 1.488556886355695, 'HP:0012639', 'Abnormal nervous system morphology'),
(24713, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0129982', 'increased size of the anatomical line', 0.40625, 2.786899518863159, 1.0640385000262718, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(24714, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0141325', 'edematous spinal cord', 0.4375, 5.483278994082134, 1.5488494310006167, 'HP:0002011', 'Morphological central nervous system abnormality'),
(24715, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0101802', 'abnormal anterior neural tube morphology', 0.4666666666666667, 5.483278994082134, 1.5996448138795258, 'HP:0002011', 'Morphological central nervous system abnormality'),
(24716, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0101740', 'abnormal cell part morphology', 0.4411764705882353, 2.786899518863159, 1.1088347458553505, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(24717, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0102201', 'abnormal motor axon morphology', 0.4222222222222222, 4.7814666189787065, 1.4208594094232423, 'HP:0012639', 'Abnormal nervous system morphology'),
(24718, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0129494', 'increased size of the neural nucleus', 0.4666666666666667, 5.483278994082134, 1.5996448138795258, 'HP:0002011', 'Morphological central nervous system abnormality'),
(24719, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0130589', 'increased size of the parabrachial area', 0.4375, 5.483278994082134, 1.5488494310006167, 'HP:0002011', 'Morphological central nervous system abnormality'),
(24720, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0130648', 'increased size of the principal cavity', 0.4418604651162791, 4.7814666189787065, 1.4535271116150168, 'HP:0012639', 'Abnormal nervous system morphology'),
(24721, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0129599', 'increased size of the neuromere', 0.45652173913043476, 5.483278994082134, 1.5821618319614958, 'HP:0002011', 'Morphological central nervous system abnormality'),
(24722, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0139791', 'abnormally necrotic peripheral nervous system', 0.40425531914893614, 4.7814666189787065, 1.3902997209433732, 'HP:0012639', 'Abnormal nervous system morphology'),
(24723, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0130514', 'increased size of the dorsal funiculus', 0.40384615384615385, 5.483278994082134, 1.4880863994491305, 'HP:0002011', 'Morphological central nervous system abnormality'),
(24724, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0102466', 'abnormal ventral lateral line morphology', 0.40425531914893614, 4.7814666189787065, 1.3902997209433732, 'HP:0012639', 'Abnormal nervous system morphology'),
(24725, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0128007', 'decreased size of the anatomical structure', 0.40625, 2.786899518863159, 1.0640385000262718, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(24726, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0107399', 'abnormal filopodium morphology', 0.4166666666666667, 2.786899518863159, 1.0775936770692605, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(24727, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0102852', 'abnormal centriole morphology', 0.40540540540540543, 2.786899518863159, 1.0629318554210558, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(24728, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0139841', 'abnormally necrotic anatomical region', 0.40625, 2.786899518863159, 1.0640385000262718, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(24729, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0101917', 'abnormal progenitor cell morphology', 0.40540540540540543, 2.786899518863159, 1.0629318554210558, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(24730, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0102353', 'abnormal centromere morphology', 0.4166666666666667, 2.786899518863159, 1.0775936770692605, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(24731, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0128014', 'decreased size of the neural nucleus', 0.4666666666666667, 5.483278994082134, 1.5996448138795258, 'HP:0002011', 'Morphological central nervous system abnormality'),
(24732, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0103080', 'abnormal myelin accumulating cell morphology', 0.40540540540540543, 2.786899518863159, 1.0629318554210558, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(24733, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0101664', 'abnormal nervous system morphology', 0.5428571428571428, 4.7814666189787065, 1.6111031337085728, 'HP:0012639', 'Abnormal nervous system morphology'),
(24734, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0115704', 'abnormally defasciculated motor neuron', 0.4418604651162791, 4.7814666189787065, 1.4535271116150168, 'HP:0012639', 'Abnormal nervous system morphology'),
(24735, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0142044', 'increased size of the cerebrospinal fluid', 0.5121951219512195, 5.483278994082134, 1.6758606007262236, 'HP:0002011', 'Morphological central nervous system abnormality'),
(24736, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0102705', 'abnormal Bowmans gland morphology', 0.4318181818181818, 4.7814666189787065, 1.4369148276191301, 'HP:0012639', 'Abnormal nervous system morphology'),
(24737, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0102871', 'abnormal olfactory epithelial support cell morphology', 0.4418604651162791, 4.7814666189787065, 1.4535271116150168, 'HP:0012639', 'Abnormal nervous system morphology'),
(24738, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0141015', 'abnormally necrotic central canal', 0.42, 5.483278994082134, 1.5175563177406288, 'HP:0002011', 'Morphological central nervous system abnormality'),
(24739, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0102219', 'abnormal vestibuloauditory system morphology', 0.5, 4.7814666189787065, 1.5461996344228495, 'HP:0012639', 'Abnormal nervous system morphology'),
(24740, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0140221', 'abnormally necrotic nervous system', 0.475, 4.7814666189787065, 1.5070489852738316, 'HP:0012639', 'Abnormal nervous system morphology'),
(24741, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0139780', 'abnormally necrotic neuron', 0.4318181818181818, 4.7814666189787065, 1.4369148276191301, 'HP:0012639', 'Abnormal nervous system morphology'),
(24742, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0115628', 'abnormally open neural tube', 0.4117647058823529, 5.483278994082134, 1.502604659339613, 'HP:0002011', 'Morphological central nervous system abnormality'),
(24743, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0102091', 'abnormal optic vesicle morphology', 0.4222222222222222, 4.7814666189787065, 1.4208594094232423, 'HP:0012639', 'Abnormal nervous system morphology'),
(24744, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0102670', 'abnormal hyomandibular lateral line morphology', 0.40425531914893614, 4.7814666189787065, 1.3902997209433732, 'HP:0012639', 'Abnormal nervous system morphology'),
(24745, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0140144', 'abnormally necrotic portion of organism substance', 0.43333333333333335, 2.786899518863159, 1.0989342374200721, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(24746, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0102323', 'abnormal keratin accumulating cell morphology', 0.40540540540540543, 2.786899518863159, 1.0629318554210558, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(24747, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0130322', 'increased size of the ventrolateral neural tube', 0.4117647058823529, 5.483278994082134, 1.502604659339613, 'HP:0002011', 'Morphological central nervous system abnormality'),
(24748, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0128162', 'decreased size of the sensory system', 0.4418604651162791, 4.7814666189787065, 1.4535271116150168, 'HP:0012639', 'Abnormal nervous system morphology'),
(24749, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0101906', 'abnormal sensory system morphology', 0.5277777777777778, 4.7814666189787065, 1.5885691129702875, 'HP:0012639', 'Abnormal nervous system morphology'),
(24750, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0128686', 'decreased size of the central nervous system', 0.4666666666666667, 5.483278994082134, 1.5996448138795258, 'HP:0002011', 'Morphological central nervous system abnormality'),
(24751, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0101952', 'abnormal lateral line morphology', 0.4222222222222222, 4.7814666189787065, 1.4208594094232423, 'HP:0012639', 'Abnormal nervous system morphology'),
(24752, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0131750', 'abnormal opening of the anterior neural tube', 0.44680851063829785, 5.483278994082134, 1.5652398285119449, 'HP:0002011', 'Morphological central nervous system abnormality'),
(24753, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0139834', 'abnormally necrotic spinal cord', 0.40384615384615385, 5.483278994082134, 1.4880863994491305, 'HP:0002011', 'Morphological central nervous system abnormality'),
(24754, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0128338', 'decreased size of the gustatory system', 0.40425531914893614, 4.7814666189787065, 1.3902997209433732, 'HP:0012639', 'Abnormal nervous system morphology'),
(24755, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0141555', 'abnormal neuron morphology in the regenerating tail', 0.41304347826086957, 4.7814666189787065, 1.405330425021534, 'HP:0012639', 'Abnormal nervous system morphology'),
(24756, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0142037', 'decreased size of the cerebrospinal fluid', 0.5121951219512195, 5.483278994082134, 1.6758606007262236, 'HP:0002011', 'Morphological central nervous system abnormality'),
(24757, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0107350', 'abnormal anatomical side morphology', 0.40625, 2.786899518863159, 1.0640385000262718, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(24758, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0140269', 'abnormally necrotic anatomical line', 0.43333333333333335, 2.786899518863159, 1.0989342374200721, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(24759, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0101871', 'abnormal acellular anatomical structure morphology', 0.41935483870967744, 2.786899518863159, 1.0810641970914296, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(24760, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0133422', 'abnormal cilium morphology in the neural progenitor cell', 0.4418604651162791, 4.7814666189787065, 1.4535271116150168, 'HP:0012639', 'Abnormal nervous system morphology'),
(24761, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0129108', 'decreased size of the ventral funiculus', 0.40384615384615385, 5.483278994082134, 1.4880863994491305, 'HP:0002011', 'Morphological central nervous system abnormality'),
(24762, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0130661', 'increased size of the lateral funiculus', 0.40384615384615385, 5.483278994082134, 1.4880863994491305, 'HP:0002011', 'Morphological central nervous system abnormality'),
(24763, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0102789', 'abnormal female organism morphology', 0.40625, 2.786899518863159, 1.0640385000262718, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(24764, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0102205', 'abnormal extraembryonic structure morphology', 0.40625, 2.786899518863159, 1.0640385000262718, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(24765, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0128328', 'decreased size of the olfactory system', 0.40425531914893614, 4.7814666189787065, 1.3902997209433732, 'HP:0012639', 'Abnormal nervous system morphology'),
(24766, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0102977', 'abnormal ascending interneuron morphology', 0.4222222222222222, 4.7814666189787065, 1.4208594094232423, 'HP:0012639', 'Abnormal nervous system morphology'),
(24767, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0103005', 'abnormal oxygen accumulating cell morphology', 0.40540540540540543, 2.786899518863159, 1.0629318554210558, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(24768, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0115510', 'abnormal degeneration of whole organism', 0.41935483870967744, 2.786899518863159, 1.0810641970914296, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(24769, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0140896', 'abnormally necrotic dorsolateral ascending neuron', 0.40425531914893614, 4.7814666189787065, 1.3902997209433732, 'HP:0012639', 'Abnormal nervous system morphology'),
(24770, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0141316', 'abnormal anatomical region morphology', 0.43333333333333335, 2.786899518863159, 1.0989342374200721, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(24771, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0131576', 'decreased size of the neuron projection', 0.41304347826086957, 4.7814666189787065, 1.405330425021534, 'HP:0012639', 'Abnormal nervous system morphology'),
(24772, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0142058', 'abnormal cerebrospinal fluid morphology', 0.5833333333333334, 5.483278994082134, 1.7884572718448095, 'HP:0002011', 'Morphological central nervous system abnormality'),
(24773, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0102113', 'abnormal anatomical line morphology', 0.4642857142857143, 2.786899518863159, 1.1375050038386183, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(24774, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0128161', 'decreased size of the visual system', 0.41304347826086957, 4.7814666189787065, 1.405330425021534, 'HP:0012639', 'Abnormal nervous system morphology'),
(24775, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0101638', 'abnormal anatomical structure morphology', 0.4642857142857143, 2.786899518863159, 1.1375050038386183, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(24776, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0102281', 'abnormal growth cone morphology', 0.4634146341463415, 4.7814666189787065, 1.488556886355695, 'HP:0012639', 'Abnormal nervous system morphology'),
(24777, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0141123', 'abnormally necrotic microglial cell', 0.40425531914893614, 4.7814666189787065, 1.3902997209433732, 'HP:0012639', 'Abnormal nervous system morphology'),
(24778, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0103146', 'abnormal dendrite morphology', 0.4523809523809524, 4.7814666189787065, 1.4707292146657451, 'HP:0012639', 'Abnormal nervous system morphology'),
(24779, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0103043', 'abnormal marginal zone (sensu neural) morphology', 0.40625, 2.786899518863159, 1.0640385000262718, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(24780, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0103167', 'abnormal absorptive cell morphology', 0.40540540540540543, 2.786899518863159, 1.0629318554210558, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(24781, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0102588', 'abnormal centrosome morphology', 0.4166666666666667, 2.786899518863159, 1.0775936770692605, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(24782, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0101658', 'abnormal germ cell morphology', 0.40540540540540543, 2.786899518863159, 1.0629318554210558, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(24783, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0141299', 'abnormal actin filament morphology', 0.40540540540540543, 2.786899518863159, 1.0629318554210558, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(24784, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0129642', 'increased size of the sensory system', 0.4418604651162791, 4.7814666189787065, 1.4535271116150168, 'HP:0012639', 'Abnormal nervous system morphology'),
(24785, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0129749', 'increased size of the central canal', 0.40384615384615385, 5.483278994082134, 1.4880863994491305, 'HP:0002011', 'Morphological central nervous system abnormality'),
(24786, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0107389', 'abnormal neurenteric canal morphology', 0.40384615384615385, 5.483278994082134, 1.4880863994491305, 'HP:0002011', 'Morphological central nervous system abnormality'),
(24787, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0102059', 'abnormal olfactory system morphology', 0.48717948717948717, 4.7814666189787065, 1.5262478355103022, 'HP:0012639', 'Abnormal nervous system morphology'),
(24788, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0102869', 'abnormal mucus secreting cell morphology', 0.40540540540540543, 2.786899518863159, 1.0629318554210558, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(24789, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0103002', 'abnormal floor plate morphology', 0.4375, 5.483278994082134, 1.5488494310006167, 'HP:0002011', 'Morphological central nervous system abnormality'),
(24790, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0101905', 'abnormal visual system morphology', 0.5, 4.7814666189787065, 1.5461996344228495, 'HP:0012639', 'Abnormal nervous system morphology'),
(24791, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0102902', 'abnormal caudal lateral line morphology', 0.40425531914893614, 4.7814666189787065, 1.3902997209433732, 'HP:0012639', 'Abnormal nervous system morphology'),
(24792, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0101713', 'abnormal anatomical entity in vitro morphology', 0.4642857142857143, 2.786899518863159, 1.1375050038386183, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(24793, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0107345', 'abnormal anatomical axis morphology', 0.43333333333333335, 2.786899518863159, 1.0989342374200721, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(24794, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0101694', 'abnormal anatomical space morphology', 0.43333333333333335, 2.786899518863159, 1.0989342374200721, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(24795, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0102366', 'abnormal lateral line system morphology', 0.4418604651162791, 4.7814666189787065, 1.4535271116150168, 'HP:0012639', 'Abnormal nervous system morphology'),
(24796, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0102318', 'abnormal olfactory organ morphology', 0.4222222222222222, 4.7814666189787065, 1.4208594094232423, 'HP:0012639', 'Abnormal nervous system morphology'),
(24797, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0139913', 'abnormally necrotic olfactory system', 0.4222222222222222, 4.7814666189787065, 1.4208594094232423, 'HP:0012639', 'Abnormal nervous system morphology'),
(24798, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0103133', 'abnormal parabrachial area morphology', 0.525, 5.483278994082134, 1.696679543076158, 'HP:0002011', 'Morphological central nervous system abnormality'),
(24799, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0101968', 'abnormal interneuron morphology', 0.4418604651162791, 4.7814666189787065, 1.4535271116150168, 'HP:0012639', 'Abnormal nervous system morphology'),
(24800, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0103117', 'abnormal descending interneuron morphology', 0.4222222222222222, 4.7814666189787065, 1.4208594094232423, 'HP:0012639', 'Abnormal nervous system morphology'),
(24801, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0142064', 'abnormal desmosome morphology', 0.4166666666666667, 2.786899518863159, 1.0775936770692605, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(24802, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0102548', 'abnormal principal cavity morphology', 0.5, 4.7814666189787065, 1.5461996344228495, 'HP:0012639', 'Abnormal nervous system morphology'),
(24803, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0102586', 'abnormal neural progenitor cell morphology', 0.4523809523809524, 4.7814666189787065, 1.4707292146657451, 'HP:0012639', 'Abnormal nervous system morphology'),
(24804, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0107253', 'abnormal enteric nervous system', 0.40625, 3.94131651835137, 1.2653694462805098, 'UPHENO:0004523', 'abnormal nervous system'),
(24805, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0129582', 'increased size of the portion of organism substance', 0.40625, 2.786899518863159, 1.0640385000262718, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(24806, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0101804', 'abnormal stem cell morphology', 0.40540540540540543, 2.786899518863159, 1.0629318554210558, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(24807, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0101890', 'abnormal organ part morphology', 0.43333333333333335, 2.786899518863159, 1.0989342374200721, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(24808, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0128502', 'decreased size of the anatomical line', 0.40625, 2.786899518863159, 1.0640385000262718, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(24809, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0102423', 'abnormal multiciliated cell precursor morphology', 0.40540540540540543, 2.786899518863159, 1.0629318554210558, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(24810, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0102792', 'abnormal ventral funiculus morphology', 0.4666666666666667, 5.483278994082134, 1.5996448138795258, 'HP:0002011', 'Morphological central nervous system abnormality'),
(24811, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0102333', 'abnormal microglial cell morphology', 0.4523809523809524, 4.7814666189787065, 1.4707292146657451, 'HP:0012639', 'Abnormal nervous system morphology'),
(24812, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0103025', 'abnormal dorsolateral neural tube morphology', 0.4666666666666667, 5.483278994082134, 1.5996448138795258, 'HP:0002011', 'Morphological central nervous system abnormality'),
(24813, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0129172', 'decreased size of the principal cavity', 0.4418604651162791, 4.7814666189787065, 1.4535271116150168, 'HP:0012639', 'Abnormal nervous system morphology'),
(24814, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0103145', 'abnormal basal body morphology', 0.4166666666666667, 2.786899518863159, 1.0775936770692605, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(24815, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0102444', 'abnormal sulcus limitans of neural tube morphology', 0.42857142857142855, 5.483278994082134, 1.5329633758669794, 'HP:0002011', 'Morphological central nervous system abnormality'),
(24816, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0128666', 'decreased size of the posterior neural tube', 0.4117647058823529, 5.483278994082134, 1.502604659339613, 'HP:0002011', 'Morphological central nervous system abnormality'),
(24817, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0128844', 'decreased size of the ventrolateral neural tube', 0.4117647058823529, 5.483278994082134, 1.502604659339613, 'HP:0002011', 'Morphological central nervous system abnormality'),
(24818, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0102601', 'abnormal disaggregated/reaggregated ectoderm treated with activin morphology', 0.43333333333333335, 2.786899518863159, 1.0989342374200721, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(24819, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0102419', 'abnormal posterior neural tube morphology', 0.4666666666666667, 5.483278994082134, 1.5996448138795258, 'HP:0002011', 'Morphological central nervous system abnormality'),
(24820, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0142031', 'abnormally necrotic cerebrospinal fluid', 0.5384615384615384, 5.483278994082134, 1.718294166598753, 'HP:0002011', 'Morphological central nervous system abnormality'),
(24821, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0130584', 'increased size of the ventral funiculus', 0.40384615384615385, 5.483278994082134, 1.4880863994491305, 'HP:0002011', 'Morphological central nervous system abnormality'),
(24822, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0102490', 'abnormal presumptive midbrain-hindbrain boundary morphology', 0.5121951219512195, 5.483278994082134, 1.6758606007262236, 'HP:0002011', 'Morphological central nervous system abnormality'),
(24823, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0141296', 'abnormal adherens junction morphology', 0.4166666666666667, 2.786899518863159, 1.0775936770692605, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(24824, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0102055', 'abnormal process morphology', 0.41935483870967744, 2.786899518863159, 1.0810641970914296, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(24825, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0102979', 'abnormal hindlimb region morphology', 0.40625, 2.786899518863159, 1.0640385000262718, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(24826, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0102109', 'abnormal pericyte morphology', 0.40540540540540543, 2.786899518863159, 1.0629318554210558, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(24827, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0140428', 'abnormally necrotic Stirnorgan', 0.4222222222222222, 4.7814666189787065, 1.4208594094232423, 'HP:0012639', 'Abnormal nervous system morphology'),
(24828, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0101990', 'abnormal ganglion morphology', 0.40425531914893614, 4.7814666189787065, 1.3902997209433732, 'HP:0012639', 'Abnormal nervous system morphology'),
(24829, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0101768', 'abnormal neural tube morphology', 0.42857142857142855, 5.483278994082134, 1.5329633758669794, 'HP:0002011', 'Morphological central nervous system abnormality'),
(24830, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0102903', 'abnormal roof plate morphology', 0.42, 5.483278994082134, 1.5175563177406288, 'HP:0002011', 'Morphological central nervous system abnormality'),
(24831, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0141286', 'abnormal neuron projection morphology', 0.475, 4.7814666189787065, 1.5070489852738316, 'HP:0012639', 'Abnormal nervous system morphology'),
(24832, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0103470', 'abnormal closing of the posterior neural tube', 0.44680851063829785, 5.483278994082134, 1.5652398285119449, 'HP:0002011', 'Morphological central nervous system abnormality'),
(24833, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0102181', 'abnormal mitotic cell morphology', 0.40540540540540543, 2.786899518863159, 1.0629318554210558, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(24834, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0129037', 'decreased size of the dorsal funiculus', 0.40384615384615385, 5.483278994082134, 1.4880863994491305, 'HP:0002011', 'Morphological central nervous system abnormality'),
(24835, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0103701', 'abnormal bending of anterior neural tube', 0.40384615384615385, 5.483278994082134, 1.4880863994491305, 'HP:0002011', 'Morphological central nervous system abnormality'),
(24836, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0101951', 'abnormal middle lateral line morphology', 0.40425531914893614, 4.7814666189787065, 1.3902997209433732, 'HP:0012639', 'Abnormal nervous system morphology'),
(24837, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0130428', 'increased size of the presumptive midbrain-hindbrain boundary', 0.44680851063829785, 5.483278994082134, 1.5652398285119449, 'HP:0002011', 'Morphological central nervous system abnormality'),
(24838, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0100274', 'abnormal sensory system', 0.40625, 3.94131651835137, 1.2653694462805098, 'UPHENO:0004523', 'abnormal nervous system'),
(24839, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0141151', 'abnormally necrotic dorsolateral commissural neuron', 0.40425531914893614, 4.7814666189787065, 1.3902997209433732, 'HP:0012639', 'Abnormal nervous system morphology'),
(24840, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0101921', 'abnormal chondroblast morphology', 0.40540540540540543, 2.786899518863159, 1.0629318554210558, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(24841, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0129113', 'decreased size of the parabrachial area', 0.4375, 5.483278994082134, 1.5488494310006167, 'HP:0002011', 'Morphological central nervous system abnormality'),
(24842, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0102667', 'abnormal ventrolateral neural tube morphology', 0.4666666666666667, 5.483278994082134, 1.5996448138795258, 'HP:0002011', 'Morphological central nervous system abnormality'),
(24843, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0107348', 'abnormal dorsal-ventral axis morphology', 0.40625, 2.786899518863159, 1.0640385000262718, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(24844, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0102434', 'abnormal exocrine cell morphology', 0.40540540540540543, 2.786899518863159, 1.0629318554210558, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(24845, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0129949', 'increased size of the vestibuloauditory system', 0.41304347826086957, 4.7814666189787065, 1.405330425021534, 'HP:0012639', 'Abnormal nervous system morphology'),
(24846, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0102347', 'abnormal ciliated cell morphology', 0.40540540540540543, 2.786899518863159, 1.0629318554210558, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(24847, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0101663', 'abnormal central nervous system morphology', 0.5675675675675675, 5.483278994082134, 1.7641233859811325, 'HP:0002011', 'Morphological central nervous system abnormality'),
(24848, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0130195', 'increased size of the Stirnorgan', 0.40425531914893614, 4.7814666189787065, 1.3902997209433732, 'HP:0012639', 'Abnormal nervous system morphology'),
(24849, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0128119', 'decreased size of the neuromere', 0.45652173913043476, 5.483278994082134, 1.5821618319614958, 'HP:0002011', 'Morphological central nervous system abnormality'),
(24850, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0103067', 'abnormal paracrine cell morphology', 0.40540540540540543, 2.786899518863159, 1.0629318554210558, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(24851, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0140414', 'abnormally necrotic posterior neural tube', 0.42857142857142855, 5.483278994082134, 1.5329633758669794, 'HP:0002011', 'Morphological central nervous system abnormality'),
(24852, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0140125', 'abnormally necrotic presumptive midbrain-hindbrain boundary', 0.4666666666666667, 5.483278994082134, 1.5996448138795258, 'HP:0002011', 'Morphological central nervous system abnormality'),
(24853, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0103058', 'abnormal dorsal funiculus morphology', 0.4666666666666667, 5.483278994082134, 1.5996448138795258, 'HP:0002011', 'Morphological central nervous system abnormality'),
(24854, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0102070', 'abnormal spinal cord morphology', 0.4666666666666667, 5.483278994082134, 1.5996448138795258, 'HP:0002011', 'Morphological central nervous system abnormality'),
(24855, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0101960', 'abnormal supraorbital lateral line morphology', 0.40425531914893614, 4.7814666189787065, 1.3902997209433732, 'HP:0012639', 'Abnormal nervous system morphology'),
(24856, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0102819', 'abnormal dorsolateral commissural neuron morphology', 0.4523809523809524, 4.7814666189787065, 1.4707292146657451, 'HP:0012639', 'Abnormal nervous system morphology'),
(24857, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0102765', 'abnormal motor neuron morphology', 0.4523809523809524, 4.7814666189787065, 1.4707292146657451, 'HP:0012639', 'Abnormal nervous system morphology'),
(24858, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0102326', 'abnormal lateral line primordium morphology', 0.40425531914893614, 4.7814666189787065, 1.3902997209433732, 'HP:0012639', 'Abnormal nervous system morphology'),
(24859, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0101716', 'abnormal anatomical group morphology', 0.41935483870967744, 2.786899518863159, 1.0810641970914296, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(24860, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0140971', 'abnormally necrotic dorsal funiculus', 0.42, 5.483278994082134, 1.5175563177406288, 'HP:0002011', 'Morphological central nervous system abnormality'),
(24861, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0103201', 'abnormal activin-induced ectoderm morphology', 0.43333333333333335, 2.786899518863159, 1.0989342374200721, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(24862, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0102024', 'abnormal cilium morphology', 0.40540540540540543, 2.786899518863159, 1.0629318554210558, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(24863, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0139718', 'abnormally necrotic anatomical structure', 0.43333333333333335, 2.786899518863159, 1.0989342374200721, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(24864, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0141277', 'abnormal actin cytoskeleton morphology', 0.4166666666666667, 2.786899518863159, 1.0775936770692605, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(24865, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0101828', 'abnormal neuron morphology', 0.475, 4.7814666189787065, 1.5070489852738316, 'HP:0012639', 'Abnormal nervous system morphology'),
(24866, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0102386', 'abnormal electrically active cell morphology', 0.40540540540540543, 2.786899518863159, 1.0629318554210558, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(24867, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0128269', 'decreased size of the central canal', 0.40384615384615385, 5.483278994082134, 1.4880863994491305, 'HP:0002011', 'Morphological central nervous system abnormality'),
(24868, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0129606', 'increased size of the anterior neural tube', 0.4117647058823529, 5.483278994082134, 1.502604659339613, 'HP:0002011', 'Morphological central nervous system abnormality'),
(24869, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0101969', 'abnormal zygote morphology', 0.40540540540540543, 2.786899518863159, 1.0629318554210558, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(24870, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0102929', 'abnormal barrier cell morphology', 0.40540540540540543, 2.786899518863159, 1.0629318554210558, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(24871, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0129487', 'increased size of the anatomical structure', 0.40625, 2.786899518863159, 1.0640385000262718, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(24872, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0140224', 'abnormally necrotic vestibuloauditory system', 0.4318181818181818, 4.7814666189787065, 1.4369148276191301, 'HP:0012639', 'Abnormal nervous system morphology'),
(24873, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0129641', 'increased size of the visual system', 0.41304347826086957, 4.7814666189787065, 1.405330425021534, 'HP:0012639', 'Abnormal nervous system morphology'),
(24874, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0140622', 'abnormally necrotic migrating neuroblast', 0.4318181818181818, 4.7814666189787065, 1.4369148276191301, 'HP:0012639', 'Abnormal nervous system morphology'),
(24875, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0101746', 'abnormal peripheral nervous system morphology', 0.4634146341463415, 4.7814666189787065, 1.488556886355695, 'HP:0012639', 'Abnormal nervous system morphology'),
(24876, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0102892', 'abnormal central canal morphology', 0.4666666666666667, 5.483278994082134, 1.5996448138795258, 'HP:0002011', 'Morphological central nervous system abnormality'),
(24877, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0102360', 'abnormal cell condensation morphology', 0.41935483870967744, 2.786899518863159, 1.0810641970914296, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(24878, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0141110', 'abnormally necrotic ventral funiculus', 0.42, 5.483278994082134, 1.5175563177406288, 'HP:0002011', 'Morphological central nervous system abnormality'),
(24879, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0102496', 'abnormal dorsolateral ascending neuron morphology', 0.4523809523809524, 4.7814666189787065, 1.4707292146657451, 'HP:0012639', 'Abnormal nervous system morphology'),
(24880, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0103198', 'abnormal posterior lateral line morphology', 0.40425531914893614, 4.7814666189787065, 1.3902997209433732, 'HP:0012639', 'Abnormal nervous system morphology'),
(24881, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0128821', 'decreased size of the dorsolateral neural tube', 0.4117647058823529, 5.483278994082134, 1.502604659339613, 'HP:0002011', 'Morphological central nervous system abnormality'),
(24882, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0102523', 'abnormal dorsal lateral line morphology', 0.40425531914893614, 4.7814666189787065, 1.3902997209433732, 'HP:0012639', 'Abnormal nervous system morphology'),
(24883, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0102633', 'abnormal ventricular zone morphology', 0.40384615384615385, 5.483278994082134, 1.4880863994491305, 'HP:0002011', 'Morphological central nervous system abnormality'),
(24884, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0128950', 'decreased size of the presumptive midbrain-hindbrain boundary', 0.44680851063829785, 5.483278994082134, 1.5652398285119449, 'HP:0002011', 'Morphological central nervous system abnormality'),
(24885, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0102356', 'abnormal kinetochore morphology', 0.4166666666666667, 2.786899518863159, 1.0775936770692605, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(24886, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0107346', 'abnormal animal-vegetal axis morphology', 0.40625, 2.786899518863159, 1.0640385000262718, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(24887, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0101796', 'abnormal neural nucleus morphology', 0.5526315789473685, 5.483278994082134, 1.740756481621869, 'HP:0002011', 'Morphological central nervous system abnormality'),
(24888, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0102520', 'abnormal microtubule morphology', 0.4166666666666667, 2.786899518863159, 1.0775936770692605, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(24889, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0140203', 'abnormally necrotic visual system', 0.4318181818181818, 4.7814666189787065, 1.4369148276191301, 'HP:0012639', 'Abnormal nervous system morphology'),
(24890, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0103099', 'abnormal alkali secreting cell morphology', 0.40540540540540543, 2.786899518863159, 1.0629318554210558, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(24891, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0100031', 'abnormal central nervous system', 0.40625, 3.94131651835137, 1.2653694462805098, 'UPHENO:0004523', 'abnormal nervous system'),
(24892, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0101976', 'abnormal portion of organism substance morphology', 0.4642857142857143, 2.786899518863159, 1.1375050038386183, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(24893, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0102274', 'abnormal gustatory system morphology', 0.48717948717948717, 4.7814666189787065, 1.5262478355103022, 'HP:0012639', 'Abnormal nervous system morphology'),
(24894, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0102747', 'abnormal trunk lateral line morphology', 0.40425531914893614, 4.7814666189787065, 1.3902997209433732, 'HP:0012639', 'Abnormal nervous system morphology'),
(24895, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0141505', 'abnormal tadpole morphology', 0.40625, 2.786899518863159, 1.0640385000262718, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(24896, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0102896', 'abnormal mitotic spindle morphology', 0.4166666666666667, 2.786899518863159, 1.0775936770692605, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(24897, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0102449', 'abnormal intersomitic neuron morphology', 0.4222222222222222, 4.7814666189787065, 1.4208594094232423, 'HP:0012639', 'Abnormal nervous system morphology'),
(24898, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0103093', 'abnormal sperm entry point morphology', 0.40540540540540543, 2.786899518863159, 1.0629318554210558, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(24899, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0103144', 'abnormal lateral funiculus morphology', 0.4666666666666667, 5.483278994082134, 1.5996448138795258, 'HP:0002011', 'Morphological central nervous system abnormality'),
(24900, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0107374', 'abnormal afferent neuron morphology', 0.4418604651162791, 4.7814666189787065, 1.4535271116150168, 'HP:0012639', 'Abnormal nervous system morphology'),
(24901, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0140183', 'abnormally necrotic dorsolateral neural tube', 0.42857142857142855, 5.483278994082134, 1.5329633758669794, 'HP:0002011', 'Morphological central nervous system abnormality'),
(24902, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0129185', 'decreased size of the lateral funiculus', 0.40384615384615385, 5.483278994082134, 1.4880863994491305, 'HP:0002011', 'Morphological central nervous system abnormality'),
(24903, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0102636', 'abnormal acid secreting cell morphology', 0.40540540540540543, 2.786899518863159, 1.0629318554210558, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(24904, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0128469', 'decreased size of the vestibuloauditory system', 0.41304347826086957, 4.7814666189787065, 1.405330425021534, 'HP:0012639', 'Abnormal nervous system morphology'),
(24905, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0130165', 'increased size of the central nervous system', 0.4666666666666667, 5.483278994082134, 1.5996448138795258, 'HP:0002011', 'Morphological central nervous system abnormality'),
(24906, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0141655', 'neoplastic spinal cord', 0.4375, 5.483278994082134, 1.5488494310006167, 'HP:0002011', 'Morphological central nervous system abnormality'),
(24907, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0139757', 'abnormally necrotic neural nucleus', 0.4883720930232558, 5.483278994082134, 1.6364230623437035, 'HP:0002011', 'Morphological central nervous system abnormality'),
(24908, 'HP:0010652', 'Abnormal dura mater morphology', 'XPO:0101807', 'abnormal migrating neuroblast morphology', 0.475, 4.7814666189787065, 1.5070489852738316, 'HP:0012639', 'Abnormal nervous system morphology'),
(24909, 'HP:0034373', 'External tibial torsion', 'XPO:0102566', 'abnormal claw primordium morphology', 0.40229885057471265, 7.61213700143767, 1.7499582755299095, 'UPHENO:0079871', 'abnormal anatomical entity morphology in the skeleton of pelvic complex'),
(24910, 'HP:0034373', 'External tibial torsion', 'XPO:0103008', 'abnormal iliac process morphology', 0.4235294117647059, 7.61213700143767, 1.7955400041467326, 'UPHENO:0079871', 'abnormal anatomical entity morphology in the skeleton of pelvic complex'),
(24911, 'HP:0034373', 'External tibial torsion', 'XPO:0140858', 'abnormally necrotic iliac process', 0.4044943820224719, 7.61213700143767, 1.7547269452159566, 'UPHENO:0079871', 'abnormal anatomical entity morphology in the skeleton of pelvic complex'),
(24912, 'HP:0034373', 'External tibial torsion', 'XPO:0100178', 'abnormal digit', 0.4126984126984127, 5.802924133159483, 1.547532739157473, 'UPHENO:0076727', 'abnormal limb bone morphology'),
(24913, 'HP:0034373', 'External tibial torsion', 'XPO:0102880', 'abnormal digit-joint region morphology', 0.4225352112676056, 5.914846961127896, 1.580895667125358, 'UPHENO:0084763', 'abnormal anatomical entity morphology in the appendage girdle complex'),
(24914, 'HP:0034373', 'External tibial torsion', 'XPO:0101810', 'abnormal digit morphology', 0.4225352112676056, 5.914846961127896, 1.580895667125358, 'UPHENO:0084763', 'abnormal anatomical entity morphology in the appendage girdle complex'),
(24915, 'HP:0034373', 'External tibial torsion', 'XPO:0141567', 'abnormal joint region morphology in the femur', 0.4105263157894737, 7.61213700143767, 1.7677620197540558, 'UPHENO:0079871', 'abnormal anatomical entity morphology in the skeleton of pelvic complex'),
(24916, 'HP:0033146', 'Elevated circulating methylsuccinic acid concentration', 'XPO:0141866', 'abnormal dicarboxylic acid metabolic process', 0.4090909090909091, 12.688487887567785, 2.2783206633207045, 'UPHENO:0078584', 'abnormal dicarboxylic acid metabolic process'),
(24917, 'HP:0033146', 'Elevated circulating methylsuccinic acid concentration', 'XPO:0141882', 'abnormal gamma-aminobutyric acid metabolic process', 0.660377358490566, 9.119292702704945, 2.4540119042732016, 'HP:0004354', 'Abnormal circulating carboxylic acid concentration'),
(24918, 'HP:0033146', 'Elevated circulating methylsuccinic acid concentration', 'XPO:0141843', 'abnormal alanine metabolic process', 0.6481481481481481, 9.119292702704945, 2.4311833903840183, 'HP:0004354', 'Abnormal circulating carboxylic acid concentration'),
(24919, 'HP:0033146', 'Elevated circulating methylsuccinic acid concentration', 'XPO:0141917', 'abnormal tryptophan metabolic process', 0.6363636363636364, 9.119292702704945, 2.4089803372708736, 'HP:0004354', 'Abnormal circulating carboxylic acid concentration'),
(24920, 'HP:0033146', 'Elevated circulating methylsuccinic acid concentration', 'XPO:0141888', 'abnormal threonine metabolic process', 0.6363636363636364, 9.119292702704945, 2.4089803372708736, 'HP:0004354', 'Abnormal circulating carboxylic acid concentration'),
(24921, 'HP:0033146', 'Elevated circulating methylsuccinic acid concentration', 'XPO:0141848', 'abnormal proline metabolic process', 0.6363636363636364, 9.119292702704945, 2.4089803372708736, 'HP:0004354', 'Abnormal circulating carboxylic acid concentration'),
(24922, 'HP:0033146', 'Elevated circulating methylsuccinic acid concentration', 'XPO:0141873', 'abnormal tricarboxylic acid metabolic process', 0.7291666666666666, 9.119292702704945, 2.5786593924729613, 'HP:0004354', 'Abnormal circulating carboxylic acid concentration'),
(24923, 'HP:0033146', 'Elevated circulating methylsuccinic acid concentration', 'XPO:0141868', 'abnormal asparagine metabolic process', 0.6363636363636364, 9.119292702704945, 2.4089803372708736, 'HP:0004354', 'Abnormal circulating carboxylic acid concentration'),
(24924, 'HP:0033146', 'Elevated circulating methylsuccinic acid concentration', 'XPO:0141869', 'abnormal alpha-amino acid metabolic process', 0.6730769230769231, 9.119292702704945, 2.4774958068530575, 'HP:0004354', 'Abnormal circulating carboxylic acid concentration'),
(24925, 'HP:0033146', 'Elevated circulating methylsuccinic acid concentration', 'XPO:0141847', 'abnormal arginine metabolic process', 0.6363636363636364, 9.119292702704945, 2.4089803372708736, 'HP:0004354', 'Abnormal circulating carboxylic acid concentration'),
(24926, 'HP:0033146', 'Elevated circulating methylsuccinic acid concentration', 'XPO:0141905', 'abnormal ornithine metabolic process', 0.6481481481481481, 9.119292702704945, 2.4311833903840183, 'HP:0004354', 'Abnormal circulating carboxylic acid concentration'),
(24927, 'HP:0033146', 'Elevated circulating methylsuccinic acid concentration', 'XPO:0141922', 'abnormal valine metabolic process', 0.6363636363636364, 9.119292702704945, 2.4089803372708736, 'HP:0004354', 'Abnormal circulating carboxylic acid concentration'),
(24928, 'HP:0033146', 'Elevated circulating methylsuccinic acid concentration', 'XPO:0141912', 'abnormal D-serine metabolic process', 0.625, 9.119292702704945, 2.387374696018744, 'HP:0004354', 'Abnormal circulating carboxylic acid concentration'),
(24929, 'HP:0033146', 'Elevated circulating methylsuccinic acid concentration', 'XPO:0141857', 'abnormal glycine metabolic process', 0.625, 9.119292702704945, 2.387374696018744, 'HP:0004354', 'Abnormal circulating carboxylic acid concentration'),
(24930, 'HP:0033146', 'Elevated circulating methylsuccinic acid concentration', 'XPO:0141918', 'abnormal tyrosine metabolic process', 0.6363636363636364, 9.119292702704945, 2.4089803372708736, 'HP:0004354', 'Abnormal circulating carboxylic acid concentration'),
(24931, 'HP:0033146', 'Elevated circulating methylsuccinic acid concentration', 'XPO:0141913', 'abnormal L-serine metabolic process', 0.625, 9.119292702704945, 2.387374696018744, 'HP:0004354', 'Abnormal circulating carboxylic acid concentration'),
(24932, 'HP:0033146', 'Elevated circulating methylsuccinic acid concentration', 'XPO:0141895', 'abnormal leucine metabolic process', 0.6363636363636364, 9.119292702704945, 2.4089803372708736, 'HP:0004354', 'Abnormal circulating carboxylic acid concentration'),
(24933, 'HP:0033146', 'Elevated circulating methylsuccinic acid concentration', 'XPO:0141889', 'abnormal homoserine metabolic process', 0.625, 9.119292702704945, 2.387374696018744, 'HP:0004354', 'Abnormal circulating carboxylic acid concentration'),
(24934, 'HP:0033146', 'Elevated circulating methylsuccinic acid concentration', 'XPO:0141893', 'abnormal isoleucine metabolic process', 0.6363636363636364, 9.119292702704945, 2.4089803372708736, 'HP:0004354', 'Abnormal circulating carboxylic acid concentration'),
(24935, 'HP:0033146', 'Elevated circulating methylsuccinic acid concentration', 'XPO:0141887', 'abnormal histidine metabolic process', 0.6363636363636364, 9.119292702704945, 2.4089803372708736, 'HP:0004354', 'Abnormal circulating carboxylic acid concentration'),
(24936, 'HP:0033146', 'Elevated circulating methylsuccinic acid concentration', 'XPO:0141853', 'abnormal glutamate metabolic process', 0.6428571428571429, 12.688487887567785, 2.8560260976712537, 'UPHENO:0078584', 'abnormal dicarboxylic acid metabolic process'),
(24937, 'HP:0033146', 'Elevated circulating methylsuccinic acid concentration', 'XPO:0141858', 'abnormal serine family amino acid metabolic process', 0.6481481481481481, 9.119292702704945, 2.4311833903840183, 'HP:0004354', 'Abnormal circulating carboxylic acid concentration'),
(24938, 'HP:0033146', 'Elevated circulating methylsuccinic acid concentration', 'XPO:0141896', 'abnormal lysine metabolic process', 0.6363636363636364, 9.119292702704945, 2.4089803372708736, 'HP:0004354', 'Abnormal circulating carboxylic acid concentration'),
(24939, 'HP:0034529', 'Reduced muscle myoadenylate deaminase activity', 'XPO:0100392', 'abnormal cilium', 0.4166666666666667, 1.8210412618256888, 0.871072438105678, 'HP:0000118', 'Phenotypic abnormality'),
(24940, 'HP:0034529', 'Reduced muscle myoadenylate deaminase activity', 'XPO:0141778', 'abnormal biosynthetic process', 0.5238095238095238, 4.758907843651163, 1.5788480773767701, 'HP:0001939', 'Abnormality of metabolism/homeostasis'),
(24941, 'HP:0034529', 'Reduced muscle myoadenylate deaminase activity', 'XPO:0141770', 'abnormal urate homeostasis', 0.5, 1.4755025719078136, 0.8589244937443028, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(24942, 'HP:0034529', 'Reduced muscle myoadenylate deaminase activity', 'XPO:0101326', 'abnormal cementoblast', 0.45454545454545453, 1.8210412618256888, 0.9098054891583067, 'HP:0000118', 'Phenotypic abnormality'),
(24943, 'HP:0034529', 'Reduced muscle myoadenylate deaminase activity', 'XPO:0100515', 'abnormal somatic stem cell', 0.43478260869565216, 1.8210412618256888, 0.8898073220416851, 'HP:0000118', 'Phenotypic abnormality'),
(24944, 'HP:0034529', 'Reduced muscle myoadenylate deaminase activity', 'XPO:0100481', 'abnormal anatomical line', 0.47058823529411764, 1.4755025719078136, 0.8332791557971614, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(24945, 'HP:0034529', 'Reduced muscle myoadenylate deaminase activity', 'XPO:0100721', 'abnormal centromere', 0.43478260869565216, 1.8210412618256888, 0.8898073220416851, 'HP:0000118', 'Phenotypic abnormality'),
(24946, 'HP:0034529', 'Reduced muscle myoadenylate deaminase activity', 'XPO:0100501', 'abnormal urogenital system', 0.43478260869565216, 1.8210412618256888, 0.8898073220416851, 'HP:0000118', 'Phenotypic abnormality'),
(24947, 'HP:0034529', 'Reduced muscle myoadenylate deaminase activity', 'XPO:0141315', 'abnormal anatomical region', 0.42105263157894735, 1.4755025719078136, 0.7882031722869998, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(24948, 'HP:0034529', 'Reduced muscle myoadenylate deaminase activity', 'XPO:0100802', 'abnormal exocrine cell', 0.45454545454545453, 1.8210412618256888, 0.9098054891583067, 'HP:0000118', 'Phenotypic abnormality'),
(24949, 'HP:0034529', 'Reduced muscle myoadenylate deaminase activity', 'XPO:0100917', 'abnormal stage III oocyte', 0.4166666666666667, 1.8210412618256888, 0.871072438105678, 'HP:0000118', 'Phenotypic abnormality'),
(24950, 'HP:0034529', 'Reduced muscle myoadenylate deaminase activity', 'XPO:0101110', 'abnormal cell-free extract', 0.4444444444444444, 1.4755025719078136, 0.8098017787384251, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(24951, 'HP:0034529', 'Reduced muscle myoadenylate deaminase activity', 'XPO:0100372', 'abnormal hematological system', 0.43478260869565216, 1.8210412618256888, 0.8898073220416851, 'HP:0000118', 'Phenotypic abnormality'),
(24952, 'HP:0034529', 'Reduced muscle myoadenylate deaminase activity', 'XPO:0101240', 'abnormal ciliated non-epidermal cell', 0.43478260869565216, 1.8210412618256888, 0.8898073220416851, 'HP:0000118', 'Phenotypic abnormality'),
(24953, 'HP:0034529', 'Reduced muscle myoadenylate deaminase activity', 'XPO:0141775', 'abnormal nitrogen compound metabolic process', 0.5238095238095238, 4.758907843651163, 1.5788480773767701, 'HP:0001939', 'Abnormality of metabolism/homeostasis'),
(24954, 'HP:0034529', 'Reduced muscle myoadenylate deaminase activity', 'XPO:0100317', 'abnormal respiratory system', 0.43478260869565216, 1.8210412618256888, 0.8898073220416851, 'HP:0000118', 'Phenotypic abnormality'),
(24955, 'HP:0034529', 'Reduced muscle myoadenylate deaminase activity', 'XPO:0131677', 'abnormal actin filament', 0.4166666666666667, 1.8210412618256888, 0.871072438105678, 'HP:0000118', 'Phenotypic abnormality'),
(24956, 'HP:0034529', 'Reduced muscle myoadenylate deaminase activity', 'XPO:0100176', 'abnormal stage VI oocyte', 0.4166666666666667, 1.8210412618256888, 0.871072438105678, 'HP:0000118', 'Phenotypic abnormality'),
(24957, 'HP:0034529', 'Reduced muscle myoadenylate deaminase activity', 'XPO:0100585', 'abnormal elastica externa', 0.4166666666666667, 1.8210412618256888, 0.871072438105678, 'HP:0000118', 'Phenotypic abnormality'),
(24958, 'HP:0034529', 'Reduced muscle myoadenylate deaminase activity', 'XPO:0141265', 'abnormal escape behavior', 0.5, 1.4755025719078136, 0.8589244937443028, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(24959, 'HP:0034529', 'Reduced muscle myoadenylate deaminase activity', 'XPO:0100888', 'abnormal microtubule', 0.43478260869565216, 1.8210412618256888, 0.8898073220416851, 'HP:0000118', 'Phenotypic abnormality'),
(24960, 'HP:0034529', 'Reduced muscle myoadenylate deaminase activity', 'XPO:0115505', 'dead whole organism', 0.42105263157894735, 1.4755025719078136, 0.7882031722869998, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(24961, 'HP:0034529', 'Reduced muscle myoadenylate deaminase activity', 'XPO:0131745', 'abnormal axis elongation', 0.4166666666666667, 1.8210412618256888, 0.871072438105678, 'HP:0000118', 'Phenotypic abnormality'),
(24962, 'HP:0034529', 'Reduced muscle myoadenylate deaminase activity', 'XPO:0100258', 'abnormal organ part', 0.4444444444444444, 1.4755025719078136, 0.8098017787384251, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(24963, 'HP:0034529', 'Reduced muscle myoadenylate deaminase activity', 'XPO:0131723', 'abnormal pathway-restricted SMAD protein phosphorylation', 0.5, 1.4755025719078136, 0.8589244937443028, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(24964, 'HP:0034529', 'Reduced muscle myoadenylate deaminase activity', 'XPO:0100084', 'abnormal anatomical group', 0.42105263157894735, 1.4755025719078136, 0.7882031722869998, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(24965, 'HP:0034529', 'Reduced muscle myoadenylate deaminase activity', 'XPO:0100956', 'abnormal centrosome', 0.43478260869565216, 1.8210412618256888, 0.8898073220416851, 'HP:0000118', 'Phenotypic abnormality'),
(24966, 'HP:0034529', 'Reduced muscle myoadenylate deaminase activity', 'XPO:0100437', 'abnormal proepicardium', 0.43478260869565216, 1.8210412618256888, 0.8898073220416851, 'HP:0000118', 'Phenotypic abnormality'),
(24967, 'HP:0034529', 'Reduced muscle myoadenylate deaminase activity', 'XPO:0100626', 'abnormal primordial germ cell', 0.43478260869565216, 1.8210412618256888, 0.8898073220416851, 'HP:0000118', 'Phenotypic abnormality'),
(24968, 'HP:0034529', 'Reduced muscle myoadenylate deaminase activity', 'XPO:0101409', 'abnormal perivitelline space', 0.4166666666666667, 1.8210412618256888, 0.871072438105678, 'HP:0000118', 'Phenotypic abnormality'),
(24969, 'HP:0034529', 'Reduced muscle myoadenylate deaminase activity', 'XPO:0100715', 'abnormal ciliated cell', 0.45454545454545453, 1.8210412618256888, 0.9098054891583067, 'HP:0000118', 'Phenotypic abnormality'),
(24970, 'HP:0034529', 'Reduced muscle myoadenylate deaminase activity', 'XPO:0100704', 'abnormal Merkel cell', 0.45454545454545453, 1.8210412618256888, 0.9098054891583067, 'HP:0000118', 'Phenotypic abnormality'),
(24971, 'HP:0034529', 'Reduced muscle myoadenylate deaminase activity', 'XPO:0141898', 'abnormal maltose metabolic process', 0.4583333333333333, 4.758907843651163, 1.4768771428276568, 'HP:0001939', 'Abnormality of metabolism/homeostasis'),
(24972, 'HP:0034529', 'Reduced muscle myoadenylate deaminase activity', 'XPO:0141771', 'abnormal urea homeostasis', 0.5, 1.4755025719078136, 0.8589244937443028, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(24973, 'HP:0034529', 'Reduced muscle myoadenylate deaminase activity', 'XPO:0100010', 'abnormal multicellular anatomical structure', 0.42105263157894735, 1.4755025719078136, 0.7882031722869998, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(24974, 'HP:0034529', 'Reduced muscle myoadenylate deaminase activity', 'XPO:0133403', 'abnormal developmental process', 0.42105263157894735, 1.4755025719078136, 0.7882031722869998, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(24975, 'HP:0034529', 'Reduced muscle myoadenylate deaminase activity', 'XPO:0141884', 'abnormal phosphagen metabolic process', 0.4230769230769231, 4.758907843651163, 1.418937661667548, 'HP:0001939', 'Abnormality of metabolism/homeostasis'),
(24976, 'HP:0034529', 'Reduced muscle myoadenylate deaminase activity', 'XPO:0115512', 'abnormally semi-erect whole organism', 0.42105263157894735, 1.4755025719078136, 0.7882031722869998, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(24977, 'HP:0034529', 'Reduced muscle myoadenylate deaminase activity', 'XPO:0131694', 'abnormal RNA polymerase II activity', 0.4583333333333333, 4.758907843651163, 1.4768771428276568, 'HP:0001939', 'Abnormality of metabolism/homeostasis'),
(24978, 'HP:0034529', 'Reduced muscle myoadenylate deaminase activity', 'XPO:0141267', 'abnormal resting posture', 0.5, 1.4755025719078136, 0.8589244937443028, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(24979, 'HP:0034529', 'Reduced muscle myoadenylate deaminase activity', 'XPO:0100477', 'abnormal pericyte', 0.45454545454545453, 1.8210412618256888, 0.9098054891583067, 'HP:0000118', 'Phenotypic abnormality'),
(24980, 'HP:0034529', 'Reduced muscle myoadenylate deaminase activity', 'XPO:0100081', 'abnormal anatomical entity in vitro', 0.47058823529411764, 1.4755025719078136, 0.8332791557971614, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(24981, 'HP:0034529', 'Reduced muscle myoadenylate deaminase activity', 'XPO:0141786', 'abnormal pigment metabolic process', 0.5238095238095238, 4.758907843651163, 1.5788480773767701, 'HP:0001939', 'Abnormality of metabolism/homeostasis'),
(24982, 'HP:0034529', 'Reduced muscle myoadenylate deaminase activity', 'XPO:0100791', 'abnormal multiciliated cell precursor', 0.45454545454545453, 1.8210412618256888, 0.9098054891583067, 'HP:0000118', 'Phenotypic abnormality'),
(24983, 'HP:0034529', 'Reduced muscle myoadenylate deaminase activity', 'XPO:0131725', 'abnormal phosphorylation of RNA polymerase II C-terminal domain', 0.5, 1.4755025719078136, 0.8589244937443028, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(24984, 'HP:0034529', 'Reduced muscle myoadenylate deaminase activity', 'XPO:0141880', 'abnormal ethanolamine metabolic process', 0.44, 4.758907843651163, 1.447038165082909, 'HP:0001939', 'Abnormality of metabolism/homeostasis'),
(24985, 'HP:0034529', 'Reduced muscle myoadenylate deaminase activity', 'XPO:0101264', 'abnormal mitotic spindle', 0.43478260869565216, 1.8210412618256888, 0.8898073220416851, 'HP:0000118', 'Phenotypic abnormality'),
(24986, 'HP:0034529', 'Reduced muscle myoadenylate deaminase activity', 'XPO:0100899', 'abnormal secondary spermatogonium', 0.43478260869565216, 1.8210412618256888, 0.8898073220416851, 'HP:0000118', 'Phenotypic abnormality'),
(24987, 'HP:0034529', 'Reduced muscle myoadenylate deaminase activity', 'XPO:0101297', 'abnormal barrier cell', 0.45454545454545453, 1.8210412618256888, 0.9098054891583067, 'HP:0000118', 'Phenotypic abnormality'),
(24988, 'HP:0034529', 'Reduced muscle myoadenylate deaminase activity', 'XPO:0107261', 'abnormal dorsal-ventral axis', 0.42105263157894735, 1.4755025719078136, 0.7882031722869998, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(24989, 'HP:0034529', 'Reduced muscle myoadenylate deaminase activity', 'XPO:0100274', 'abnormal sensory system', 0.4166666666666667, 1.8210412618256888, 0.871072438105678, 'HP:0000118', 'Phenotypic abnormality'),
(24990, 'HP:0034529', 'Reduced muscle myoadenylate deaminase activity', 'XPO:0141264', 'abnormal schooling behavior', 0.5, 1.4755025719078136, 0.8589244937443028, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(24991, 'HP:0034529', 'Reduced muscle myoadenylate deaminase activity', 'XPO:0141789', 'abnormal hormone catabolic process', 0.44, 4.758907843651163, 1.447038165082909, 'HP:0001939', 'Abnormality of metabolism/homeostasis'),
(24992, 'HP:0034529', 'Reduced muscle myoadenylate deaminase activity', 'XPO:0100032', 'abnormal nervous system', 0.43478260869565216, 1.8210412618256888, 0.8898073220416851, 'HP:0000118', 'Phenotypic abnormality'),
(24993, 'HP:0034529', 'Reduced muscle myoadenylate deaminase activity', 'XPO:0100599', 'abnormal adult immune system', 0.4166666666666667, 1.8210412618256888, 0.871072438105678, 'HP:0000118', 'Phenotypic abnormality'),
(24994, 'HP:0034529', 'Reduced muscle myoadenylate deaminase activity', 'XPO:0141860', 'abnormal malate-aspartate shuttle', 0.5, 4.758907843651163, 1.5425478669479211, 'HP:0001939', 'Abnormality of metabolism/homeostasis'),
(24995, 'HP:0034529', 'Reduced muscle myoadenylate deaminase activity', 'XPO:0100225', 'abnormal endocrine system', 0.43478260869565216, 1.8210412618256888, 0.8898073220416851, 'HP:0000118', 'Phenotypic abnormality'),
(24996, 'HP:0034529', 'Reduced muscle myoadenylate deaminase activity', 'XPO:0141911', 'abnormal ribose phosphate metabolic process', 0.4583333333333333, 4.758907843651163, 1.4768771428276568, 'HP:0001939', 'Abnormality of metabolism/homeostasis'),
(24997, 'HP:0034529', 'Reduced muscle myoadenylate deaminase activity', 'XPO:0141600', 'absent metamorphosis', 0.42105263157894735, 1.4755025719078136, 0.7882031722869998, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(24998, 'HP:0034529', 'Reduced muscle myoadenylate deaminase activity', 'XPO:0100031', 'abnormal central nervous system', 0.4166666666666667, 1.8210412618256888, 0.871072438105678, 'HP:0000118', 'Phenotypic abnormality'),
(24999, 'HP:0034529', 'Reduced muscle myoadenylate deaminase activity', 'XPO:0141904', 'abnormal glucosamine metabolic process', 0.5238095238095238, 4.758907843651163, 1.5788480773767701, 'HP:0001939', 'Abnormality of metabolism/homeostasis'),
(25000, 'HP:0034529', 'Reduced muscle myoadenylate deaminase activity', 'XPO:0100969', 'abnormal disaggregated/reaggregated ectoderm treated with activin', 0.4444444444444444, 1.4755025719078136, 0.8098017787384251, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(25001, 'HP:0034529', 'Reduced muscle myoadenylate deaminase activity', 'XPO:0101468', 'abnormal stage I oocyte', 0.4166666666666667, 1.8210412618256888, 0.871072438105678, 'HP:0000118', 'Phenotypic abnormality'),
(25002, 'HP:0034529', 'Reduced muscle myoadenylate deaminase activity', 'XPO:0131691', 'abnormal molecular function', 0.47058823529411764, 1.4755025719078136, 0.8332791557971614, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(25003, 'HP:0034529', 'Reduced muscle myoadenylate deaminase activity', 'XPO:0141272', 'absent surface breathing', 0.5, 1.4755025719078136, 0.8589244937443028, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(25004, 'HP:0034529', 'Reduced muscle myoadenylate deaminase activity', 'XPO:0107270', 'abnormal proximal-distal axis', 0.42105263157894735, 1.4755025719078136, 0.7882031722869998, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(25005, 'HP:0034529', 'Reduced muscle myoadenylate deaminase activity', 'XPO:0100653', 'abnormal myoblast', 0.45454545454545453, 1.8210412618256888, 0.9098054891583067, 'HP:0000118', 'Phenotypic abnormality'),
(25006, 'HP:0034529', 'Reduced muscle myoadenylate deaminase activity', 'XPO:0100285', 'abnormal progenitor cell', 0.45454545454545453, 1.8210412618256888, 0.9098054891583067, 'HP:0000118', 'Phenotypic abnormality'),
(25007, 'HP:0034529', 'Reduced muscle myoadenylate deaminase activity', 'XPO:0107253', 'abnormal enteric nervous system', 0.4166666666666667, 1.8210412618256888, 0.871072438105678, 'HP:0000118', 'Phenotypic abnormality'),
(25008, 'HP:0034529', 'Reduced muscle myoadenylate deaminase activity', 'XPO:0141852', 'abnormal glucose metabolic process', 0.4230769230769231, 4.758907843651163, 1.418937661667548, 'HP:0001939', 'Abnormality of metabolism/homeostasis'),
(25009, 'HP:0034529', 'Reduced muscle myoadenylate deaminase activity', 'XPO:0101241', 'abnormal nucleate erythrocyte', 0.45454545454545453, 1.8210412618256888, 0.9098054891583067, 'HP:0000118', 'Phenotypic abnormality'),
(25010, 'HP:0034529', 'Reduced muscle myoadenylate deaminase activity', 'XPO:0141859', 'abnormal lactose catabolic process', 0.4230769230769231, 4.758907843651163, 1.418937661667548, 'HP:0001939', 'Abnormality of metabolism/homeostasis'),
(25011, 'HP:0034529', 'Reduced muscle myoadenylate deaminase activity', 'XPO:0141881', 'abnormal fructose metabolic process', 0.4230769230769231, 4.758907843651163, 1.418937661667548, 'HP:0001939', 'Abnormality of metabolism/homeostasis'),
(25012, 'HP:0034529', 'Reduced muscle myoadenylate deaminase activity', 'XPO:0100533', 'abnormal melanoblast', 0.45454545454545453, 1.8210412618256888, 0.9098054891583067, 'HP:0000118', 'Phenotypic abnormality'),
(25013, 'HP:0034529', 'Reduced muscle myoadenylate deaminase activity', 'XPO:0100004', 'abnormal cell', 0.47619047619047616, 1.8210412618256888, 0.9312156064152277, 'HP:0000118', 'Phenotypic abnormality'),
(25014, 'HP:0034529', 'Reduced muscle myoadenylate deaminase activity', 'XPO:0141795', 'abnormal glycosylation', 0.4782608695652174, 4.758907843651163, 1.508641575552437, 'HP:0001939', 'Abnormality of metabolism/homeostasis'),
(25015, 'HP:0034529', 'Reduced muscle myoadenylate deaminase activity', 'XPO:0141263', 'abnormal visually guided collision avoidance behavior', 0.5, 1.4755025719078136, 0.8589244937443028, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(25016, 'HP:0034529', 'Reduced muscle myoadenylate deaminase activity', 'XPO:0100026', 'abnormal germ cell', 0.45454545454545453, 1.8210412618256888, 0.9098054891583067, 'HP:0000118', 'Phenotypic abnormality'),
(25017, 'HP:0034529', 'Reduced muscle myoadenylate deaminase activity', 'XPO:0100545', 'abnormal male organism', 0.42105263157894735, 1.4755025719078136, 0.7882031722869998, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(25018, 'HP:0034529', 'Reduced muscle myoadenylate deaminase activity', 'XPO:0141864', 'abnormal 5-methylcytosine metabolic process', 0.4230769230769231, 4.758907843651163, 1.418937661667548, 'HP:0001939', 'Abnormality of metabolism/homeostasis'),
(25019, 'HP:0034529', 'Reduced muscle myoadenylate deaminase activity', 'XPO:0101132', 'abnormal apoptotic cell', 0.45454545454545453, 1.8210412618256888, 0.9098054891583067, 'HP:0000118', 'Phenotypic abnormality'),
(25020, 'HP:0034529', 'Reduced muscle myoadenylate deaminase activity', 'XPO:0100754', 'abnormal electrically active cell', 0.45454545454545453, 1.8210412618256888, 0.9098054891583067, 'HP:0000118', 'Phenotypic abnormality'),
(25021, 'HP:0034529', 'Reduced muscle myoadenylate deaminase activity', 'XPO:0100108', 'abnormal cell part', 0.45454545454545453, 1.8210412618256888, 0.9098054891583067, 'HP:0000118', 'Phenotypic abnormality'),
(25022, 'HP:0034529', 'Reduced muscle myoadenylate deaminase activity', 'XPO:0141788', 'abnormal hormone biosynthetic process', 0.44, 4.758907843651163, 1.447038165082909, 'HP:0001939', 'Abnormality of metabolism/homeostasis'),
(25023, 'HP:0034529', 'Reduced muscle myoadenylate deaminase activity', 'XPO:0141745', 'abnormal creatinine homeostasis', 0.5, 1.4755025719078136, 0.8589244937443028, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(25024, 'HP:0034529', 'Reduced muscle myoadenylate deaminase activity', 'XPO:0100728', 'abnormal cell condensation', 0.42105263157894735, 1.4755025719078136, 0.7882031722869998, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(25025, 'HP:0034529', 'Reduced muscle myoadenylate deaminase activity', 'XPO:0100429', 'abnormal spermatid', 0.43478260869565216, 1.8210412618256888, 0.8898073220416851, 'HP:0000118', 'Phenotypic abnormality'),
(25026, 'HP:0034529', 'Reduced muscle myoadenylate deaminase activity', 'XPO:0141883', 'abnormal glycerol metabolic process', 0.4230769230769231, 4.758907843651163, 1.418937661667548, 'HP:0001939', 'Abnormality of metabolism/homeostasis'),
(25027, 'HP:0034529', 'Reduced muscle myoadenylate deaminase activity', 'XPO:0141784', 'abnormal cellular hormone metabolic process', 0.5, 1.4755025719078136, 0.8589244937443028, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(25028, 'HP:0034529', 'Reduced muscle myoadenylate deaminase activity', 'XPO:0101113', 'abnormal stage IV oocyte', 0.4166666666666667, 1.8210412618256888, 0.871072438105678, 'HP:0000118', 'Phenotypic abnormality'),
(25029, 'HP:0034529', 'Reduced muscle myoadenylate deaminase activity', 'XPO:0100239', 'abnormal acellular anatomical structure', 0.42105263157894735, 1.4755025719078136, 0.7882031722869998, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(25030, 'HP:0034529', 'Reduced muscle myoadenylate deaminase activity', 'XPO:0116494', 'absent biological process', 0.47058823529411764, 1.4755025719078136, 0.8332791557971614, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(25031, 'HP:0034529', 'Reduced muscle myoadenylate deaminase activity', 'XPO:0100289', 'abnormal chondroblast', 0.45454545454545453, 1.8210412618256888, 0.9098054891583067, 'HP:0000118', 'Phenotypic abnormality'),
(25032, 'HP:0034529', 'Reduced muscle myoadenylate deaminase activity', 'XPO:0141892', 'abnormal inositol metabolic process', 0.4782608695652174, 4.758907843651163, 1.508641575552437, 'HP:0001939', 'Abnormality of metabolism/homeostasis'),
(25033, 'HP:0034529', 'Reduced muscle myoadenylate deaminase activity', 'XPO:0101448', 'abnormal myelin accumulating cell', 0.45454545454545453, 1.8210412618256888, 0.9098054891583067, 'HP:0000118', 'Phenotypic abnormality'),
(25034, 'HP:0034529', 'Reduced muscle myoadenylate deaminase activity', 'XPO:0100546', 'abnormal whole organism', 0.4444444444444444, 1.4755025719078136, 0.8098017787384251, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(25035, 'HP:0034529', 'Reduced muscle myoadenylate deaminase activity', 'XPO:0141866', 'abnormal dicarboxylic acid metabolic process', 0.4074074074074074, 4.758907843651163, 1.392413123563799, 'HP:0001939', 'Abnormality of metabolism/homeostasis'),
(25036, 'HP:0034529', 'Reduced muscle myoadenylate deaminase activity', 'XPO:0100574', 'abnormal gastrula cell', 0.4166666666666667, 1.8210412618256888, 0.871072438105678, 'HP:0000118', 'Phenotypic abnormality'),
(25037, 'HP:0034529', 'Reduced muscle myoadenylate deaminase activity', 'XPO:0100638', 'abnormal polar body', 0.45454545454545453, 1.8210412618256888, 0.9098054891583067, 'HP:0000118', 'Phenotypic abnormality'),
(25038, 'HP:0034529', 'Reduced muscle myoadenylate deaminase activity', 'XPO:0141877', 'abnormal 2-deoxyribose 1-phosphate metabolic process', 0.4583333333333333, 4.758907843651163, 1.4768771428276568, 'HP:0001939', 'Abnormality of metabolism/homeostasis'),
(25039, 'HP:0034529', 'Reduced muscle myoadenylate deaminase activity', 'XPO:0100062', 'abnormal anatomical space', 0.42105263157894735, 1.4755025719078136, 0.7882031722869998, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(25040, 'HP:0034529', 'Reduced muscle myoadenylate deaminase activity', 'XPO:0133388', 'absent insulin receptor signaling pathway', 0.42105263157894735, 1.4755025719078136, 0.7882031722869998, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(25041, 'HP:0034529', 'Reduced muscle myoadenylate deaminase activity', 'XPO:0141783', 'abnormal collagen metabolic process', 0.5238095238095238, 4.758907843651163, 1.5788480773767701, 'HP:0001939', 'Abnormality of metabolism/homeostasis'),
(25042, 'HP:0034529', 'Reduced muscle myoadenylate deaminase activity', 'XPO:0101071', 'abnormal endoplasmic reticulum', 0.43478260869565216, 1.8210412618256888, 0.8898073220416851, 'HP:0000118', 'Phenotypic abnormality'),
(25043, 'HP:0034529', 'Reduced muscle myoadenylate deaminase activity', 'XPO:0128000', 'absent behavior', 0.42105263157894735, 1.4755025719078136, 0.7882031722869998, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(25044, 'HP:0034529', 'Reduced muscle myoadenylate deaminase activity', 'XPO:0141908', 'abnormal pyridine metabolic process', 0.4230769230769231, 4.758907843651163, 1.418937661667548, 'HP:0001939', 'Abnormality of metabolism/homeostasis'),
(25045, 'HP:0034529', 'Reduced muscle myoadenylate deaminase activity', 'XPO:0141266', 'abnormal surface breathing', 0.5, 1.4755025719078136, 0.8589244937443028, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(25046, 'HP:0034529', 'Reduced muscle myoadenylate deaminase activity', 'XPO:0101221', 'abnormal larval immune system', 0.4166666666666667, 1.8210412618256888, 0.871072438105678, 'HP:0000118', 'Phenotypic abnormality'),
(25047, 'HP:0034529', 'Reduced muscle myoadenylate deaminase activity', 'XPO:0101109', 'abnormal egg cell-free extract', 0.42105263157894735, 1.4755025719078136, 0.7882031722869998, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(25048, 'HP:0034529', 'Reduced muscle myoadenylate deaminase activity', 'XPO:0107258', 'abnormal anatomical axis', 0.4444444444444444, 1.4755025719078136, 0.8098017787384251, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(25049, 'HP:0034529', 'Reduced muscle myoadenylate deaminase activity', 'XPO:0100006', 'abnormal anatomical structure', 0.47058823529411764, 1.4755025719078136, 0.8332791557971614, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(25050, 'HP:0034529', 'Reduced muscle myoadenylate deaminase activity', 'XPO:0142057', 'abnormal desmosome', 0.43478260869565216, 1.8210412618256888, 0.8898073220416851, 'HP:0000118', 'Phenotypic abnormality'),
(25051, 'HP:0034529', 'Reduced muscle myoadenylate deaminase activity', 'XPO:0141276', 'decreased surface breathing', 0.47058823529411764, 1.4755025719078136, 0.8332791557971614, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(25052, 'HP:0034529', 'Reduced muscle myoadenylate deaminase activity', 'XPO:0100852', 'abnormal interdigital region', 0.45454545454545453, 1.8210412618256888, 0.9098054891583067, 'HP:0000118', 'Phenotypic abnormality'),
(25053, 'HP:0034529', 'Reduced muscle myoadenylate deaminase activity', 'XPO:0100976', 'abnormal multiciliated cell', 0.43478260869565216, 1.8210412618256888, 0.8898073220416851, 'HP:0000118', 'Phenotypic abnormality'),
(25054, 'HP:0034529', 'Reduced muscle myoadenylate deaminase activity', 'XPO:0101467', 'abnormal alkali secreting cell', 0.45454545454545453, 1.8210412618256888, 0.9098054891583067, 'HP:0000118', 'Phenotypic abnormality'),
(25055, 'HP:0034529', 'Reduced muscle myoadenylate deaminase activity', 'XPO:0141872', 'abnormal cholesterol metabolic process', 0.4074074074074074, 4.758907843651163, 1.392413123563799, 'HP:0001939', 'Abnormality of metabolism/homeostasis'),
(25056, 'HP:0034529', 'Reduced muscle myoadenylate deaminase activity', 'XPO:0100172', 'abnormal stem cell', 0.45454545454545453, 1.8210412618256888, 0.9098054891583067, 'HP:0000118', 'Phenotypic abnormality'),
(25057, 'HP:0034529', 'Reduced muscle myoadenylate deaminase activity', 'XPO:0141772', 'abnormal water homeostasis', 0.5, 1.4755025719078136, 0.8589244937443028, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(25058, 'HP:0034529', 'Reduced muscle myoadenylate deaminase activity', 'XPO:0141792', 'abnormal small molecule metabolic process', 0.5238095238095238, 4.758907843651163, 1.5788480773767701, 'HP:0001939', 'Abnormality of metabolism/homeostasis'),
(25059, 'HP:0034529', 'Reduced muscle myoadenylate deaminase activity', 'XPO:0101228', 'abnormal mesenchymal stem cell', 0.43478260869565216, 1.8210412618256888, 0.8898073220416851, 'HP:0000118', 'Phenotypic abnormality'),
(25060, 'HP:0034529', 'Reduced muscle myoadenylate deaminase activity', 'XPO:0141499', 'abnormal tadpole', 0.42105263157894735, 1.4755025719078136, 0.7882031722869998, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(25061, 'HP:0034529', 'Reduced muscle myoadenylate deaminase activity', 'XPO:0101498', 'abnormal stage II oocyte', 0.4166666666666667, 1.8210412618256888, 0.871072438105678, 'HP:0000118', 'Phenotypic abnormality'),
(25062, 'HP:0034529', 'Reduced muscle myoadenylate deaminase activity', 'XPO:0100025', 'abnormal oocyte', 0.43478260869565216, 1.8210412618256888, 0.8898073220416851, 'HP:0000118', 'Phenotypic abnormality'),
(25063, 'HP:0034529', 'Reduced muscle myoadenylate deaminase activity', 'XPO:0131730', 'abnormal regulation of protein folding', 0.42105263157894735, 1.4755025719078136, 0.7882031722869998, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(25064, 'HP:0034529', 'Reduced muscle myoadenylate deaminase activity', 'XPO:0141738', 'abnormal carbon dioxide homeostasis', 0.5, 1.4755025719078136, 0.8589244937443028, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(25065, 'HP:0034529', 'Reduced muscle myoadenylate deaminase activity', 'XPO:0115509', 'abnormally semi-viable whole organism', 0.42105263157894735, 1.4755025719078136, 0.7882031722869998, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(25066, 'HP:0034529', 'Reduced muscle myoadenylate deaminase activity', 'XPO:0100337', 'abnormal zygote', 0.45454545454545453, 1.8210412618256888, 0.9098054891583067, 'HP:0000118', 'Phenotypic abnormality'),
(25067, 'HP:0034529', 'Reduced muscle myoadenylate deaminase activity', 'XPO:0100573', 'abnormal extraembryonic structure', 0.42105263157894735, 1.4755025719078136, 0.7882031722869998, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(25068, 'HP:0034529', 'Reduced muscle myoadenylate deaminase activity', 'XPO:0101547', 'abnormal lampbrush chromosome', 0.43478260869565216, 1.8210412618256888, 0.8898073220416851, 'HP:0000118', 'Phenotypic abnormality'),
(25069, 'HP:0034529', 'Reduced muscle myoadenylate deaminase activity', 'XPO:0101435', 'abnormal paracrine cell', 0.45454545454545453, 1.8210412618256888, 0.9098054891583067, 'HP:0000118', 'Phenotypic abnormality'),
(25070, 'HP:0034529', 'Reduced muscle myoadenylate deaminase activity', 'XPO:0101569', 'abnormal activin-induced ectoderm', 0.4444444444444444, 1.4755025719078136, 0.8098017787384251, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(25071, 'HP:0034529', 'Reduced muscle myoadenylate deaminase activity', 'XPO:0101157', 'abnormal female organism', 0.42105263157894735, 1.4755025719078136, 0.7882031722869998, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(25072, 'HP:0034529', 'Reduced muscle myoadenylate deaminase activity', 'XPO:0101472', 'abnormal zygote cortex', 0.4166666666666667, 1.8210412618256888, 0.871072438105678, 'HP:0000118', 'Phenotypic abnormality'),
(25073, 'HP:0034529', 'Reduced muscle myoadenylate deaminase activity', 'XPO:0100907', 'abnormal cytoplasm', 0.43478260869565216, 1.8210412618256888, 0.8898073220416851, 'HP:0000118', 'Phenotypic abnormality'),
(25074, 'HP:0034529', 'Reduced muscle myoadenylate deaminase activity', 'XPO:0100423', 'abnormal process', 0.42105263157894735, 1.4755025719078136, 0.7882031722869998, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(25075, 'HP:0034529', 'Reduced muscle myoadenylate deaminase activity', 'XPO:0141748', 'abnormal gas homeostasis', 0.5, 1.4755025719078136, 0.8589244937443028, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(25076, 'HP:0034529', 'Reduced muscle myoadenylate deaminase activity', 'XPO:0100344', 'abnormal portion of organism substance', 0.47058823529411764, 1.4755025719078136, 0.8332791557971614, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(25077, 'HP:0034529', 'Reduced muscle myoadenylate deaminase activity', 'XPO:0131667', 'abnormal actin cytoskeleton', 0.43478260869565216, 1.8210412618256888, 0.8898073220416851, 'HP:0000118', 'Phenotypic abnormality'),
(25078, 'HP:0034529', 'Reduced muscle myoadenylate deaminase activity', 'XPO:0100581', 'abnormal immune system', 0.43478260869565216, 1.8210412618256888, 0.8898073220416851, 'HP:0000118', 'Phenotypic abnormality'),
(25079, 'HP:0034529', 'Reduced muscle myoadenylate deaminase activity', 'XPO:0101535', 'abnormal absorptive cell', 0.45454545454545453, 1.8210412618256888, 0.9098054891583067, 'HP:0000118', 'Phenotypic abnormality'),
(25080, 'HP:0034529', 'Reduced muscle myoadenylate deaminase activity', 'XPO:0101333', 'abnormal barrier epithelial cell', 0.45454545454545453, 1.8210412618256888, 0.9098054891583067, 'HP:0000118', 'Phenotypic abnormality'),
(25081, 'HP:0034529', 'Reduced muscle myoadenylate deaminase activity', 'XPO:0141777', 'abnormal catabolic process', 0.5238095238095238, 4.758907843651163, 1.5788480773767701, 'HP:0001939', 'Abnormality of metabolism/homeostasis'),
(25082, 'HP:0034529', 'Reduced muscle myoadenylate deaminase activity', 'XPO:0100202', 'abnormal embryo', 0.42105263157894735, 1.4755025719078136, 0.7882031722869998, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(25083, 'HP:0034529', 'Reduced muscle myoadenylate deaminase activity', 'XPO:0100307', 'abnormal blastomere', 0.4166666666666667, 1.8210412618256888, 0.871072438105678, 'HP:0000118', 'Phenotypic abnormality'),
(25084, 'HP:0034529', 'Reduced muscle myoadenylate deaminase activity', 'XPO:0141798', 'abnormal lipid metabolic process', 0.4782608695652174, 4.758907843651163, 1.508641575552437, 'HP:0001939', 'Abnormality of metabolism/homeostasis'),
(25085, 'HP:0034529', 'Reduced muscle myoadenylate deaminase activity', 'XPO:0100902', 'abnormal spermatocyte', 0.43478260869565216, 1.8210412618256888, 0.8898073220416851, 'HP:0000118', 'Phenotypic abnormality'),
(25086, 'HP:0034529', 'Reduced muscle myoadenylate deaminase activity', 'XPO:00000000', 'Xenopus phenotype', 0.5333333333333333, 1.4755025719078136, 0.8870934026456857, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(25087, 'HP:0034529', 'Reduced muscle myoadenylate deaminase activity', 'XPO:0141754', 'abnormal homeostatic process', 0.42105263157894735, 1.4755025719078136, 0.7882031722869998, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(25088, 'HP:0034529', 'Reduced muscle myoadenylate deaminase activity', 'XPO:0131685', 'abnormal cortical actin cytoskeleton', 0.4166666666666667, 1.8210412618256888, 0.871072438105678, 'HP:0000118', 'Phenotypic abnormality'),
(25089, 'HP:0034529', 'Reduced muscle myoadenylate deaminase activity', 'XPO:0141796', 'abnormal demethylation', 0.5238095238095238, 4.758907843651163, 1.5788480773767701, 'HP:0001939', 'Abnormality of metabolism/homeostasis'),
(25090, 'HP:0034529', 'Reduced muscle myoadenylate deaminase activity', 'XPO:0101461', 'abnormal sperm entry point', 0.4166666666666667, 1.8210412618256888, 0.871072438105678, 'HP:0000118', 'Phenotypic abnormality'),
(25091, 'HP:0034529', 'Reduced muscle myoadenylate deaminase activity', 'XPO:0107262', 'abnormal left-right axis', 0.42105263157894735, 1.4755025719078136, 0.7882031722869998, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(25092, 'HP:0034529', 'Reduced muscle myoadenylate deaminase activity', 'XPO:0107312', 'abnormal filopodium', 0.43478260869565216, 1.8210412618256888, 0.8898073220416851, 'HP:0000118', 'Phenotypic abnormality'),
(25093, 'HP:0034529', 'Reduced muscle myoadenylate deaminase activity', 'XPO:0100308', 'abnormal early embryonic cell', 0.43478260869565216, 1.8210412618256888, 0.8898073220416851, 'HP:0000118', 'Phenotypic abnormality'),
(25094, 'HP:0034529', 'Reduced muscle myoadenylate deaminase activity', 'XPO:0101061', 'abnormal plasma membrane', 0.43478260869565216, 1.8210412618256888, 0.8898073220416851, 'HP:0000118', 'Phenotypic abnormality'),
(25095, 'HP:0034529', 'Reduced muscle myoadenylate deaminase activity', 'XPO:0131675', 'abnormal spindle microtubule', 0.4166666666666667, 1.8210412618256888, 0.871072438105678, 'HP:0000118', 'Phenotypic abnormality'),
(25096, 'HP:0034529', 'Reduced muscle myoadenylate deaminase activity', 'XPO:0100377', 'abnormal connective tissue', 0.4166666666666667, 1.8210412618256888, 0.871072438105678, 'HP:0000118', 'Phenotypic abnormality'),
(25097, 'HP:0034529', 'Reduced muscle myoadenylate deaminase activity', 'XPO:0100724', 'abnormal kinetochore', 0.43478260869565216, 1.8210412618256888, 0.8898073220416851, 'HP:0000118', 'Phenotypic abnormality'),
(25098, 'HP:0034529', 'Reduced muscle myoadenylate deaminase activity', 'XPO:0141797', 'abnormal hydrogen metabolic process', 0.5238095238095238, 4.758907843651163, 1.5788480773767701, 'HP:0001939', 'Abnormality of metabolism/homeostasis'),
(25099, 'HP:0034529', 'Reduced muscle myoadenylate deaminase activity', 'XPO:0141794', 'abnormal prosthetic group metabolic process', 0.5238095238095238, 4.758907843651163, 1.5788480773767701, 'HP:0001939', 'Abnormality of metabolism/homeostasis'),
(25100, 'HP:0034529', 'Reduced muscle myoadenylate deaminase activity', 'XPO:0141743', 'abnormal chemical homeostasis within a tissue', 0.5, 1.4755025719078136, 0.8589244937443028, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(25101, 'HP:0034529', 'Reduced muscle myoadenylate deaminase activity', 'XPO:0101237', 'abnormal mucus secreting cell', 0.45454545454545453, 1.8210412618256888, 0.9098054891583067, 'HP:0000118', 'Phenotypic abnormality'),
(25102, 'HP:0034529', 'Reduced muscle myoadenylate deaminase activity', 'XPO:0141791', 'abnormal primary metabolic process', 0.5238095238095238, 4.758907843651163, 1.5788480773767701, 'HP:0001939', 'Abnormality of metabolism/homeostasis'),
(25103, 'HP:0034529', 'Reduced muscle myoadenylate deaminase activity', 'XPO:0141903', 'abnormal inositol phosphate metabolic process', 0.4230769230769231, 4.758907843651163, 1.418937661667548, 'HP:0001939', 'Abnormality of metabolism/homeostasis'),
(25104, 'HP:0034529', 'Reduced muscle myoadenylate deaminase activity', 'XPO:0141782', 'abnormal methylation', 0.5238095238095238, 4.758907843651163, 1.5788480773767701, 'HP:0001939', 'Abnormality of metabolism/homeostasis'),
(25105, 'HP:0034529', 'Reduced muscle myoadenylate deaminase activity', 'XPO:0141900', 'abnormal mannose metabolic process', 0.4230769230769231, 4.758907843651163, 1.418937661667548, 'HP:0001939', 'Abnormality of metabolism/homeostasis'),
(25106, 'HP:0034529', 'Reduced muscle myoadenylate deaminase activity', 'XPO:0141910', 'abnormal D-ribose metabolic process', 0.4230769230769231, 4.758907843651163, 1.418937661667548, 'HP:0001939', 'Abnormality of metabolism/homeostasis'),
(25107, 'HP:0034529', 'Reduced muscle myoadenylate deaminase activity', 'XPO:0101366', 'abnormal morula cell', 0.4166666666666667, 1.8210412618256888, 0.871072438105678, 'HP:0000118', 'Phenotypic abnormality'),
(25108, 'HP:0034529', 'Reduced muscle myoadenylate deaminase activity', 'XPO:0100232', 'abnormal lymphatic system', 0.43478260869565216, 1.8210412618256888, 0.8898073220416851, 'HP:0000118', 'Phenotypic abnormality'),
(25109, 'HP:0034529', 'Reduced muscle myoadenylate deaminase activity', 'XPO:0141854', 'abnormal glutathione metabolic process', 0.4230769230769231, 4.758907843651163, 1.418937661667548, 'HP:0001939', 'Abnormality of metabolism/homeostasis'),
(25110, 'HP:0034529', 'Reduced muscle myoadenylate deaminase activity', 'XPO:0100894', 'abnormal nucleus', 0.43478260869565216, 1.8210412618256888, 0.8898073220416851, 'HP:0000118', 'Phenotypic abnormality'),
(25111, 'HP:0034529', 'Reduced muscle myoadenylate deaminase activity', 'XPO:0131666', 'abnormal adherens junction', 0.43478260869565216, 1.8210412618256888, 0.8898073220416851, 'HP:0000118', 'Phenotypic abnormality'),
(25112, 'HP:0034529', 'Reduced muscle myoadenylate deaminase activity', 'XPO:0141787', 'abnormal hormone metabolic process', 0.5238095238095238, 4.758907843651163, 1.5788480773767701, 'HP:0001939', 'Abnormality of metabolism/homeostasis'),
(25113, 'HP:0034529', 'Reduced muscle myoadenylate deaminase activity', 'XPO:0100674', 'abnormal secondary oogonium', 0.43478260869565216, 1.8210412618256888, 0.8898073220416851, 'HP:0000118', 'Phenotypic abnormality'),
(25114, 'HP:0034529', 'Reduced muscle myoadenylate deaminase activity', 'XPO:0107284', 'abnormal migrating myoblast', 0.43478260869565216, 1.8210412618256888, 0.8898073220416851, 'HP:0000118', 'Phenotypic abnormality'),
(25115, 'HP:0034529', 'Reduced muscle myoadenylate deaminase activity', 'XPO:0141790', 'abnormal cellular metabolic process', 0.5, 4.758907843651163, 1.5425478669479211, 'HP:0001939', 'Abnormality of metabolism/homeostasis'),
(25116, 'HP:0034529', 'Reduced muscle myoadenylate deaminase activity', 'XPO:0141271', 'increased surface breathing', 0.47058823529411764, 1.4755025719078136, 0.8332791557971614, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(25117, 'HP:0034529', 'Reduced muscle myoadenylate deaminase activity', 'XPO:0116434', 'abnormal biological process', 0.47058823529411764, 1.4755025719078136, 0.8332791557971614, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(25118, 'HP:0034529', 'Reduced muscle myoadenylate deaminase activity', 'XPO:0100386', 'abnormal limb', 0.4166666666666667, 1.8210412618256888, 0.871072438105678, 'HP:0000118', 'Phenotypic abnormality'),
(25119, 'HP:0034529', 'Reduced muscle myoadenylate deaminase activity', 'XPO:0101480', 'abnormal stage V oocyte', 0.4166666666666667, 1.8210412618256888, 0.871072438105678, 'HP:0000118', 'Phenotypic abnormality'),
(25120, 'HP:0034529', 'Reduced muscle myoadenylate deaminase activity', 'XPO:0100549', 'abnormal mitotic cell', 0.45454545454545453, 1.8210412618256888, 0.9098054891583067, 'HP:0000118', 'Phenotypic abnormality'),
(25121, 'HP:0034529', 'Reduced muscle myoadenylate deaminase activity', 'XPO:0141809', 'abnormal catalytic activity', 0.42105263157894735, 1.4755025719078136, 0.7882031722869998, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(25122, 'HP:0034529', 'Reduced muscle myoadenylate deaminase activity', 'XPO:0107260', 'abnormal anterior-posterior axis', 0.42105263157894735, 1.4755025719078136, 0.7882031722869998, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(25123, 'HP:0034529', 'Reduced muscle myoadenylate deaminase activity', 'XPO:0141850', 'abnormal galactose metabolic process', 0.4230769230769231, 4.758907843651163, 1.418937661667548, 'HP:0001939', 'Abnormality of metabolism/homeostasis'),
(25124, 'HP:0034529', 'Reduced muscle myoadenylate deaminase activity', 'XPO:0141907', 'abnormal putrescine metabolic process', 0.4782608695652174, 4.758907843651163, 1.508641575552437, 'HP:0001939', 'Abnormality of metabolism/homeostasis'),
(25125, 'HP:0034529', 'Reduced muscle myoadenylate deaminase activity', 'XPO:0107259', 'abnormal animal-vegetal axis', 0.42105263157894735, 1.4755025719078136, 0.7882031722869998, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(25126, 'HP:0034529', 'Reduced muscle myoadenylate deaminase activity', 'XPO:0131469', 'abnormal heart process', 0.42105263157894735, 1.4755025719078136, 0.7882031722869998, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(25127, 'HP:0034529', 'Reduced muscle myoadenylate deaminase activity', 'XPO:0101513', 'abnormal basal body', 0.43478260869565216, 1.8210412618256888, 0.8898073220416851, 'HP:0000118', 'Phenotypic abnormality'),
(25128, 'HP:0034529', 'Reduced muscle myoadenylate deaminase activity', 'XPO:0101220', 'abnormal centriole', 0.4166666666666667, 1.8210412618256888, 0.871072438105678, 'HP:0000118', 'Phenotypic abnormality'),
(25129, 'HP:0034529', 'Reduced muscle myoadenylate deaminase activity', 'XPO:0131729', 'abnormal regulation of growth rate', 0.42105263157894735, 1.4755025719078136, 0.7882031722869998, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(25130, 'HP:0034529', 'Reduced muscle myoadenylate deaminase activity', 'XPO:0141776', 'abnormal metabolic process', 0.5789473684210527, 4.758907843651163, 1.6598666129060333, 'HP:0001939', 'Abnormality of metabolism/homeostasis'),
(25131, 'HP:0034529', 'Reduced muscle myoadenylate deaminase activity', 'XPO:0141767', 'abnormal temperature homeostasis', 0.44, 4.758907843651163, 1.447038165082909, 'HP:0001939', 'Abnormality of metabolism/homeostasis'),
(25132, 'HP:0034529', 'Reduced muscle myoadenylate deaminase activity', 'XPO:0100691', 'abnormal keratin accumulating cell', 0.45454545454545453, 1.8210412618256888, 0.9098054891583067, 'HP:0000118', 'Phenotypic abnormality'),
(25133, 'HP:0034529', 'Reduced muscle myoadenylate deaminase activity', 'XPO:0101373', 'abnormal oxygen accumulating cell', 0.45454545454545453, 1.8210412618256888, 0.9098054891583067, 'HP:0000118', 'Phenotypic abnormality'),
(25134, 'HP:0034529', 'Reduced muscle myoadenylate deaminase activity', 'XPO:0141781', 'abnormal secondary metabolic process', 0.5238095238095238, 4.758907843651163, 1.5788480773767701, 'HP:0001939', 'Abnormality of metabolism/homeostasis'),
(25135, 'HP:0034529', 'Reduced muscle myoadenylate deaminase activity', 'XPO:0115508', 'abnormally peramorphic growth of whole organism', 0.42105263157894735, 1.4755025719078136, 0.7882031722869998, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(25136, 'HP:0034529', 'Reduced muscle myoadenylate deaminase activity', 'XPO:0101141', 'abnormal Keller explant', 0.4444444444444444, 1.4755025719078136, 0.8098017787384251, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(25137, 'HP:0034529', 'Reduced muscle myoadenylate deaminase activity', 'XPO:0101004', 'abnormal acid secreting cell', 0.45454545454545453, 1.8210412618256888, 0.9098054891583067, 'HP:0000118', 'Phenotypic abnormality'),
(25138, 'HP:0007792', 'Microsaccadic pursuit', 'XPO:0101173', 'abnormal retinal layer', 0.40350877192982454, 6.02624522851634, 1.5593725698198597, 'HP:0000478', 'Abnormality of the eye'),
(25139, 'HP:0006501', 'Aplasia/Hypoplasia of the radius', 'XPO:0100399', 'abnormal radio-ulna', 0.4069767441860465, 10.032140753609863, 2.0206058450673385, 'UPHENO:0002751', 'abnormal forelimb zeugopod bone'),
(25140, 'HP:0006501', 'Aplasia/Hypoplasia of the radius', 'XPO:0100178', 'abnormal digit', 0.41935483870967744, 5.802924133159483, 1.5599629206829213, 'UPHENO:0076727', 'abnormal limb bone morphology'),
(25141, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0100384', 'abnormal amputated tissue', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(25142, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0131032', 'abnormally increased number of acid secreting cell', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(25143, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0100189', 'abnormal enteroendocrine cell', 0.48148148148148145, 3.6715585125471644, 1.3295816755533123, 'UPHENO:0086172', 'abnormal cell'),
(25144, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0100665', 'abnormal egg jelly', 0.42857142857142855, 1.706362323152461, 0.8551597151958877, 'UPHENO:0002536', 'abnormal anatomical entity'),
(25145, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0127257', 'abnormally localised wedge region', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(25146, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0125115', 'absent paracrine cell', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(25147, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0124984', 'absent progenitor cell', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(25148, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0103099', 'abnormal alkali secreting cell morphology', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(25149, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0101040', 'abnormal axial mesoderm', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(25150, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0131691', 'abnormal molecular function', 0.42105263157894735, 1.4755025719078136, 0.7882031722869998, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(25151, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0131189', 'abnormally decreased number of stem cell', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(25152, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0102323', 'abnormal keratin accumulating cell morphology', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(25153, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0102147', 'abnormal somatic stem cell morphology', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(25154, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0100861', 'abnormal blastomere D2.2.2', 0.4482758620689655, 3.6715585125471644, 1.2829150624062098, 'UPHENO:0086172', 'abnormal cell'),
(25155, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0100449', 'abnormal lymphocyte', 0.5, 3.6715585125471644, 1.3549093166236559, 'UPHENO:0086172', 'abnormal cell'),
(25156, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0100003', 'abnormal organism subdivision', 0.42857142857142855, 1.706362323152461, 0.8551597151958877, 'UPHENO:0002536', 'abnormal anatomical entity'),
(25157, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0101107', 'abnormal erythroid cell', 0.5, 3.6715585125471644, 1.3549093166236559, 'UPHENO:0086172', 'abnormal cell'),
(25158, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0127339', 'abnormally localised migrating myoblast', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(25159, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0141782', 'abnormal methylation', 0.4166666666666667, 1.8210412618256888, 0.871072438105678, 'HP:0000118', 'Phenotypic abnormality'),
(25160, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0131685', 'abnormal cortical actin cytoskeleton', 0.5652173913043478, 3.6715585125471644, 1.440565418328227, 'UPHENO:0086172', 'abnormal cell'),
(25161, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0100675', 'abnormal dorsal vegetal hemisphere blastomere', 0.4642857142857143, 3.6715585125471644, 1.305623286610558, 'UPHENO:0086172', 'abnormal cell'),
(25162, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0125698', 'absent filopodium', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(25163, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0130964', 'abnormally increased number of cell', 0.4482758620689655, 3.6715585125471644, 1.2829150624062098, 'UPHENO:0086172', 'abnormal cell'),
(25164, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0131004', 'abnormally increased number of proepicardium', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(25165, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0127363', 'abnormally localised barrier cell', 0.4482758620689655, 3.6715585125471644, 1.2829150624062098, 'UPHENO:0086172', 'abnormal cell'),
(25166, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0101212', 'abnormal glomeral mesenchyme', 0.4074074074074074, 1.8210412618256888, 0.861339479684008, 'HP:0000118', 'Phenotypic abnormality'),
(25167, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0101657', 'abnormal oocyte morphology', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(25168, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0101547', 'abnormal lampbrush chromosome', 0.5909090909090909, 3.6715585125471644, 1.4729417174039097, 'UPHENO:0086172', 'abnormal cell'),
(25169, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0131706', 'abnormal ciliary basal body organization', 0.4482758620689655, 3.6715585125471644, 1.2829150624062098, 'UPHENO:0086172', 'abnormal cell'),
(25170, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0126783', 'abnormally localised exocrine cell', 0.4482758620689655, 3.6715585125471644, 1.2829150624062098, 'UPHENO:0086172', 'abnormal cell'),
(25171, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0141743', 'abnormal chemical homeostasis within a tissue', 0.4444444444444444, 1.4755025719078136, 0.8098017787384251, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(25172, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0131723', 'abnormal pathway-restricted SMAD protein phosphorylation', 0.4444444444444444, 1.4755025719078136, 0.8098017787384251, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(25173, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0127217', 'abnormally localised cilium', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(25174, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0131708', 'abnormal cilium disassembly', 0.4482758620689655, 3.6715585125471644, 1.2829150624062098, 'UPHENO:0086172', 'abnormal cell'),
(25175, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0100786', 'abnormal presumptive axial mesoderm', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(25176, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0131031', 'abnormally increased number of nucleate erythrocyte', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(25177, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0126082', 'absent perivitelline space', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(25178, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0100032', 'abnormal nervous system', 0.4583333333333333, 1.8210412618256888, 0.9135884804823818, 'HP:0000118', 'Phenotypic abnormality'),
(25179, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0127018', 'abnormally localised ciliated cell', 0.4482758620689655, 3.6715585125471644, 1.2829150624062098, 'UPHENO:0086172', 'abnormal cell'),
(25180, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0142064', 'abnormal desmosome morphology', 0.4482758620689655, 3.6715585125471644, 1.2829150624062098, 'UPHENO:0086172', 'abnormal cell'),
(25181, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0100676', 'abnormal blastomere D2.2', 0.4482758620689655, 3.6715585125471644, 1.2829150624062098, 'UPHENO:0086172', 'abnormal cell'),
(25182, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0141781', 'abnormal secondary metabolic process', 0.4166666666666667, 1.8210412618256888, 0.871072438105678, 'HP:0000118', 'Phenotypic abnormality'),
(25183, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0100520', 'abnormal blastomere D1.2', 0.4482758620689655, 3.6715585125471644, 1.2829150624062098, 'UPHENO:0086172', 'abnormal cell'),
(25184, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0100274', 'abnormal sensory system', 0.44, 1.8210412618256888, 0.8951302448265857, 'HP:0000118', 'Phenotypic abnormality'),
(25185, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0100856', 'abnormal simple organ', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(25186, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0101241', 'abnormal nucleate erythrocyte', 0.6190476190476191, 3.6715585125471644, 1.5076039119696991, 'UPHENO:0086172', 'abnormal cell'),
(25187, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0115512', 'abnormally semi-erect whole organism', 0.45, 1.706362323152461, 0.8762779498644294, 'UPHENO:0002536', 'abnormal anatomical entity'),
(25188, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0107303', 'abnormal migratory trunk neural crest cell', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(25189, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0131090', 'abnormally increased number of oxygen accumulating cell', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(25190, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0125824', 'absent nucleus', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(25191, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0126162', 'absent alkali secreting cell', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(25192, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0131129', 'abnormally increased number of chondroblast', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(25193, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0101485', 'abnormal descending interneuron', 0.4482758620689655, 3.6715585125471644, 1.2829150624062098, 'UPHENO:0086172', 'abnormal cell'),
(25194, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0102069', 'abnormal proepicardium morphology', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(25195, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0126628', 'abnormally localised blastomere', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(25196, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0102994', 'abnormal vegetal cortex morphology', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(25197, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0101009', 'abnormal blastomere D1.1.1', 0.4482758620689655, 3.6715585125471644, 1.2829150624062098, 'UPHENO:0086172', 'abnormal cell'),
(25198, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0125644', 'absent pericyte', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(25199, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0101198', 'abnormal digestive enzyme secreting cell', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(25200, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0131531', 'absent cortical actin cytoskeleton', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(25201, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0107323', 'abnormal thrombocyte', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(25202, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0100954', 'abnormal neural progenitor cell', 0.48148148148148145, 3.6715585125471644, 1.3295816755533123, 'UPHENO:0086172', 'abnormal cell'),
(25203, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0100002', 'abnormal head', 0.4074074074074074, 1.8210412618256888, 0.861339479684008, 'HP:0000118', 'Phenotypic abnormality'),
(25204, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0102703', 'abnormal endoplasmic reticulum morphology', 0.4482758620689655, 3.6715585125471644, 1.2829150624062098, 'UPHENO:0086172', 'abnormal cell'),
(25205, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0100104', 'abnormal embryonic structure', 0.42857142857142855, 1.706362323152461, 0.8551597151958877, 'UPHENO:0002536', 'abnormal anatomical entity'),
(25206, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0131131', 'abnormally increased number of absorptive cell', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(25207, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0131134', 'abnormally increased number of barrier cell', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(25208, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0100960', 'abnormal postmigratory neural crest cell', 0.4482758620689655, 3.6715585125471644, 1.2829150624062098, 'UPHENO:0086172', 'abnormal cell'),
(25209, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0102423', 'abnormal multiciliated cell precursor morphology', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(25210, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0101480', 'abnormal stage V oocyte', 0.5652173913043478, 3.6715585125471644, 1.440565418328227, 'UPHENO:0086172', 'abnormal cell'),
(25211, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0131371', 'abnormally decreased number of electrically active cell', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(25212, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0127819', 'abnormally localised ciliary axoneme', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(25213, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0101448', 'abnormal myelin accumulating cell', 0.6190476190476191, 3.6715585125471644, 1.5076039119696991, 'UPHENO:0086172', 'abnormal cell'),
(25214, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0101490', 'abnormal ectodermal cell', 0.48148148148148145, 3.6715585125471644, 1.3295816755533123, 'UPHENO:0086172', 'abnormal cell'),
(25215, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0101374', 'abnormal migratory neural crest cell', 0.4482758620689655, 3.6715585125471644, 1.2829150624062098, 'UPHENO:0086172', 'abnormal cell'),
(25216, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0131687', 'abnormal astral microtubule', 0.5416666666666666, 3.6715585125471644, 1.4102343283876786, 'UPHENO:0086172', 'abnormal cell'),
(25217, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0107258', 'abnormal anatomical axis', 0.47368421052631576, 1.706362323152461, 0.8990422069704646, 'UPHENO:0002536', 'abnormal anatomical entity'),
(25218, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0101494', 'abnormal blastomere D1.2.1', 0.4482758620689655, 3.6715585125471644, 1.2829150624062098, 'UPHENO:0086172', 'abnormal cell'),
(25219, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0141797', 'abnormal hydrogen metabolic process', 0.4166666666666667, 1.8210412618256888, 0.871072438105678, 'HP:0000118', 'Phenotypic abnormality'),
(25220, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0107311', 'abnormal apical junction complex', 0.5, 3.6715585125471644, 1.3549093166236559, 'UPHENO:0086172', 'abnormal cell'),
(25221, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0100307', 'abnormal blastomere', 0.5652173913043478, 3.6715585125471644, 1.440565418328227, 'UPHENO:0086172', 'abnormal cell'),
(25222, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0101240', 'abnormal ciliated non-epidermal cell', 0.5909090909090909, 3.6715585125471644, 1.4729417174039097, 'UPHENO:0086172', 'abnormal cell'),
(25223, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0100429', 'abnormal spermatid', 0.5909090909090909, 3.6715585125471644, 1.4729417174039097, 'UPHENO:0086172', 'abnormal cell'),
(25224, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0126697', 'abnormally localised proepicardium', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(25225, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0100653', 'abnormal myoblast', 0.6190476190476191, 3.6715585125471644, 1.5076039119696991, 'UPHENO:0086172', 'abnormal cell'),
(25226, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0141796', 'abnormal demethylation', 0.4166666666666667, 1.8210412618256888, 0.871072438105678, 'HP:0000118', 'Phenotypic abnormality'),
(25227, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0129551', 'increased size of the cell part', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(25228, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0100120', 'abnormal genital system', 0.4074074074074074, 1.8210412618256888, 0.861339479684008, 'HP:0000118', 'Phenotypic abnormality'),
(25229, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0127743', 'abnormally localised perivitelline space', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(25230, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0100802', 'abnormal exocrine cell', 0.6190476190476191, 3.6715585125471644, 1.5076039119696991, 'UPHENO:0086172', 'abnormal cell'),
(25231, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0107272', 'abnormal axial region', 0.42857142857142855, 1.706362323152461, 0.8551597151958877, 'UPHENO:0002536', 'abnormal anatomical entity'),
(25232, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0131654', 'abnormal neuron projection', 0.4642857142857143, 3.6715585125471644, 1.305623286610558, 'UPHENO:0086172', 'abnormal cell'),
(25233, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0102852', 'abnormal centriole morphology', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(25234, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0131297', 'abnormally decreased number of melanoblast', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(25235, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0100915', 'abnormal dermal system', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(25236, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0100151', 'abnormal primordium', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(25237, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0131354', 'abnormally decreased number of multiciliated cell precursor', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(25238, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0102608', 'abnormal multiciliated cell morphology', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(25239, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0100339', 'abnormal circumblastoporal collar', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(25240, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0127643', 'abnormally localised somatic stem cell', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(25241, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0101514', 'abnormal dendrite', 0.4482758620689655, 3.6715585125471644, 1.2829150624062098, 'UPHENO:0086172', 'abnormal cell'),
(25242, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0100888', 'abnormal microtubule', 0.5909090909090909, 3.6715585125471644, 1.4729417174039097, 'UPHENO:0086172', 'abnormal cell'),
(25243, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0100728', 'abnormal cell condensation', 0.45, 1.706362323152461, 0.8762779498644294, 'UPHENO:0002536', 'abnormal anatomical entity'),
(25244, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0107266', 'abnormal dorsal side', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(25245, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0124716', 'absent cell', 0.4482758620689655, 3.6715585125471644, 1.2829150624062098, 'UPHENO:0086172', 'abnormal cell'),
(25246, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0125785', 'absent mitotic spindle', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(25247, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0100386', 'abnormal limb', 0.44, 1.8210412618256888, 0.8951302448265857, 'HP:0000118', 'Phenotypic abnormality'),
(25248, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0101326', 'abnormal cementoblast', 0.6190476190476191, 3.6715585125471644, 1.5076039119696991, 'UPHENO:0086172', 'abnormal cell'),
(25249, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0125577', 'absent cilium', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(25250, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0125715', 'absent barrier cell', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(25251, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0103093', 'abnormal sperm entry point morphology', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(25252, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0100396', 'abnormal dorsal animal hemisphere blastomere', 0.4642857142857143, 3.6715585125471644, 1.305623286610558, 'UPHENO:0086172', 'abnormal cell'),
(25253, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0100913', 'abnormal Brachets cleft', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(25254, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0100394', 'abnormal marginal zone', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(25255, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0100791', 'abnormal multiciliated cell precursor', 0.6190476190476191, 3.6715585125471644, 1.5076039119696991, 'UPHENO:0086172', 'abnormal cell'),
(25256, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0131513', 'absent actin cytoskeleton', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(25257, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0101133', 'abnormal motor neuron', 0.48148148148148145, 3.6715585125471644, 1.3295816755533123, 'UPHENO:0086172', 'abnormal cell'),
(25258, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0100521', 'abnormal animal blastomere', 0.48148148148148145, 3.6715585125471644, 1.3295816755533123, 'UPHENO:0086172', 'abnormal cell'),
(25259, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0131136', 'abnormally increased number of multiciliated cell precursor', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(25260, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0100991', 'abnormal iliac process primordium', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(25261, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0127476', 'abnormally localised nucleus', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(25262, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0100010', 'abnormal multicellular anatomical structure', 0.45, 1.706362323152461, 0.8762779498644294, 'UPHENO:0002536', 'abnormal anatomical entity'),
(25263, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0100599', 'abnormal adult immune system', 0.44, 1.8210412618256888, 0.8951302448265857, 'HP:0000118', 'Phenotypic abnormality'),
(25264, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0141718', 'abnormal posterior notochord', 0.4074074074074074, 1.8210412618256888, 0.861339479684008, 'HP:0000118', 'Phenotypic abnormality'),
(25265, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0127089', 'abnormally localised myoblast', 0.4482758620689655, 3.6715585125471644, 1.2829150624062098, 'UPHENO:0086172', 'abnormal cell'),
(25266, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0102181', 'abnormal mitotic cell morphology', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(25267, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0101078', 'abnormal mucous gland', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(25268, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0100814', 'abnormal natural killer cell', 0.4642857142857143, 3.6715585125471644, 1.305623286610558, 'UPHENO:0086172', 'abnormal cell'),
(25269, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0103104', 'abnormal zygote cortex morphology', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(25270, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0133438', 'abnormal cilium morphology in the ciliated non-epidermal cell', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(25271, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0101083', 'abnormal T cell', 0.48148148148148145, 3.6715585125471644, 1.3295816755533123, 'UPHENO:0086172', 'abnormal cell'),
(25272, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0130979', 'abnormally increased number of Merkel cell', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(25273, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0141498', 'abnormal axon microtubule bundle', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(25274, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0126388', 'abnormally localised oocyte', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(25275, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0142052', 'abnormal nasal region', 0.4074074074074074, 1.8210412618256888, 0.861339479684008, 'HP:0000118', 'Phenotypic abnormality'),
(25276, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0127824', 'abnormally localised alkali secreting cell', 0.4482758620689655, 3.6715585125471644, 1.2829150624062098, 'UPHENO:0086172', 'abnormal cell'),
(25277, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0100162', 'abnormal presumptive rhombomere', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(25278, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0131089', 'abnormally increased number of mitotic cell', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(25279, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0107324', 'abnormal embryonic thrombocyte', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(25280, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0101023', 'abnormal ultimobranchial body', 0.4074074074074074, 1.8210412618256888, 0.861339479684008, 'HP:0000118', 'Phenotypic abnormality'),
(25281, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0100503', 'abnormal blastomere D2', 0.5416666666666666, 3.6715585125471644, 1.4102343283876786, 'UPHENO:0086172', 'abnormal cell'),
(25282, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0100585', 'abnormal elastica externa', 0.44, 1.8210412618256888, 0.8951302448265857, 'HP:0000118', 'Phenotypic abnormality'),
(25283, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0127428', 'abnormally localised endoplasmic reticulum', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(25284, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0100610', 'abnormal appendage', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(25285, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0100511', 'abnormal stylopod', 0.4074074074074074, 1.8210412618256888, 0.861339479684008, 'HP:0000118', 'Phenotypic abnormality'),
(25286, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0100551', 'abnormal oocyte cortex', 0.5416666666666666, 3.6715585125471644, 1.4102343283876786, 'UPHENO:0086172', 'abnormal cell'),
(25287, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0100882', 'abnormal perichondrial cell', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(25288, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0100574', 'abnormal gastrula cell', 0.5652173913043478, 3.6715585125471644, 1.440565418328227, 'UPHENO:0086172', 'abnormal cell'),
(25289, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0141787', 'abnormal hormone metabolic process', 0.4166666666666667, 1.8210412618256888, 0.871072438105678, 'HP:0000118', 'Phenotypic abnormality'),
(25290, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0103129', 'abnormal ciliary axoneme morphology', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(25291, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0103067', 'abnormal paracrine cell morphology', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(25292, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0100216', 'abnormal hepato-pancreatic progenitor cell', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(25293, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0127975', 'abnormally localised mitochondrial cloud', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(25294, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0100642', 'abnormal gustatory system', 0.4230769230769231, 1.8210412618256888, 0.8777474203034321, 'HP:0000118', 'Phenotypic abnormality'),
(25295, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0107325', 'abnormal adult thrombocyte', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(25296, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0127391', 'abnormally localised lampbrush chromosome', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(25297, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0100569', 'abnormal motor axon', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(25298, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0131202', 'abnormally decreased number of germ cell', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(25299, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0101373', 'abnormal oxygen accumulating cell', 0.6190476190476191, 3.6715585125471644, 1.5076039119696991, 'UPHENO:0086172', 'abnormal cell'),
(25300, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0126548', 'abnormally localised centrosome', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(25301, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0127896', 'abnormally localised ring structure', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(25302, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0126725', 'abnormally localised epithelial cell', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(25303, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0125693', 'absent mucus secreting cell', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(25304, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0100258', 'abnormal organ part', 0.47368421052631576, 1.706362323152461, 0.8990422069704646, 'UPHENO:0002536', 'abnormal anatomical entity'),
(25305, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0101658', 'abnormal germ cell morphology', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(25306, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0100481', 'abnormal anatomical line', 0.5, 1.706362323152461, 0.9236780616514774, 'UPHENO:0002536', 'abnormal anatomical entity'),
(25307, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0102386', 'abnormal electrically active cell morphology', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(25308, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0101327', 'abnormal blastomere V1.2.1', 0.4482758620689655, 3.6715585125471644, 1.2829150624062098, 'UPHENO:0086172', 'abnormal cell'),
(25309, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0102896', 'abnormal mitotic spindle morphology', 0.4482758620689655, 3.6715585125471644, 1.2829150624062098, 'UPHENO:0086172', 'abnormal cell'),
(25310, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0100062', 'abnormal anatomical space', 0.45, 1.706362323152461, 0.8762779498644294, 'UPHENO:0002536', 'abnormal anatomical entity'),
(25311, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0141738', 'abnormal carbon dioxide homeostasis', 0.4444444444444444, 1.4755025719078136, 0.8098017787384251, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(25312, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0100924', 'abnormal spermatozoon', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(25313, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0107270', 'abnormal proximal-distal axis', 0.45, 1.706362323152461, 0.8762779498644294, 'UPHENO:0002536', 'abnormal anatomical entity'),
(25314, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0103642', 'increased cell population proliferation', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(25315, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0100570', 'abnormal axon', 0.4482758620689655, 3.6715585125471644, 1.2829150624062098, 'UPHENO:0086172', 'abnormal cell'),
(25316, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0100398', 'abnormal vegetal blastomere', 0.48148148148148145, 3.6715585125471644, 1.3295816755533123, 'UPHENO:0086172', 'abnormal cell'),
(25317, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0100545', 'abnormal male organism', 0.45, 1.706362323152461, 0.8762779498644294, 'UPHENO:0002536', 'abnormal anatomical entity'),
(25318, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0101362', 'abnormal vegetal cortex', 0.52, 3.6715585125471644, 1.3817418089225373, 'UPHENO:0086172', 'abnormal cell'),
(25319, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0102534', 'abnormal spermatocyte morphology', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(25320, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0102869', 'abnormal mucus secreting cell morphology', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(25321, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0107371', 'abnormal migrating myoblast morphology', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(25322, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0141314', 'abnormal Roux spot morphology', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(25323, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0100864', 'abnormal dorsolateral ascending neuron', 0.48148148148148145, 3.6715585125471644, 1.3295816755533123, 'UPHENO:0086172', 'abnormal cell'),
(25324, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0125859', 'absent nucleate erythrocyte', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(25325, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0100192', 'abnormal epithelium', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(25326, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0100344', 'abnormal portion of organism substance', 0.5, 1.706362323152461, 0.9236780616514774, 'UPHENO:0002536', 'abnormal anatomical entity'),
(25327, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0100643', 'abnormal thoracic region', 0.42857142857142855, 1.706362323152461, 0.8551597151958877, 'UPHENO:0002536', 'abnormal anatomical entity'),
(25328, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0100907', 'abnormal cytoplasm', 0.5909090909090909, 3.6715585125471644, 1.4729417174039097, 'UPHENO:0086172', 'abnormal cell'),
(25329, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0127029', 'abnormally localised multiciliated cell precursor', 0.4482758620689655, 3.6715585125471644, 1.2829150624062098, 'UPHENO:0086172', 'abnormal cell'),
(25330, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0141511', 'abnormally localised nucleus in myoblast', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(25331, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0131307', 'abnormally decreased number of mitotic cell', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(25332, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0100733', 'abnormal fibroblast', 0.4642857142857143, 3.6715585125471644, 1.305623286610558, 'UPHENO:0086172', 'abnormal cell'),
(25333, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0141771', 'abnormal urea homeostasis', 0.4444444444444444, 1.4755025719078136, 0.8098017787384251, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(25334, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0100084', 'abnormal anatomical group', 0.45, 1.706362323152461, 0.8762779498644294, 'UPHENO:0002536', 'abnormal anatomical entity'),
(25335, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0100277', 'abnormal blastocoel', 0.42857142857142855, 1.706362323152461, 0.8551597151958877, 'UPHENO:0002536', 'abnormal anatomical entity'),
(25336, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0100544', 'abnormal neuromast support cell', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(25337, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0141285', 'abnormal cortical actin cytoskeleton morphology', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(25338, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0131165', 'abnormally increased number of cementoblast', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(25339, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0100417', 'abnormal dense regular connective tissue', 0.4230769230769231, 1.8210412618256888, 0.8777474203034321, 'HP:0000118', 'Phenotypic abnormality'),
(25340, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0142051', 'abnormal cerebrospinal fluid', 0.4074074074074074, 1.8210412618256888, 0.861339479684008, 'HP:0000118', 'Phenotypic abnormality'),
(25341, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0101467', 'abnormal alkali secreting cell', 0.6190476190476191, 3.6715585125471644, 1.5076039119696991, 'UPHENO:0086172', 'abnormal cell'),
(25342, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0103005', 'abnormal oxygen accumulating cell morphology', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(25343, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0126737', 'abnormally localised mesenchymal stem cell', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(25344, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0100688', 'abnormal adipose tissue', 0.4230769230769231, 1.8210412618256888, 0.8777474203034321, 'HP:0000118', 'Phenotypic abnormality'),
(25345, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0100702', 'abnormal glial cell', 0.5, 3.6715585125471644, 1.3549093166236559, 'UPHENO:0086172', 'abnormal cell'),
(25346, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0116434', 'abnormal biological process', 0.42105263157894735, 1.4755025719078136, 0.7882031722869998, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(25347, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0133473', 'abnormally decreased number of cilium in the ciliated non-epidermal cell', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(25348, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0131667', 'abnormal actin cytoskeleton', 0.5909090909090909, 3.6715585125471644, 1.4729417174039097, 'UPHENO:0086172', 'abnormal cell'),
(25349, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0101503', 'abnormal organ cortex', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(25350, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0125053', 'absent zygote', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(25351, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0100667', 'abnormal vegetal yolk mass', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(25352, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0116494', 'absent biological process', 0.42105263157894735, 1.4755025719078136, 0.7882031722869998, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(25353, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0107265', 'abnormal posterior side', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(25354, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0125061', 'absent basal body', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(25355, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0125976', 'absent centriole', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(25356, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0100225', 'abnormal endocrine system', 0.4583333333333333, 1.8210412618256888, 0.9135884804823818, 'HP:0000118', 'Phenotypic abnormality'),
(25357, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0127522', 'abnormally localised cementoblast', 0.4482758620689655, 3.6715585125471644, 1.2829150624062098, 'UPHENO:0086172', 'abnormal cell'),
(25358, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0131669', 'abnormal Roux spot', 0.5416666666666666, 3.6715585125471644, 1.4102343283876786, 'UPHENO:0086172', 'abnormal cell'),
(25359, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0100784', 'abnormal left blastomere', 0.5416666666666666, 3.6715585125471644, 1.4102343283876786, 'UPHENO:0086172', 'abnormal cell'),
(25360, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0102434', 'abnormal exocrine cell morphology', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(25361, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0100232', 'abnormal lymphatic system', 0.4583333333333333, 1.8210412618256888, 0.9135884804823818, 'HP:0000118', 'Phenotypic abnormality'),
(25362, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0141904', 'abnormal glucosamine metabolic process', 0.4166666666666667, 1.8210412618256888, 0.871072438105678, 'HP:0000118', 'Phenotypic abnormality'),
(25363, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0101513', 'abnormal basal body', 0.5909090909090909, 3.6715585125471644, 1.4729417174039097, 'UPHENO:0086172', 'abnormal cell'),
(25364, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0101162', 'abnormal stromal cell', 0.48148148148148145, 3.6715585125471644, 1.3295816755533123, 'UPHENO:0086172', 'abnormal cell'),
(25365, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0125559', 'absent electrically active cell', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(25366, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0127815', 'abnormally localised ciliated non-epidermal cell', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(25367, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0141289', 'abnormal spindle microtubule morphology', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(25368, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0102347', 'abnormal ciliated cell morphology', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(25369, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0100724', 'abnormal kinetochore', 0.5909090909090909, 3.6715585125471644, 1.4729417174039097, 'UPHENO:0086172', 'abnormal cell'),
(25370, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0125854', 'absent barrier epithelial cell', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(25371, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0127794', 'abnormally localised mitotic cell', 0.4482758620689655, 3.6715585125471644, 1.2829150624062098, 'UPHENO:0086172', 'abnormal cell'),
(25372, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0102165', 'abnormal melanoblast morphology', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(25373, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0131383', 'abnormally decreased number of cementoblast', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(25374, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0141794', 'abnormal prosthetic group metabolic process', 0.4166666666666667, 1.8210412618256888, 0.871072438105678, 'HP:0000118', 'Phenotypic abnormality'),
(25375, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0141715', 'abnormal septum', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(25376, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:00000000', 'Xenopus phenotype', 0.47058823529411764, 1.4755025719078136, 0.8332791557971614, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(25377, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0115505', 'dead whole organism', 0.45, 1.706362323152461, 0.8762779498644294, 'UPHENO:0002536', 'abnormal anatomical entity'),
(25378, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0101804', 'abnormal stem cell morphology', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(25379, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0100316', 'abnormal gamete', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(25380, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0100186', 'abnormal uveal tract', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(25381, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0107285', 'abnormal flexural organ', 0.4074074074074074, 1.8210412618256888, 0.861339479684008, 'HP:0000118', 'Phenotypic abnormality'),
(25382, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0100114', 'abnormal peripheral nervous system', 0.4074074074074074, 1.8210412618256888, 0.861339479684008, 'HP:0000118', 'Phenotypic abnormality'),
(25383, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0126495', 'abnormally localised keratin accumulating cell', 0.4482758620689655, 3.6715585125471644, 1.2829150624062098, 'UPHENO:0086172', 'abnormal cell'),
(25384, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0101168', 'abnormal circulating cell', 0.52, 3.6715585125471644, 1.3817418089225373, 'UPHENO:0086172', 'abnormal cell'),
(25385, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0131352', 'abnormally decreased number of barrier cell', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(25386, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0131569', 'abnormally localised cortical actin cytoskeleton', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(25387, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0103041', 'abnormal perivitelline space morphology', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(25388, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0131247', 'abnormally decreased number of nucleate erythrocyte', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(25389, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0100415', 'abnormal secretory epithelial cell', 0.52, 3.6715585125471644, 1.3817418089225373, 'UPHENO:0086172', 'abnormal cell'),
(25390, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0101004', 'abnormal acid secreting cell', 0.6190476190476191, 3.6715585125471644, 1.5076039119696991, 'UPHENO:0086172', 'abnormal cell'),
(25391, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0100917', 'abnormal stage III oocyte', 0.5652173913043478, 3.6715585125471644, 1.440565418328227, 'UPHENO:0086172', 'abnormal cell'),
(25392, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0103631', 'abnormally increased number of apoptotic cell', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(25393, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0141499', 'abnormal tadpole', 0.45, 1.706362323152461, 0.8762779498644294, 'UPHENO:0002536', 'abnormal anatomical entity'),
(25394, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0101468', 'abnormal stage I oocyte', 0.5652173913043478, 3.6715585125471644, 1.440565418328227, 'UPHENO:0086172', 'abnormal cell'),
(25395, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0102693', 'abnormal plasma membrane morphology', 0.4482758620689655, 3.6715585125471644, 1.2829150624062098, 'UPHENO:0086172', 'abnormal cell'),
(25396, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0102636', 'abnormal acid secreting cell morphology', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(25397, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0130989', 'abnormally increased number of ciliated cell', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(25398, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0141841', 'abnormality of whole organism mass', 0.4074074074074074, 1.8210412618256888, 0.861339479684008, 'HP:0000118', 'Phenotypic abnormality'),
(25399, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0141263', 'abnormal visually guided collision avoidance behavior', 0.4444444444444444, 1.4755025719078136, 0.8098017787384251, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(25400, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0127196', 'abnormally localised electrically active cell', 0.4482758620689655, 3.6715585125471644, 1.2829150624062098, 'UPHENO:0086172', 'abnormal cell'),
(25401, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0125454', 'absent myoblast', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(25402, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0131292', 'abnormally decreased number of mucus secreting cell', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(25403, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0131735', 'abnormal spindle assembly', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(25404, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0127876', 'abnormally localised microtubule', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(25405, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0100152', 'abnormal alimentary system', 0.4230769230769231, 1.8210412618256888, 0.8777474203034321, 'HP:0000118', 'Phenotypic abnormality'),
(25406, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0101158', 'abnormal blastomere V2.2.2', 0.4482758620689655, 3.6715585125471644, 1.2829150624062098, 'UPHENO:0086172', 'abnormal cell'),
(25407, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0126413', 'abnormally localised cell part', 0.4642857142857143, 3.6715585125471644, 1.305623286610558, 'UPHENO:0086172', 'abnormal cell'),
(25408, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0131096', 'abnormally increased number of exocrine cell', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(25409, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0115508', 'abnormally peramorphic growth of whole organism', 0.45, 1.706362323152461, 0.8762779498644294, 'UPHENO:0002536', 'abnormal anatomical entity'),
(25410, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0100203', 'abnormal endocrine cell', 0.5, 3.6715585125471644, 1.3549093166236559, 'UPHENO:0086172', 'abnormal cell'),
(25411, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0100070', 'abnormal anatomical system', 0.42857142857142855, 1.706362323152461, 0.8551597151958877, 'UPHENO:0002536', 'abnormal anatomical entity'),
(25412, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0126472', 'abnormally localised secondary spermatogonium', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(25413, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0127338', 'abnormally localised mucus secreting cell', 0.4482758620689655, 3.6715585125471644, 1.2829150624062098, 'UPHENO:0086172', 'abnormal cell'),
(25414, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0141277', 'abnormal actin cytoskeleton morphology', 0.4482758620689655, 3.6715585125471644, 1.2829150624062098, 'UPHENO:0086172', 'abnormal cell'),
(25415, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0101096', 'abnormal tendon', 0.4074074074074074, 1.8210412618256888, 0.861339479684008, 'HP:0000118', 'Phenotypic abnormality'),
(25416, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0101072', 'abnormal mitochondrial cloud', 0.5416666666666666, 3.6715585125471644, 1.4102343283876786, 'UPHENO:0086172', 'abnormal cell'),
(25417, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0101016', 'abnormal egg', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(25418, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0102258', 'abnormal primordial germ cell morphology', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(25419, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0101576', 'abnormal blastomere V1.2.2', 0.4482758620689655, 3.6715585125471644, 1.2829150624062098, 'UPHENO:0086172', 'abnormal cell'),
(25420, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0100402', 'abnormal zeugopod', 0.4074074074074074, 1.8210412618256888, 0.861339479684008, 'HP:0000118', 'Phenotypic abnormality'),
(25421, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0100999', 'abnormal serous membrane', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(25422, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0141786', 'abnormal pigment metabolic process', 0.4166666666666667, 1.8210412618256888, 0.871072438105678, 'HP:0000118', 'Phenotypic abnormality'),
(25423, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0100899', 'abnormal secondary spermatogonium', 0.5909090909090909, 3.6715585125471644, 1.4729417174039097, 'UPHENO:0086172', 'abnormal cell'),
(25424, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0126982', 'abnormally localised secondary oogonium', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(25425, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0100317', 'abnormal respiratory system', 0.4583333333333333, 1.8210412618256888, 0.9135884804823818, 'HP:0000118', 'Phenotypic abnormality'),
(25426, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0100721', 'abnormal centromere', 0.5909090909090909, 3.6715585125471644, 1.4729417174039097, 'UPHENO:0086172', 'abnormal cell'),
(25427, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0100218', 'abnormal epithelial cell', 0.5416666666666666, 3.6715585125471644, 1.4102343283876786, 'UPHENO:0086172', 'abnormal cell'),
(25428, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0107399', 'abnormal filopodium morphology', 0.4482758620689655, 3.6715585125471644, 1.2829150624062098, 'UPHENO:0086172', 'abnormal cell'),
(25429, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0127337', 'abnormally localised oxygen accumulating cell', 0.4482758620689655, 3.6715585125471644, 1.2829150624062098, 'UPHENO:0086172', 'abnormal cell'),
(25430, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0107263', 'abnormal anatomical side', 0.42857142857142855, 1.706362323152461, 0.8551597151958877, 'UPHENO:0002536', 'abnormal anatomical entity'),
(25431, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0100175', 'abnormal migrating neuroblast', 0.5, 3.6715585125471644, 1.3549093166236559, 'UPHENO:0086172', 'abnormal cell'),
(25432, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0100295', 'abnormal extracellular matrix', 0.42857142857142855, 1.706362323152461, 0.8551597151958877, 'UPHENO:0002536', 'abnormal anatomical entity'),
(25433, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0100231', 'abnormal compound organ', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(25434, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0101406', 'abnormal cleavage furrow', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(25435, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0101519', 'abnormal hypobranchial placode', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(25436, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0127979', 'abnormally localised absorptive cell', 0.4482758620689655, 3.6715585125471644, 1.2829150624062098, 'UPHENO:0086172', 'abnormal cell'),
(25437, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0100887', 'abnormal right-dorsal blastomere', 0.5416666666666666, 3.6715585125471644, 1.4102343283876786, 'UPHENO:0086172', 'abnormal cell'),
(25438, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0102965', 'abnormal barrier epithelial cell morphology', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(25439, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0131707', 'abnormal cilium assembly', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(25440, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0127372', 'abnormally localised polar body', 0.4482758620689655, 3.6715585125471644, 1.2829150624062098, 'UPHENO:0086172', 'abnormal cell'),
(25441, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0133443', 'abnormally increased number of cilium in the multiciliated cell', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(25442, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0101061', 'abnormal plasma membrane', 0.5909090909090909, 3.6715585125471644, 1.4729417174039097, 'UPHENO:0086172', 'abnormal cell'),
(25443, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0131553', 'abnormally localised Roux spot', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(25444, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0100289', 'abnormal chondroblast', 0.6190476190476191, 3.6715585125471644, 1.5076039119696991, 'UPHENO:0086172', 'abnormal cell'),
(25445, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0101120', 'abnormal cardiac progenitor cell', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(25446, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0107271', 'abnormal apical region', 0.42857142857142855, 1.706362323152461, 0.8551597151958877, 'UPHENO:0002536', 'abnormal anatomical entity'),
(25447, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0141296', 'abnormal adherens junction morphology', 0.4482758620689655, 3.6715585125471644, 1.2829150624062098, 'UPHENO:0086172', 'abnormal cell'),
(25448, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0100596', 'abnormal myocyte', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(25449, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0100859', 'abnormal blastomere V1.1.2', 0.4482758620689655, 3.6715585125471644, 1.2829150624062098, 'UPHENO:0086172', 'abnormal cell'),
(25450, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0101940', 'abnormal early embryonic cell morphology', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(25451, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0126454', 'abnormally localised stem cell', 0.4482758620689655, 3.6715585125471644, 1.2829150624062098, 'UPHENO:0086172', 'abnormal cell'),
(25452, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0101166', 'abnormal premigratory neural crest cell', 0.4482758620689655, 3.6715585125471644, 1.2829150624062098, 'UPHENO:0086172', 'abnormal cell'),
(25453, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0100273', 'abnormal visual system', 0.4230769230769231, 1.8210412618256888, 0.8777474203034321, 'HP:0000118', 'Phenotypic abnormality'),
(25454, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0107269', 'abnormal right side', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(25455, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0130986', 'abnormally increased number of germ cell', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(25456, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0101466', 'abnormal secondary myofiber', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(25457, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0100397', 'abnormal ventral vegetal hemisphere blastomere', 0.4642857142857143, 3.6715585125471644, 1.305623286610558, 'UPHENO:0086172', 'abnormal cell'),
(25458, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0131561', 'abnormally localised actin filament', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(25459, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0126983', 'abnormally localised primordial germ cell', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(25460, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0101221', 'abnormal larval immune system', 0.44, 1.8210412618256888, 0.8951302448265857, 'HP:0000118', 'Phenotypic abnormality'),
(25461, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0131347', 'abnormally decreased number of myelin accumulating cell', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(25462, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0101500', 'abnormal endodermal cell', 0.48148148148148145, 3.6715585125471644, 1.3295816755533123, 'UPHENO:0086172', 'abnormal cell'),
(25463, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0124845', 'absent stem cell', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(25464, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0126214', 'absent microtubule', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(25465, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0100009', 'abnormal multi-tissue structure', 0.42857142857142855, 1.706362323152461, 0.8551597151958877, 'UPHENO:0002536', 'abnormal anatomical entity'),
(25466, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0102109', 'abnormal pericyte morphology', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(25467, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0101071', 'abnormal endoplasmic reticulum', 0.5909090909090909, 3.6715585125471644, 1.4729417174039097, 'UPHENO:0086172', 'abnormal cell'),
(25468, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0100493', 'abnormal liver and biliary system', 0.4074074074074074, 1.8210412618256888, 0.861339479684008, 'HP:0000118', 'Phenotypic abnormality'),
(25469, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0107286', 'abnormal efferent neuron', 0.4642857142857143, 3.6715585125471644, 1.305623286610558, 'UPHENO:0086172', 'abnormal cell'),
(25470, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0127168', 'abnormally localised chondroblast', 0.4482758620689655, 3.6715585125471644, 1.2829150624062098, 'UPHENO:0086172', 'abnormal cell'),
(25471, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0131082', 'abnormally increased number of alkali secreting cell', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(25472, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0102704', 'abnormal mitochondrial cloud morphology', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(25473, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0100282', 'abnormal pelvic girdle primordium', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(25474, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0141266', 'abnormal surface breathing', 0.4444444444444444, 1.4755025719078136, 0.8098017787384251, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(25475, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0100135', 'abnormal surface structure', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(25476, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0101136', 'abnormal ooplasm', 0.5416666666666666, 3.6715585125471644, 1.4102343283876786, 'UPHENO:0086172', 'abnormal cell'),
(25477, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0100427', 'abnormal olfactory system', 0.4230769230769231, 1.8210412618256888, 0.8777474203034321, 'HP:0000118', 'Phenotypic abnormality'),
(25478, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0100901', 'abnormal blastomere D1.2.2', 0.4482758620689655, 3.6715585125471644, 1.2829150624062098, 'UPHENO:0086172', 'abnormal cell'),
(25479, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0101481', 'abnormal skeletal muscle satellite cell', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(25480, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0115391', 'abnormally undifferentiated alimentary system', 0.4074074074074074, 1.8210412618256888, 0.861339479684008, 'HP:0000118', 'Phenotypic abnormality'),
(25481, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0141783', 'abnormal collagen metabolic process', 0.4166666666666667, 1.8210412618256888, 0.871072438105678, 'HP:0000118', 'Phenotypic abnormality'),
(25482, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0125533', 'absent myelin accumulating cell', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(25483, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0130968', 'abnormally increased number of early embryonic cell', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(25484, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0102336', 'abnormal Merkel cell morphology', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(25485, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0100742', 'abnormal musculoskeletal system', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(25486, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0124864', 'absent germ cell', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(25487, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0100823', 'abnormal blood', 0.4230769230769231, 1.8210412618256888, 0.8777474203034321, 'HP:0000118', 'Phenotypic abnormality'),
(25488, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0100293', 'abnormal duct', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(25489, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0100035', 'abnormal ventral animal hemisphere blastomere', 0.4642857142857143, 3.6715585125471644, 1.305623286610558, 'UPHENO:0086172', 'abnormal cell'),
(25490, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0101570', 'abnormal forelimb region', 0.42857142857142855, 1.706362323152461, 0.8551597151958877, 'UPHENO:0002536', 'abnormal anatomical entity'),
(25491, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0100332', 'abnormal germinal granule', 0.48148148148148145, 3.6715585125471644, 1.3295816755533123, 'UPHENO:0086172', 'abnormal cell'),
(25492, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0100654', 'abnormal blastomere V2.1', 0.4482758620689655, 3.6715585125471644, 1.2829150624062098, 'UPHENO:0086172', 'abnormal cell'),
(25493, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0130973', 'abnormally increased number of stem cell', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(25494, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0100852', 'abnormal interdigital region', 0.4782608695652174, 1.8210412618256888, 0.9332377925239069, 'HP:0000118', 'Phenotypic abnormality'),
(25495, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0107260', 'abnormal anterior-posterior axis', 0.45, 1.706362323152461, 0.8762779498644294, 'UPHENO:0002536', 'abnormal anatomical entity'),
(25496, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0142057', 'abnormal desmosome', 0.5909090909090909, 3.6715585125471644, 1.4729417174039097, 'UPHENO:0086172', 'abnormal cell'),
(25497, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0100025', 'abnormal oocyte', 0.5909090909090909, 3.6715585125471644, 1.4729417174039097, 'UPHENO:0086172', 'abnormal cell'),
(25498, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0116091', 'abnormally increased variability of size of cell in endoderm', 0.48148148148148145, 3.6715585125471644, 1.3295816755533123, 'UPHENO:0086172', 'abnormal cell'),
(25499, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0142030', 'abnormally localised desmosome', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(25500, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0102860', 'abnormal mesenchymal stem cell morphology', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(25501, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0101450', 'abnormal myeloid cell', 0.5, 3.6715585125471644, 1.3549093166236559, 'UPHENO:0086172', 'abnormal cell'),
(25502, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0101302', 'abnormal subcortical cytoplasm', 0.5416666666666666, 3.6715585125471644, 1.4102343283876786, 'UPHENO:0086172', 'abnormal cell'),
(25503, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0125160', 'absent exocrine cell', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(25504, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0101575', 'abnormal vitelline membrane', 0.5416666666666666, 3.6715585125471644, 1.4102343283876786, 'UPHENO:0086172', 'abnormal cell'),
(25505, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0100392', 'abnormal cilium', 0.5652173913043478, 3.6715585125471644, 1.440565418328227, 'UPHENO:0086172', 'abnormal cell'),
(25506, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0107264', 'abnormal anterior side', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(25507, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0127508', 'abnormally localised barrier epithelial cell', 0.4482758620689655, 3.6715585125471644, 1.2829150624062098, 'UPHENO:0086172', 'abnormal cell'),
(25508, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0107284', 'abnormal migrating myoblast', 0.5909090909090909, 3.6715585125471644, 1.4729417174039097, 'UPHENO:0086172', 'abnormal cell'),
(25509, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0107278', 'abnormal medial region', 0.42857142857142855, 1.706362323152461, 0.8551597151958877, 'UPHENO:0002536', 'abnormal anatomical entity'),
(25510, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0102873', 'abnormal nucleate erythrocyte morphology', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(25511, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0100509', 'abnormal germ plasm', 0.5, 3.6715585125471644, 1.3549093166236559, 'UPHENO:0086172', 'abnormal cell'),
(25512, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0126738', 'abnormally localised paracrine cell', 0.4482758620689655, 3.6715585125471644, 1.2829150624062098, 'UPHENO:0086172', 'abnormal cell'),
(25513, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0102531', 'abnormal secondary spermatogonium morphology', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(25514, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0131551', 'abnormally localised actin cytoskeleton', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(25515, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0100581', 'abnormal immune system', 0.4583333333333333, 1.8210412618256888, 0.9135884804823818, 'HP:0000118', 'Phenotypic abnormality'),
(25516, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0128071', 'decreased size of the cell part', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(25517, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0100967', 'abnormal blastomere V2.1.2', 0.4482758620689655, 3.6715585125471644, 1.2829150624062098, 'UPHENO:0086172', 'abnormal cell'),
(25518, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0107259', 'abnormal animal-vegetal axis', 0.45, 1.706362323152461, 0.8762779498644294, 'UPHENO:0002536', 'abnormal anatomical entity'),
(25519, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0101264', 'abnormal mitotic spindle', 0.5909090909090909, 3.6715585125471644, 1.4729417174039097, 'UPHENO:0086172', 'abnormal cell'),
(25520, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0101405', 'abnormal ring structure', 0.5416666666666666, 3.6715585125471644, 1.4102343283876786, 'UPHENO:0086172', 'abnormal cell'),
(25521, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0100894', 'abnormal nucleus', 0.5909090909090909, 3.6715585125471644, 1.4729417174039097, 'UPHENO:0086172', 'abnormal cell'),
(25522, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0100912', 'abnormal trabecula', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(25523, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0127486', 'abnormally localised kinetochore', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(25524, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0102539', 'abnormal cytoplasm morphology', 0.4482758620689655, 3.6715585125471644, 1.2829150624062098, 'UPHENO:0086172', 'abnormal cell'),
(25525, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0102061', 'abnormal spermatid morphology', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(25526, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0127533', 'abnormally localised spermatocyte', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(25527, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0127160', 'abnormally localised acid secreting cell', 0.4482758620689655, 3.6715585125471644, 1.2829150624062098, 'UPHENO:0086172', 'abnormal cell'),
(25528, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0100754', 'abnormal electrically active cell', 0.6190476190476191, 3.6715585125471644, 1.5076039119696991, 'UPHENO:0086172', 'abnormal cell'),
(25529, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0101311', 'abnormal bottle cell', 0.5416666666666666, 3.6715585125471644, 1.4102343283876786, 'UPHENO:0086172', 'abnormal cell'),
(25530, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0131204', 'abnormally decreased number of pericyte', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(25531, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0100557', 'abnormal prime meridian', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(25532, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0101515', 'abnormal neuromast mantle cell', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(25533, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0115615', 'abnormally posteriorly mislocalised primordial germ cell', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(25534, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0100989', 'abnormal right blastomere', 0.5416666666666666, 3.6715585125471644, 1.4102343283876786, 'UPHENO:0086172', 'abnormal cell'),
(25535, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0100993', 'abnormal ligament cell', 0.4482758620689655, 3.6715585125471644, 1.2829150624062098, 'UPHENO:0086172', 'abnormal cell'),
(25536, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0100377', 'abnormal connective tissue', 0.44, 1.8210412618256888, 0.8951302448265857, 'HP:0000118', 'Phenotypic abnormality'),
(25537, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0101347', 'abnormal hindlimb region', 0.42857142857142855, 1.706362323152461, 0.8551597151958877, 'UPHENO:0002536', 'abnormal anatomical entity'),
(25538, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0126318', 'abnormally localised cell', 0.48148148148148145, 3.6715585125471644, 1.3295816755533123, 'UPHENO:0086172', 'abnormal cell'),
(25539, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0102520', 'abnormal microtubule morphology', 0.4482758620689655, 3.6715585125471644, 1.2829150624062098, 'UPHENO:0086172', 'abnormal cell'),
(25540, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0115509', 'abnormally semi-viable whole organism', 0.45, 1.706362323152461, 0.8762779498644294, 'UPHENO:0002536', 'abnormal anatomical entity'),
(25541, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0101037', 'abnormal hatching gland cell', 0.4642857142857143, 3.6715585125471644, 1.305623286610558, 'UPHENO:0086172', 'abnormal cell'),
(25542, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0100395', 'abnormal blastomere D1.1', 0.4482758620689655, 3.6715585125471644, 1.2829150624062098, 'UPHENO:0086172', 'abnormal cell'),
(25543, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0101378', 'abnormal blastomere D1', 0.5416666666666666, 3.6715585125471644, 1.4102343283876786, 'UPHENO:0086172', 'abnormal cell'),
(25544, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0101461', 'abnormal sperm entry point', 0.5652173913043478, 3.6715585125471644, 1.440565418328227, 'UPHENO:0086172', 'abnormal cell'),
(25545, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0141792', 'abnormal small molecule metabolic process', 0.4166666666666667, 1.8210412618256888, 0.871072438105678, 'HP:0000118', 'Phenotypic abnormality'),
(25546, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0133436', 'abnormal cilium morphology in the multiciliated cell', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(25547, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0101113', 'abnormal stage IV oocyte', 0.5652173913043478, 3.6715585125471644, 1.440565418328227, 'UPHENO:0086172', 'abnormal cell'),
(25548, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0131351', 'abnormally decreased number of apoptotic cell', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(25549, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0101497', 'abnormal ciliary axoneme', 0.5416666666666666, 3.6715585125471644, 1.4102343283876786, 'UPHENO:0086172', 'abnormal cell'),
(25550, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0100458', 'abnormal autopod', 0.4074074074074074, 1.8210412618256888, 0.861339479684008, 'HP:0000118', 'Phenotypic abnormality'),
(25551, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0101325', 'abnormal blastomere D2.1.1', 0.4482758620689655, 3.6715585125471644, 1.2829150624062098, 'UPHENO:0086172', 'abnormal cell'),
(25552, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0131153', 'abnormally increased number of electrically active cell', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(25553, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0102929', 'abnormal barrier cell morphology', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(25554, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0107268', 'abnormal left side', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(25555, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0131666', 'abnormal adherens junction', 0.5909090909090909, 3.6715585125471644, 1.4729417174039097, 'UPHENO:0086172', 'abnormal cell'),
(25556, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0102588', 'abnormal centrosome morphology', 0.4482758620689655, 3.6715585125471644, 1.2829150624062098, 'UPHENO:0086172', 'abnormal cell'),
(25557, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0126473', 'abnormally localised germ cell', 0.4482758620689655, 3.6715585125471644, 1.2829150624062098, 'UPHENO:0086172', 'abnormal cell'),
(25558, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0100649', 'abnormal growth cone', 0.4482758620689655, 3.6715585125471644, 1.2829150624062098, 'UPHENO:0086172', 'abnormal cell'),
(25559, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0100006', 'abnormal anatomical structure', 0.5, 1.706362323152461, 0.9236780616514774, 'UPHENO:0002536', 'abnormal anatomical entity'),
(25560, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0127364', 'abnormally localised multiciliated cell', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(25561, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0131348', 'abnormally decreased number of absorptive cell', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(25562, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0101435', 'abnormal paracrine cell', 0.6190476190476191, 3.6715585125471644, 1.5076039119696991, 'UPHENO:0086172', 'abnormal cell'),
(25563, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0125833', 'absent kinetochore', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(25564, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0133471', 'abnormally decreased number of cilium in the ciliated cell', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(25565, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0100701', 'abnormal microglial cell', 0.48148148148148145, 3.6715585125471644, 1.3295816755533123, 'UPHENO:0086172', 'abnormal cell'),
(25566, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0101921', 'abnormal chondroblast morphology', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(25567, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0101411', 'abnormal marginal zone (sensu neural)', 0.42857142857142855, 1.706362323152461, 0.8551597151958877, 'UPHENO:0002536', 'abnormal anatomical entity'),
(25568, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0125743', 'absent lampbrush chromosome', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(25569, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0100363', 'abnormal cardiovascular system', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(25570, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0127435', 'abnormally localised mitotic spindle', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(25571, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0101498', 'abnormal stage II oocyte', 0.5652173913043478, 3.6715585125471644, 1.440565418328227, 'UPHENO:0086172', 'abnormal cell'),
(25572, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0127683', 'abnormally localised centromere', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(25573, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0100004', 'abnormal cell', 0.65, 3.6715585125471644, 1.5448343060521594, 'UPHENO:0086172', 'abnormal cell'),
(25574, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0100202', 'abnormal embryo', 0.45, 1.706362323152461, 0.8762779498644294, 'UPHENO:0002536', 'abnormal anatomical entity'),
(25575, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0107273', 'abnormal basal region', 0.42857142857142855, 1.706362323152461, 0.8551597151958877, 'UPHENO:0002536', 'abnormal anatomical entity'),
(25576, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0101366', 'abnormal morula cell', 0.5652173913043478, 3.6715585125471644, 1.440565418328227, 'UPHENO:0086172', 'abnormal cell'),
(25577, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0100781', 'abnormal presumptive ectoderm', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(25578, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0131283', 'abnormally decreased number of myoblast', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(25579, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0102526', 'abnormal nucleus morphology', 0.4482758620689655, 3.6715585125471644, 1.2829150624062098, 'UPHENO:0086172', 'abnormal cell'),
(25580, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0141791', 'abnormal primary metabolic process', 0.4166666666666667, 1.8210412618256888, 0.871072438105678, 'HP:0000118', 'Phenotypic abnormality'),
(25581, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0103644', 'abnormally decreased number of cilium in the multiciliated cell', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(25582, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0102306', 'abnormal secondary oogonium morphology', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(25583, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0131550', 'abnormally localised adherens junction', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(25584, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0100423', 'abnormal process', 0.45, 1.706362323152461, 0.8762779498644294, 'UPHENO:0002536', 'abnormal anatomical entity'),
(25585, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0100546', 'abnormal whole organism', 0.47368421052631576, 1.706362323152461, 0.8990422069704646, 'UPHENO:0002536', 'abnormal anatomical entity'),
(25586, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0100573', 'abnormal extraembryonic structure', 0.45, 1.706362323152461, 0.8762779498644294, 'UPHENO:0002536', 'abnormal anatomical entity'),
(25587, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0142066', 'abnormally increased number of desmosome', 0.4642857142857143, 3.6715585125471644, 1.305623286610558, 'UPHENO:0086172', 'abnormal cell'),
(25588, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0100164', 'abnormal neural nucleus', 0.4074074074074074, 1.8210412618256888, 0.861339479684008, 'HP:0000118', 'Phenotypic abnormality'),
(25589, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0141772', 'abnormal water homeostasis', 0.4444444444444444, 1.4755025719078136, 0.8098017787384251, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(25590, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0100842', 'abnormal left-dorsal blastomere', 0.5416666666666666, 3.6715585125471644, 1.4102343283876786, 'UPHENO:0086172', 'abnormal cell'),
(25591, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0102285', 'abnormal myoblast morphology', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(25592, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0127288', 'abnormally localised pericyte', 0.4482758620689655, 3.6715585125471644, 1.2829150624062098, 'UPHENO:0086172', 'abnormal cell'),
(25593, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0131061', 'abnormally increased number of keratin accumulating cell', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(25594, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0107276', 'abnormal dorsal region', 0.42857142857142855, 1.706362323152461, 0.8551597151958877, 'UPHENO:0002536', 'abnormal anatomical entity'),
(25595, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0100336', 'abnormal interneuron', 0.4642857142857143, 3.6715585125471644, 1.305623286610558, 'UPHENO:0086172', 'abnormal cell'),
(25596, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0101345', 'abnormal ascending interneuron', 0.4482758620689655, 3.6715585125471644, 1.2829150624062098, 'UPHENO:0086172', 'abnormal cell'),
(25597, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0131145', 'abnormally increased number of polar body', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(25598, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0142023', 'absent desmosome', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(25599, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0101451', 'abnormal dorsal lymph space', 0.4230769230769231, 1.8210412618256888, 0.8777474203034321, 'HP:0000118', 'Phenotypic abnormality'),
(25600, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0126133', 'absent mitotic cell', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(25601, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0101389', 'abnormal wedge region', 0.5416666666666666, 3.6715585125471644, 1.4102343283876786, 'UPHENO:0086172', 'abnormal cell'),
(25602, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0101237', 'abnormal mucus secreting cell', 0.6190476190476191, 3.6715585125471644, 1.5076039119696991, 'UPHENO:0086172', 'abnormal cell'),
(25603, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0126600', 'abnormally localised progenitor cell', 0.4482758620689655, 3.6715585125471644, 1.2829150624062098, 'UPHENO:0086172', 'abnormal cell'),
(25604, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0103167', 'abnormal absorptive cell morphology', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(25605, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0100732', 'abnormal tendon fibroblast', 0.4482758620689655, 3.6715585125471644, 1.2829150624062098, 'UPHENO:0086172', 'abnormal cell'),
(25606, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0107262', 'abnormal left-right axis', 0.45, 1.706362323152461, 0.8762779498644294, 'UPHENO:0002536', 'abnormal anatomical entity'),
(25607, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0101228', 'abnormal mesenchymal stem cell', 0.5909090909090909, 3.6715585125471644, 1.4729417174039097, 'UPHENO:0086172', 'abnormal cell'),
(25608, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0115758', 'abnormally decreased mobility of melanoblast', 0.52, 3.6715585125471644, 1.3817418089225373, 'UPHENO:0086172', 'abnormal cell'),
(25609, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0107426', 'abnormal yolk platelet morphology', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(25610, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0100976', 'abnormal multiciliated cell', 0.5909090909090909, 3.6715585125471644, 1.4729417174039097, 'UPHENO:0086172', 'abnormal cell'),
(25611, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0100956', 'abnormal centrosome', 0.5909090909090909, 3.6715585125471644, 1.4729417174039097, 'UPHENO:0086172', 'abnormal cell'),
(25612, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0131075', 'abnormally increased number of mucus secreting cell', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(25613, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0100034', 'abnormal blastomere V1.1', 0.4482758620689655, 3.6715585125471644, 1.2829150624062098, 'UPHENO:0086172', 'abnormal cell'),
(25614, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0131130', 'abnormally increased number of myelin accumulating cell', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(25615, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0142056', 'abnormal main body axis', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(25616, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0100501', 'abnormal urogenital system', 0.4583333333333333, 1.8210412618256888, 0.9135884804823818, 'HP:0000118', 'Phenotypic abnormality'),
(25617, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0131675', 'abnormal spindle microtubule', 0.5652173913043478, 3.6715585125471644, 1.440565418328227, 'UPHENO:0086172', 'abnormal cell'),
(25618, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0101504', 'abnormal blastomere D2.2.1', 0.4482758620689655, 3.6715585125471644, 1.2829150624062098, 'UPHENO:0086172', 'abnormal cell'),
(25619, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0101297', 'abnormal barrier cell', 0.6190476190476191, 3.6715585125471644, 1.5076039119696991, 'UPHENO:0086172', 'abnormal cell'),
(25620, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0107312', 'abnormal filopodium', 0.5909090909090909, 3.6715585125471644, 1.4729417174039097, 'UPHENO:0086172', 'abnormal cell'),
(25621, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0127703', 'abnormally localised morula cell', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(25622, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0142065', 'abnormally decreased number of desmosome', 0.4482758620689655, 3.6715585125471644, 1.2829150624062098, 'UPHENO:0086172', 'abnormal cell'),
(25623, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0100531', 'abnormal proliferative region', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(25624, 'HP:0031552', 'Reduced fibroblast surface marker level', 'XPO:0100872', 'abnormal neuroendocrine cell', 0.48148148148148145, 3.6715585125471644, 1.3295816755533123, 'UPHENO:0086172', 'abnormal cell'),
